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Whilst mechanical impact is known to be essential for cartilage maintenance, it 
has been noted that altered joint loading and increased force may lead to cartilage 
degradation and increase the risk for the development of osteoarthritis (OA). This 
study investigated the cellular responses of chondrocytes to mechanical impact, 
and the effects of possible chondroprotective agents for OA preventative 
strategies in individuals exposed to high impact, repetitive loading. Single-impact 
mechanical trauma (force 1.14 N, pressure 6.47 KPa) was determined to induce 
biphasic decrease in cell volume to 647.38±60.38 µm3 at 2 h and 516.52±38.86 
µm3 at 48 h, the initial phase of which was observed to be an active 
mechanotransduction mechanism, termed Impact-Induced Volume Decrease 
(IIVD), and the subsequent phase to be Apoptotic Volume Decrease (AVD). The 
newly defined IIVD was concluded to be dependent upon the PKC/PLCβ3 
pathway, and possibly mediated by intracellular Ca2+ store release and Volume 
Sensitive Organic Anion Channel (VSOAC) activity. Furthermore, mechanical 
impact was observed to induce a rapid decrease in F-actin from 1.19±0.13 MU to 
0.87±0.02 MU, termed Impact-Induced Actin Decrease (IIAD) and associated with 
the biphasic rise in cell death at rates of 2.75±0.41 %.h-1 and 0.66±0.03 %.h-1. 
Both in vivo exercise and in vitro mechanical load induced a release IL-1β 
(20.67±2.58 % and 5.86±0.21 AU), MCP-1 (25.69±0.53 % and 1.45±0.01 AU) and 
IL-10 (8.97±2.40 % and 5.55±0.28 AU), with in vivo concentrations correlating with 
joint magnitude and strike patterns. Decreased levels of IL-1β and MCP-1 (to 
9.60±2.34 % and 9.01±2.34 %, respectively) observed in the evening were further 
confirmed using a hyperosmotic-treated in vitro model of prolonged static-loaded 
cartilage with evidence for a IL-1β-dominated paracrine loop between articular 
cartilage and mononuclear phagocytes. In vitro, chondroprotective and anti-
inflammatory actions of chondroitin sulphate, glucosamine sulphate, REV 5901 
and Tamoxifen were associated with a reduction in pre-impact cell volume 
(average of 31.91±4.19 %) and increased pre-impact actin levels (average of 
39.92±9.29 %). Anti-inflammatory agents, curcumin and dexamethasone exhibited 
less effective chondroprotective actions, via inhibition of IL-1β (average of 
83.45±1.30 %) and thus apoptosis. To conclude, high impact exercise is 
recommended with a place for chondroprotective properties of chondroitin, 


























The participation in sports and exercise are both generally acknowledged to 
benefit both the individual and society, in terms of physical & mental health, 
and socioeconomic status (Saxon et al., 1999). However, the safety of 
sporting/exercise activity from a musculoskeletal stand-point with respect to 
osteoarthritis (OA) is less well researched. It is hypothesised that 
continuous stress placed on the joints by long-term and prolonged exercise 
training may result in microtrauma and degeneration (Moskowitz, 1984), as 
observed in the development of overuse injury (Gosling et al., 2007) and, 
subsequently, in increased risk or hastened onset of OA (Saxon et al., 
1999, Bush and Hall, 2001b, Bush et al., 2005).  
1.1 Cartilage and Chondrocytes 
Articular cartilage (mainly hyaline cartilage) is found on the articular 
surfaces of long bones in diarthrodial joints (Darling et al., 2006). It is a 
dense connective tissue that results in a low friction surface for smooth joint 
articulation as well as a framework for bone deposition during skeletal 
growth (Stockwell, 1978, Gray, 2000). Articular cartilage has a high tensile 
strength and is resistant to pressure, thus providing effective protection 
against joint pressures as a result of articulation (Darling et al., 2006, Gray, 
2000, Matthews et al., 1977). To support this, articular cartilage is aneural, 
avascular and alymphatic as these structures would be damaged during 
joint use (Stockwell, 1979).  
1.1.1 Structure of Cartilage 
Articular cartilage comprises of an extracellular matrix (ECM), which is 
synthesised and maintained in a constant state of turnover by the single 
resident cell type, the chondrocyte (Byers et al., 1977, Darling et al., 2006, 
Hall, 1998). The ECM is adapted to the changing environmental pressures 
by the balance of catabolism and anabolism of the macromolecule 
constituents (Archer, 2003, Lin, 2006, Urban, 1994). 
 
The principle constituents of articular cartilage ECM are collagen and 
proteoglycan (PG). Collagen II (col2) is the most abundant form of collagen 
in healthy articular tissue, comprising ≥ 90 % of the collagen present in 
mature cartilage (Eyre, 1987) and two thirds of the dry weight of the tissue 




which form hetropolymer complexes with other cartilage specific collagens, 
namely collagen IX and XI (Goldring, 2000, Mayne, 1993, Poole, 1997). 
Zonal changes in fibrillation pattern provide the tissue with tensile strength 
and the ability to resist tension (Hall et al., 1996a, Goldring, 2000). 
 
PGs are negatively charged molecules, which are responsible for providing 
articular cartilage with the ability to resist tension (Hall et al., 1996a, Urban, 
1994) by attracting cations and osmotically obliged water. Consequently, 
this induces swelling of the PGs and increased tension within the collagen 
network where they reside, whereby the collagen mesh resists the swelling. 
Maintained at a steady state, this allows the tissue to resist compression 
(Heinegård and Oldberg, 1989, Hall et al., 1996a). A core protein of 
aggrecan and glucosaminoglycan side chains, primarily chondroitin 
sulphate and keratan sulphate, comprise the PGs present in articular 
cartilage, which subsequently interlinks with a backbone of polymeric 
hyaluronic acid (Hardingham, 1992, Goldring, 2000). Hyaluronic acid itself 
is bound to clusters of differentiation 44 (CD 44) on the cell membrane 
(Urban, 1994) (Fig. 1.1). An interesting polymorphism of the CS1 domain 
on the aggrecan gene results in differing concentrations of chondroitin 
sulphate found in cartilage (Roughley, 2001, Doege et al., 1997). 
Decreased levels of chondroitin sulphate have been noted to be associated 
with both increasing age and degenerative joint disease (Anderson, 1959, 
Matthews, 1952, Matthews, 1953)and thus implicated in increased risk of 
cartilage degeneration due to impaired aggrecan function (Doege et al., 
1997, Roughley, 2001).  
 
The polyanionic nature of the PGs trapped within the collagen network 
creates an unusual ionic environment whereby increased cations and 
decreased anions are present within the interstitial fluid arising from the 
Donnan effect (Hall et al., 1996a, Maroudas et al., 1980). The Donnan 
effect describes the uneven distribution of charged ions as a result of 
impermeable or immobilised charged molecules, in this instance PGs 
(Nguyen and Kurtz, 2004). The elevated cation concentration and 
associated decreased anion concentration results in a raised osmotic 




(Maroudas and Bannon, 1981, Urban, 1994, Urban et al., 1993), resulting in 
osmosis and tissue swelling, subsequently resisted by the collagen 
network. Thus, a hydrostatic pressure of 0.2 MPa is observed at rest 
(Maroudas and Bannon, 1981, Urban, 1994). Upon joint loading, fluid is 
expelled from cartilage, inducing an increased concentration of PGs and 
thus an increased osmotic pressure, a consequence of the associated 
elevation in cation concentration and decrease in anion concentration (Hall 
et al., 1996a, James and Uhl, 2001). The osmotic pressure is increased 
until equilibrium with the applied load is reached, thus providing the 
cartilage with its compressive resistance. After removal of the load, the 
increased osmotic pressure induces the PGs to function hydrophilically, 
imbibing fluid back into the tissue in an action similar to that of a sponge 
soaking up water, thus preparing the cartilage for the next load (James and 
Uhl, 2001, Mow and Rosenwasser, 1988).  
 
In addition to the described structural proteins, cartilage comprises several 
other proteins involved in the regulation of the ECM, including fibronectin 
and anchorin (Goldring and Marcu, 2009), whereby fibronectin, a dimeric 
glycoprotein, regulates cellular adhesion and differentiation (Ruoslahti, 
1988), and anchorin, a member of the annexin family, is a collagen binding 







Figure 1.1:  Schematic diagram of the structure of the extracellular matrix (ECM) 
The main components of the ECM are collagen II (col2) fibres and proteoglycans (PGs). 
PGs branch from a spine of hyaluronan that extends from the chondrocyte surface. 
Negatively charged glucosaminglycan side branches of the PGs attract cations, resulting in 
osmotic pressure. Col2 fibres form a mesh frame work, interlinking with collagen IX fibres, 





1.1.2 Matrix Regulation and Metabolism 
The matrix of articular cartilage displays slow turnover and remodelling to 
maintain a healthy tissue (Aigner et al., 2006). Mechanical stress imposed 
on the joints induces damage to the ECM, which is compensated for by the 
turnover of ECM components, predominantly damaged PGs (Aigner et al., 
2006). Within healthy cartilage, an equal balance between the anabolism 
and catabolism of ECM is evident, however disruption of this careful 
balance by tipping the impetus to catabolism results in ECM degeneration 
(Aigner et al., 2006).  
 
Catabolism of the ECM is driven by a variety of proteinases, including 
matrix metalloproteinases (MMPs) and ADAMTS (A Disintegrin And 
Metalloproteinase with Thrombospondin Motifs). MMPs cleave ECM 
components, in addition to other proteinases, cell surface receptors and 
cell-cell adhesion molecules (Sternlicht and Werb, 2001), and are 
traditionally grouped according to the substrate they cleave (Nagase and 
Woessner, 1999). MMP-3 and MMP-10 (stromelysin-1 and -2 respectively) 
have a broad substrate specificity, but are noted to cleave PGs and 
fibronectin, similarly to ADAMTS, also termed aggrecanases, which 
additionally cleave PGs (Nagase and Woessner, 1999, Caterson et al., 
2000).  MMP-1, MMP-8 and MMP-13 cleave collagens, thus often referred 
to as collagenase-1, -2 and -3 respectively, though the specificity of 
collagen type differs, with MMP-13 cleaving col2 and MMP-1 and -8 
cleaving collagen III and I respectively (Knauper et al., 1996, Cawston and 
Young, 2010). MMP-2 and -9, referred to as gelatinases, cleave denatured 
collagenases in addition to collagen IV, collagen V and elastin (Aimes and 
Quigley, 1995). Unsurprisingly, given the ECM degradation present in 
arthritic diseases, MMPs and ADAMTS are noted to be present in 
increased concentrations in the synovial of both rheumatoid and 
ostoarthritic patients (Cawston and Young, 2010, Hembry et al., 1995, 
Tetlow et al., 2001, Yoshihara et al., 2000). MMPs and ADAMTS are 
regulated somewhat by the endogenous production of tissue inhibitors of 
metalloproteinases (TIMPs), whereby TIMPs bind 1:1 with MMPs to control 
ECM breakdown, and inhibit ADAMTS activity (Brew et al., 2000, Cawston, 




1.1.3  The Chondrocyte 
The single resident cell type within articular cartilage is the chondrocyte. 
This terminally differentiated cell (Goldring, 2000) exists at a density of 
10,000 chondrocytes/µm3 in the human femoral head (Stockwell, 1971) and 
comprises 1-5 % of cartilage tissue volume (Stockwell, 1979). 
Chondrocytes sense and respond to loading to produce ECM of the 
required durability via a yet to be fully-elucidated combination of signalling 
(Hall et al., 1996a, Ramage et al., 2009) resulting in the synthesis and 
breakdown of the ECM (Stockwell, 1978). The avascular nature of cartilage 
ensures chondrocytes operate at low oxygen levels and rely on diffusion 
from the articular surface for nutrients (Rajpurohit, 1996). 
 
Chondrocytes arrangement within articular cartilage is not homogenous, 
when observed in cross-section (Fig. 1.2), articular cartilage is revealed to 
be comprised of a zonal organisation featuring 4 distinct zones; superficial 
zone (SZ), middle zone (MZ), deep zone (DZ) and calcified zone 
(Stockwell, 1991). The SZ, which comprises 10-20 % of the full depth (Kim 
et al., 1994), has characteristically ellipsoid chondrocytes, arranged parallel 
to the synovial surface of an approximate volume of 454±18 µm3 (Bush and 
Hall, 2001b) which are densely packed in surrounding collagen fibres 
(Stockwell, 1991). In contrast, MZ chondrocytes are observed to be 
spherical in shape and of a slightly larger volume of 553±15 µm3 (Bush and 
Hall, 2001b). MZ chondrocytes are often arranged in pairs and are 
embedded in a random distribution in a “basket-weave” of collagen fibres 
(Table 1.1). In the DZ, ellipsoid chondrocytes of 805±79 µm3 (Bush and 
Hall, 2001b) are arranged in columns distributed between radially 
orientated collagen fibres which extend from the calcified zone (Darling et 










Figure 1.2: Representative zonal image of bovine articular cartilage 
Full-depth cartilage explants were dissected aseptically from bovine metacarpal and 
metatarsal pharyngeal joints and loaded with 5 µM calcein-AM (green) and 1 µM propidium 
iodide (red). Explants were visualised using confocal laser scanning microscopy. 
Superficial Zone chondrocytes are aligned parallel to the articular surface, Mid Zone 
chondrocytes are found in pairs and Deep Zone chondrocytes in columnar stacks, 
perpendicular to the articular surface. Image acquired by Dr Mark J. P. Kerrigan-Holt, 















Volume (µm3) Collagen Orientation 
SZ Single, ellipsoid 454±18 
Tight fibrils, aligned 
with shear stress 
MZ 









Table 1.1: Summary of the characteristics of zonal articular cartilage 
Chondrocytes possess differing properties dependent on the Zone. Superficial Zone (SZ) 
chondrocytes are ellipsoid in morphology and embedded in tangentially arranged collagen 
fibres, whereas Mid Zone (MZ) chondrocytes have a more spherical morphology, a larger 
volume and found in pairs within a ‘basketweave’ structure of collagen fibres. Deep Zone 
(DZ) chondrocytes possess a larger still volume and are arranged in columns within 
collagen fibres which extend perpendicularly to the articular surface (Bush and Hall, 




1.2 Osteoarthritis.  
Osteoarthritis (OA), is the most common form of arthritis (Felson and 
Zhang, 1998, Silman, 2008), affecting 10-20% of the UK population over 
the age of 65 with ~8 million sufferers in the UK (ARC, 2008). It is 
associated with defective articular cartilage, changes in the regulation of 
matrix synthesis, increased hydration, changes in chondrocyte morphology 
and changes to the underlying bone and joint margins (Buckwalter, 1996, 
Panush and Lane, 1994). These changes result in a loss of protection at 
the synovial joint interface during the process of joint articulation and 
movement. The symptoms of OA include intense joint pain, decreased 
mobility and a decreased ‘Quality of Life’ (Dunlop et al., 2005, Hennessy et 
al., 1994). OA accounts for more dependency in walking, stair climbing and 
other lower extremity tasks than any other disease and more than three 
times that of rheumatoid arthritis (Guccione et al., 1994). Economically, 
OA’s costs are a cause for increasing concern such that in the UK alone, 
the cost is an estimated £5.7 billion annually (mostly due to work loss and 
disability claims)  (ARC, 2008). Therefore research into the events which 
initiate and progress OA are of major interest to public health (Fernandes et 
al., 2002). 
 
OA is acknowledged to involve multiple etiolgies, including biomechanical, 
biochemical and genetic factors contributing to the development of OA by 
disrupting chondrocyte-ECM associations and metabolic processes 
(Goldring, 2000, Poole, 1997, Radin et al., 1991). Whilst biomechanical 
stresses are observed to be significant in OA development, with continual 
mechanical wear a prevalent theory behind OA, ageing is traditionally 
considered as the major risk factor (Fig. 1.3). Aged cartilage is 
characterised by a decrease in PGs, both in size and in concentration, and 
an increase in collagen cross-linking, which induce a decreased water 
content and increased stiffness respectively (Verzijl et al., 2003). 
Additionally, a decrease in the anabolic activity of chondrocytes in aged 
cartilage is observed (Loeser, 2004). It is thought that loss of viable 
chondrocytes due to apoptosis and programmed cell death renders aging 




(Horton et al., 2006, Loeser, 2008). Abnormal loading leading to 
mechanical trauma has been observed to increase risk of OA development 
(Buckwalter, 2004, Lotz, 2010) with the risk further increasing with age 
upon mechanical trauma and time post trauma (Gelber et al., 2000, Lotz, 
2010, Roos et al., 1995). Cartilage damage resultant from trauma is 
irreversible, and thus is likely to be a major determinant in later OA 
development (Lotz, 2010). Mechanical trauma is observed to initiate 
localised necrosis and structural tissue damage (Otsuki et al., 2008) and 
further cell death subsequently spreads throughout the tissue (Quinn et al., 
1998, D'Lima et al., 2001a). Additionally, increased IL-1 is observed post 
mechanical trauma. IL-1 is noted to have catabolic effects on the ECM, 
whereby it induces an increase in proteinases, including MMP-1, -3, -13 
and ADAMTS-4 (Bau et al., 2002, Mengshol et al., 2000), and stimulates 
the release of additional cytokines with which IL-1 acts synergistically to 
promote ECM catabolism (Bender et al., 1990, Geng et al., 1996). IL-1 is 
additionally associated with a decrease in aggrecan and col2 expression 
(Goldring et al., 1988, Lefebvre et al., 1990), thus IL-1 promotes ECM 
catabolism whilst reducing anabolism, driving ECM degradation. Cell death, 
ECM degradation and increased IL-1 are all noted features of OA tissue 
(Kuhn et al., 2004, Lotz, 2010).  
 
In OA tissue, there is a transient proliferative response in chondrocytes and 
increased synthesis of ECM initially, as an attempt at tissue repair 
(Goldring, 2000). Further to this, there is observed a local loss of PGs and 
cleavage of col2 at the surface of the affected tissue which leads to 
increased fluid and thus a decreased tensile strength (Goldring, 2000, 
Horton et al., 2006). The damaged ECM results in the production of matrix 
protein fragments (including, but not limited to, collagen and fibronectin) 
which stimulate the chondrocyte to produce inflammatory mediators and 
proteolytic enzymes including matrix metalloproteinases (MMPs) (Table 







Figure 1.3: Model of the role of mechanical stress in the pathogenesis of OA 
Tissue damage resultant from mechanical stress induces decreased proteoglycans (PGs), 
collagen II (col2) and matrix fragments. Increased fluid into the tissue due to the loss of 
PGs induces cell swelling. Additionally, matrix metalloproteinases (MMPs) production is 
increased as a result of the mechanical stress and the matrix fragments, resulting in further 
extracellular matrix (ECM) degradation. IL-1 is released by the chondrocytes in response 
to the matrix degradation and mechanical stress, further stimulating matrix degradation 














↑(early OA) ↓ (late OA) Collagen II and aggrecan synthesis  
↑ Cell proliferation 
↑ Catabolic cytokine production 
↑ Proteinases (MMPs, aggrecanase, cathepsins) 
↑ IL-1 receptor type I 
↑ Apoptosis 
↑ Collagen IIA, III, VI and X expression 
↓ IL-1 receptor antagonist 
 
Table 1.2: Characteristic functions of osteoarthritic articular chondrocytes 
The initial stages of osteoarthritis (early OA) are characterised by an increase of collagen II 
and aggrecan synthesis as an early attempt at tissue repair. Subsequent to this, (late OA), 
both collagen II and aggrecan synthesis are reduced. Additionally, an increase is observed 
in cell proliferation, cytokine production, proteinases, cell death by apoptosis, and the 
expression of other collagens, including IIA, III, VI and X, and IL-1 receptors. Conversely, 
IL-1 receptor antagonist production is decreased (Goldring, 2000, Goldring and Marcu, 




1.3 Cytoskeletal Organisation 
The chondrocyte cytoskeleton is a 3D, dynamic intracellular network 
comprising of vimentin, tubulin and actin. Vimentin exists within the 
chondrocyte as a highly organised fibrous protein filaments, observed to be 
interspersed within the cytoplasm, connecting the periphery of the cell to 
the nucleus (Fioravanti et al., 2003, Trickey et al., 2004). Whilst the exact 
function of vimentin is yet to be uncovered, they are thought to play a role in 
mechanical signal transduction, and maintaining cell mechanical integrity 
(Lazarides, 1980, Traub, 1995, Trickey et al., 2004, Wang et al., 1993). 
Vimentin filaments are increased within load bearing regions (Eggli et al., 
1988) and whilst static load is observed to increase filament organisation, 
dynamic, cyclic load decreases vimentin mRNA expression (Durrant et al., 
1999, Lahiji et al., 2004). Additionally, vimentin is noted to be decreased 
within OA chondrocytes (Lambrecht et al., 2008). Tubulin exists as dimeric 
proteins which self-assemble to form polymeric microtubules (Valiron et al., 
2001). Within the chondrocyte, they have a loose, ‘basket-mesh’ uniform 
distribution (Fioravanti et al., 2003, Jortikka et al., 2000, Langelier et al., 
2000, Trickey et al., 2004), and although are not thought to be essential to 
cell mechanical integrity (Trickey et al., 2004), they are noted to have 
crucial involvement within PG and collagen synthesis, whereby disruption of 
microtubules with colchicine inhibited PG and collagen synthesis and 
secretion (Jansen and Bornstein, 1974, Lohmander et al., 1976). Loading 
has no noted effects on tubulin distribution or concentration, however 
tubulin microtubules are observed to be absent in human OA chondrocytes 
(Fioravanti et al., 2003).  
 
The actin cytoskeleton provides mechanical support and is involved in a 
vast number of cellular functions. Actin, the most abundant protein in 
eukaryotic  cells (Disanza et al., 2005), is a 43 kDa globular protein 
monomer (termed G-actin) which forms highly organised polymer filaments 
(termed F-actin; Fig. 1.4). Polymerisation of actin has been observed to be 
both ATP and Mg2+/Ca2+ dependent (Cooper and Schafer, 2000, Ono, 
2007) and regulated by a collection of proteins, including nucleation 




depolymerising proteins ADF and Cofilin (Ono, 2007), G-actin sequestering 
protein Thymosin β4 (Yarmola and Bubb, 2004) and capping protein 
Gelsolin (Yarmola and Bubb, 2004).  
 
Actin is observed to have a role in a variety of cellular functions, including 
cell migration (Heath and Holifield, 1991), adhesion (Turner and Burridge, 
1991), endocytosis (Riezman et al., 1996, Sontag et al., 1988), secretion 
and changes in cell shape (Sims et al., 1992). Within chondrocytes, the 
actin cytoskeleton has been noted to provide the cell with mechanical 
integrity required to withstand mechanical loading (Guilak, 1995). When 
treated with Cytochalasin D, a fungal metabolite known to inhibit actin 
polymerisation (Schliwa, 1982), chondrocyte stiffness was observed to be 
decreased by 90 %, and, conversely, viscosity to be increased by 80 % 
(Trickey et al., 2004). Additionally, Cytochalasin D treatment decreased 
ECM synthesis and chondrocyte anchorage to extracellular PGs (Nofal and 
Knudson, 2002).  
 
F-actin is observed to be distributed cortically in in situ chondrocytes, 
predominantly localised to the periphery of the cell (Fig. 1.5; (Durrant et al., 
1999, Langelier et al., 2000). The organisation of the F-actin filaments is 
known to be influenced by the osmotic environment, mechanical loading 
and inflammation, all of which are linked to OA. Subsequently, 
chondrocytes from OA tissue are noted to display an adjusted distribution of 
F-actin, with filaments less defined and locally diffused in the cytoplasm 
(Table 1.3). Similar to OA, in which cell swelling is observed, hypo-osmotic 
conditions have been observed to result in a decrease in F-actin, 
conversely, hyperosmotic conditions induce an increase (Guilak et al., 
2002). Mechanical pressure has been observed to result in F-actin 
remodelling (Knight et al., 2006) in a load dependent fashion, with 
hydrostatic pressure of 15 MPa inducing a decrease in F-actin filaments, 
and 30 MPa inducing a near total disappearance of F-actin (Parkkinen et 
al., 1995). The distribution of F-actin is additionally observed to be affected 
by mechanical load, with a more interspersed organisation noted (Knight et 
al., 2006). Furthermore, mechanical loading induced a 20 fold transient 




in addition to an increase in Cofilin (Blain, 2009). Finally, IL-1β has been 
shown to disrupt F-actin in astrocytes (Liu et al., 1994) and regulate 
cytoskeletal genes (Joos et al., 2008), thus it is suggested inflammatory 









Figure 1.4: Schematic representation of the structure of cytoskeletal actin  
Actin exists within the chondrocyte as globular monomeric proteins, termed G-actin (A). G-
actin polymerises in an ATP and Mg2+/Ca2+ dependent manner to form highly organised 
filaments termed F-actin (B; (Blain, 2009, Cooper and Schafer, 2000, Disanza et al., 2005, 















Figure 1.5: Actin organisation in in situ articular chondrocytes 
Full-depth cartilage explants were dissected aseptically from bovine metacarpal and 
metatarsal pharyngeal joints. Explants were fixed using 4 % paraformaldehyde, 
permeabilsed using Triton x100 and subsequently labelled with 5 µl/ml Alexa-488 
Phalloidin. Explants were visualised using confocal laser scanning microscopy. Actin was 
observed to be distributed cortically and predominantly localised to the periphery of the cell 










Chondrocyte Organisation of F-actin Reference 
Healthy in situ 
Cortical distribution, 
predominantly localised to 
the periphery. 
(Blain et al., 2006, Langelier 
et al., 2000, Trickey et al., 
2004, Fioravanti et al., 
2003) 
Mechanical loading 
Load dependent, reversible 
loss of actin fibres. 
More interspersed 
arrangement. 
(Blain et al., 2006, Knight et 
al., 2006, Langelier et al., 
2000, Parkkinen et al., 
1995, Trickey et al., 2004) 
Osmotic stress 
Hyperosmotic induces 
increased actin fibres, hypo-
osmotic induces decreased 
actin fibres. 
(Chao et al., 2006, Erickson, 
2003) 
OA 
Less defined and localised 
diffusely in the cytoplasm. 
(Fioravanti et al., 2003) 
 
Table 1.3: The organisation of actin in healthy, osteoarthritic and stressed articular 
chondrocytes 
In healthy chondrocytes, actin is distributed cortically and peripherally localised. Upon 
mechanical loading, a decrease in actin fibres is induced in a load dependent manner. 
Similarly, increased osmotic pressure reduces actin fibres, whereas in contrast, decreased 
osmotic pressure decreases actin. In osteoarthritic tissue (OA) actin is less defined and 




1.4  Mechanical Loading 
Mechanical load is essential for cartilage regulation, providing the 
necessary signalling for the production of an ECM of sufficient durability to 
withstand the stress level (Helminen, 1987). However, it has been noted 
that abnormal loading can lead to cartilage degradation, increasing the risk 
for the development of OA (Griffin and Guilak, 2005). Previous work has 
concluded that factors such as obesity and increased body mass have a 
link to an increased incidence of OA (Felson et al., 1988). This is thought to 
be a result of the increased force to the joint leading to a loss of 
chondrocyte function and thinning of the articular cartilage (Oliveria et al., 
1999).  
 
1.4.1 Mechanical Load and Cartilage Viability 
Abnormal joint loading can lead to an imbalance in cartilage metabolism 
and thus cartilage deterioration. Excessive loading activates IL-1β 
pathways, promoting synthesis of catabolic proteases as well as inhibiting 
ECM synthesis. High impact mechanical loading results in tissue swelling, 
indicative of damage to the collagen network, and chondrocyte death by 
apoptosis and necrosis (Tew et al., 2000). This decreased chondrocyte 
viability, another feature of OA, places an increased metabolic burden on 
the remaining cells.  
 
Chondrocyte cytoskeletal elements are components of mechanical 
signalling, whereby actin converts the mechanical stimuli to a biochemical 
response and vimentin is increased in areas of greatest weight bearing 
(Blain, 2009). Abnormal loading causes an increase in actin disassembly 
proteins, such as thymosin β4, resulting in remodelling of the actin skeleton 
from a uniform cortical distribution to a more intermittent organisation as 
well as a loss of actin stress fibres (Blain, 2009). In addition mechanical 
load injury causes the collapse of the vimentin network around the nuclei of 






1.4.2 Static Loading and Cartilage Integrity 
It is known that static loading compresses articular cartilage, leading to the 
expulsion of water from the ECM and thus raising the extracellular 
osmolarity of the tissue and consequently decreasing chondrocyte cell 
volume. Previous studies have linked matrix metabolism to cell volume and 
extracellular osmolarity. Both decreased osmolarity (resulting in cell 
swelling) and increased osmolarity (resulting in cell shrinkage), a result of 
prolonged static loading, significantly reduce matrix synthesis 
(Schneiderman et al., 1986, Urban et al., 1993). Whilst swollen cartilage (as 
characteristic of the early stages of OA) results in increased cartilage 
deformation when subjected to abnormal loading (Bush and Hall, 2001a), it 
is currently unknown what effect cartilage with a higher extracellular 
osmolarity (resulting from prolonged static loading that occurs over the 
course of a day) will have on cartilage integrity when subjected to similar 





Chondrocytes, as previously described, are constantly subjected to varying 
mechanical stimuli to which they possess the vital ability to ‘sense’ and  
convert to chemical and physical responses; a process termed 
mechanotransduction. Thus, chondrocytes can ‘respond’ to the constant 
changes in their extracellular environment to adapt and maintain optimal 
intracellular environment and adapt the ECM to withstand the external 
pressures. Joint articulation is commonly the cause of such changes to the 
extracellular environment, inducing stimuli that result in a 
mechanotransduction response including fluid flow (Yellowley et al., 1997), 
osmotic changes (Hall, 1998), membrane deformation (Roberts et al., 2001) 
and changes in pressure (Roberts et al., 2001). In Vitro compression of 
cartilage has additionally been observed to induce these 
mechanotransduction stimuli (Hall et al., 1999, Hall et al., 1996a, Maroudas 
et al., 1980).  
 
Pressure is applied to articular cartilage almost constantly, with pressure 
when walking oscillating between 0.2 and 4 - 5 MPa in the hip joint (Hodge 
et al., 1986). Pressure has been observed to induce deformation of 
chondrocytes (Broom and Myers, 1980), loss of interstitial fluid and 
concentration of PGs (Maroudas and Bannon, 1981, Urban, 1994), and 
thus increase tissue osmolarity. However, when the pressure is removed 
(for example during period of unloading – e.g. supine sleep), these changes 
can be reversed to resting equilibrium in healthy tissue (Maroudas and 
Bannon, 1981, Urban, 1994). Importantly, pressure induces an increase in 
aggrecan, col2 and matrix metalloproteinase 3 (MMP-3), thus influencing 
ECM metabolism, likely to generate a matrix of sufficient durability to 





1.5.1 The Role of Calcium Signalling in Mechanotransduction 
Calcium signalling is thought to play a role in mechanotransduction, with 
changes in [Ca2+]i linked to fluid flow (Yellowley et al., 1999, Yellowley et 
al., 1997), osmotic changes (Hopewell and Urban, 2003, Kerrigan et al., 
2006, Urban et al., 1993, Yellowley et al., 1999, Yellowley et al., 1997), 
membrane deformation (Guilak et al., 1999b) and pressure (Guilak et al., 
1999a). Fluid flow has been observed to induce both an influx of Ca2+ into 
the cell via stretch-activated cation channel (SACC) activation, and release 
of Ca2+ from intracellular stores (Yellowley et al., 1999, Yellowley et al., 
1997). Conversely, membrane deformation, when induced by in vivo fluid 
flow and in vitro mechanical load, gave rise to an increase in [Ca2+]i 
determined to be intracellular store independent, but which was inhibited by 
both SACC and Sodium Calcium Exchanger (NCX) pharmacological 
inhibitors (Guilak et al., 1999b). Osmotic changes induced a similar 
increase in [Ca2+]i (Hopewell and Urban, 2003, Urban et al., 1993), 
observed to be SACC mediated when induced by hypo-osmotic challenge 
(Kerrigan and Hall, 2007), as confirmed by inhibition in response to 
gadolinium (Gd3+; a SACC inhibitor), and NCX mediated when induced by 
hyperosmotic challenge (Sánchez and Wilkins, 2004). Additionally, hypo-
osmotic challenge induced [Ca2+]i was observed to involve release from the 














Stimuli [Ca2+]i  changes Mediated by: 
Fluid Flow ↑ Intracellular store release and SACC 
Membrane 
Deformation 
↑ SACC and NCX 
Hypo-osmotic 
Challenge 





Table 1.4: Changes in [Ca2+]i in mechanotransduction 
Mechanotransduction stimuli induce an increase in [Ca2+]i mediated by intracellular store 
release, stretch-activated calcium channels (SACC) or sodium calcium exchanger 




1.5.2 Chondrocyte Volume Regulation 
Joint-loading induces chondrocyte mechanotransduction responses and 
cell volume changes, as detailed previously. These responses, 
consequently, activate volume regulatory mechanisms, including 
Regulatory Volume Decrease (RVD) and Regulatory Volume Increase (RVI; 
(Kerrigan et al., 2006). RVI and RVD are mechanisms by which some cell 
types, including chondrocytes, maintain a dynamic volume equilibrium and 
ionic environment necessary for optimal physiological and metabolic 
processes (O'Neill, 1999). Restoration of cell volume following cell swelling 
or shrinkage is the resultant effect of these mechanisms within healthy 
tissue (Hoffmann et al., 2007). Whilst RVI has been observed in 2D 
cultured chondrocytes, limited RVI response to hyperosmotic challenge has 
been observed in either freshly isolated or in situ chondrocytes (Kerrigan et 
al., 2006), indicating mechanotransduction mechanisms adapt upon culture 
as a result of changing phenotype. Interestingly, in situ chondrocytes have 
been observed to have a decreased cell volume after mechanical loading, 
compared to unloaded tissue (Buschmann et al., 1996, Wilkins et al., 2000). 
The lack of RVI response in situ is not a chondrocyte specific phenomenon, 
it being attributed to adverse Cl- gradients in other cell types (Hoffmann et 
al., 1983, Wilkins et al., 2000). Thus it can be postulated that low Cl- 
concentration with the ECM are responsible for the absence of RVI in situ 
(Wilkins et al., 2000). However, despite in situ and freshly isolated 
chondrocytes not exhibiting RVI responses, treatment with Latrunculin B, 
an actin capping agent, induced a bumetanide-sensitive RVI response, and 
increased the speed of RVD in freshly isolated chondrocytes (Kerrigan et 
al., 2006). Taken together, it is suggested that actin is involved in volume 
regulation and mechanotransduction mechanisms (Grodzinsky et al., 2000, 
Guilak, 1995, Wang et al., 1993). 
 
Conversely, RVD has been observed in both freshly isolated and in situ 
chondrocytes (Bush and Hall, 2001a). It is of note that the disruption of 
RVD may have a significance in the onset of OA, as the characteristic 
decrease of PGs and thus decreased osmolarity induce cell swelling (Hall, 
1995, Wilkins et al., 2000). However, RVD mechanisms in chondrocytes 




permeable, low selectivity osmolyte channel thought to be the major 
component of RVD (Hall and Bush, 2001b, Hall et al., 1996b, Hall et al., 
1996a). Cell swelling, resultant from hypo-osmotic challenge, is observed to 
induce an efflux of K+ (Hall et al., 1996b), Cl- (Yellowley et al., 2002, 
Yellowley et al., 2000) and taurine (Hall and Bush, 2001a, Hall, 1995). In 
other cell types, including erythrocytes, this K+ and Cl- efflux is mediated by 
the K+-Cl- co-transporter (KCC; (O'Neill, 1999), however, KCC has been 
previously observed to play no role in volume sensitive K+ efflux (Hall et al., 
1996b). Within chondrocytes, taurine, K+ and Cl- efflux induced in RVD is 
inhibited by tamoxifen, an inhibitor of volume-sensitive organic osmolyte 
anion channels (VSOAC; (Hall, 1995), thus suggesting the unidentified 













Figure 1.6: Representative diagram of the theorised regulatory volume decrease 
mechanism 
Stimulation of regulatory volume decrease (RVD) by hypo-osmotic challenge induces an 
intracellular calcium ([Ca2+]i) rise, mediated by stretch-activated cation channel (SACC), 
unknown Ca2+ channel and release from intracellular Ca2+ stores. Potassium (K+) and 
chloride (Cl-) in addition to taurine are released from the chondrocyte during RVD by a 
tamoxifen sensitive osmolyte channel, similar to volume-sensitive organic osmolyte anion 
channels (Hall, 1995, Hall and Bush, 2001b, Hall et al., 1996a, Hall et al., 1996b, Kerrigan 





1.6 Mechanical Trauma and Tissue Inflammation 
Following an initial mechanical impact to the tissue surrounding the knee 
joint, polymorphonuclear granulocytes (PMN’s) followed by monocytes 
which differentiate into macrophages, will traffic to the site of insult 
(Cassatella, 1995). Mast cells and macrophages present within tissue 
degranulate following impact resulting in an “inflammatory milieu” 
comprising of mediators including cytokines/chemokines (e.g. Interleukin 
(IL-) 1β, 6 and 8). These mediators have the ability to influence the 
biological activities of responsive cells, leading to an up-regulation of 
adhesion molecules on the endothelium (e.g. ICAM 1) and also to L-
selectin (CD62L) shedding (from PMN cell surface) thus initiating the 
“rolling”, adhesion and subsequent emigration of leukocytes into tissue 
(Walzog and Gaehtgens, 2000, Lawrence and Gilroy, 2007). Following the 
release of these cytokines, the infiltrating leukocytes (PMN’s) are no longer 
required and if left unchecked will lead to tissue damage due to the release 
of an array of toxic mediators designed to combat infection, such as 
hydrolytic and proteolytic enzymes and ROS. The removal of these PMNs 
is termed the “Resolution of Inflammation”. Soon after infiltrating the tissue, 
the PMNs promote the production of lipoxins which initiate the resolution 
phase (Serhan et al., 2007). The cells undergo apoptosis, induced by the 
synthesis of resolvins and protectins, and express surface molecules which 
result in the release of anti-inflammatory “pro-resolving” cytokines including 
IL-10 from macrophages (Lawrence and Gilroy, 2007). The PMNs are 
subsequently phagocytosed by macrophages (Serhan et al., 2007). 
1.6.1 The Link Between Mechanical Trauma, the Inflammatory 
Response and Cartilage Integrity 
Cartilage metabolism is sensitive to cytokines whereby IL-1β, TNF-α and IL-
17 suppress proteoglycan synthesis, change the type of collagen produced 
and up-regulate enzymes that breakdown cartilage (Rowan and Young, 
2007, Westacott and Sharif, 1996). IL-10 and IL-13 (anti-inflammatory 
cytokines) are able to down regulate the effects of IL-1, TNFα and IL-17, 




1.7 Chondrocyte Death 
A common feature of OA is a decrease in the number of viable 
chondrocytes. Cell death occurs via several pathways, notably apoptosis 
and/or necrosis.  
 
1.7.1 Apoptosis 
Apoptotic cell death is the controlled breakdown of cells via a cell intrinsic 
mechanism, often referred to as ‘programmed cell death’ (Duprez et al., 
2009). Two main protein families are involved in apoptotic signalling 
pathways, BCl-2 proteins which are responsible for mitochondrial integrity 
(Youle and Strasser, 2008), and cysteinyl aspartate-specific proteases 
(Caspases) which moderate the execution phase of apoptosis (Fuentes-
Prior and Salvesen, 2004).  
 
Caspases have 2 sub-families; initiators (Caspase-2, -8, -9, -10) and 
executioners (Caspase-3, -6, -7). Initiator Caspases are present as inactive 
monomers which recruited and activated by oligomerisation (Salvesen and 
Riedl, 2007). Caspase-mediated apoptosis is activated by intrinsic or 
extrinsic pathways (Fig. 1.7).  
 
The intrinsic pathway is stimulated by factors such as DNA damage or 
cytotoxic insults and acts through the mitochondria. The mitochondrial 
apoptotic pathway is regulated by the BCl-2 protein family, whereby anti-
apoptotic BCl-2 proteins inhibit pro-apoptotic BCl-2 proteins (Bax and Bak) 
from mitochondrial damage (Youle and Strasser, 2008). Upon stimulation of 
the intrinsic pathway, Bax and Bak inhibition is removed leading to their 
oligomerisation and subsequent formation of channels through which 
cytochrome c (cyt c) is released (Duprez et al., 2009). Cyt c associates with 
Apaf-1 and ATP, thus recruiting and activating procaspase-9 (also known 
as apoptosome) which in turn activates caspase-3, -6 and 7 and initiates 
apoptotic death (Riedl and Salvesen, 2007).  
 
The extrinsic pathway is initiated by the stimulation of ‘death receptors’, of 




family. Stimulation of these receptors can induce proliferation and 
differentiation in addition to cell death. In order for apoptosis to be resultant, 
a death-inducing signalling complex (DISC) is formed, of which a Fas-
associated death domain (FADD) is a component. FADD recruits and 
activates Caspase-8 and/or Caspase-10 which subsequently activate the 
executioner Caspases (Peter and Krammer, 2003). Additionally, Caspase-8 
mediates the cleavage of the anti-apoptotic BCL-2 protein Bid, thus 
activating the intrinsic mitochondrial pathway (Duprez et al., 2009).  
 
An indicative feature of apoptosis is apoptotic volume decrease (AVD), 
whereby cells are observed to under-go shrinkage which facilitates the 
breakdown of the cell into smaller, apoptotic bodies, aiding their eventual 
engulfment (Bortner and Cidlowski, 2002). Whilst previously thought to be a 
passive consequence of apoptosis, AVD is know noted to play a more 
active role within the apoptotic process, regulating activity of apoptotic 
caspases (Bortner et al., 1997, Hughes et al., 1997, Dallaporta et al., 1998). 
Whilst the mechanisms of AVD are not yet elucidated, an efflux of 
potassium ions is thought to be a key feature (Yu et al., 2001, Gomez-






Figure 1.7: Schematic representation of extrinsic and intrinsic apoptotic signalling 
Stimulation of ‘death receptors’ (e.g. Fas) on the cell membrane initiates the extrinsic 
signalling pathway (1). Upon stimulation, a death-inducing signalling complex (DISC) is 
formed and nuclear factor (NF)κβ activated.  Fas-associated death domain (FADD) is a 
main DISC component which recruits and activates Caspase-8 and-10 which subsequently 
activate the executioner Caspases-3,6,7. Additionally, Caspase-8 mediates the cleavage 
of the anti-apoptotic BCL-2 protein Bid, thus activating the intrinsic mitochondrial pathway 
(2).  Intrinsic cell stress activates Bax/Bac, inducing cytochrome c (cyt c) release from the 
mitochondria. Subsequent formation of the apoptosome results in the activation of 
Caspase-9 and thus the executioner Caspases (Duprez et al., 2009, Peter and Krammer, 







Necrosis is typically thought of as ‘accidental’ and ‘uncontrolled’ cell death. 
It is characterised by cytoplasmic and organelle swelling leading to loss of 
membrane integrity and release of cell contents into the extracellular 
environment (Duprez et al., 2009).  Physical damage to the cell, for 
example as a result of mechanical insult, results in cell death via necrosis. 
However, more recent studies have demonstrated the activation of necrosis 
via TNFR activation when in the presence of Caspase inhibition, indicating 
necrosis may also be a cell-mediated form of cell death and thus termed 
necroptosis (Degterev et al., 2005). Evidence suggests this pathway to be 
mediated by receptor interacting protein (RIP)1 (Festjens et al., 2007), 
usually cleaved by Caspase-8 and subsequently suppressing necrotic 
activity and promoting apoptotic (Lin et al., 1999, Feng et al., 2007). 
Necrosis (and necroptosis) are executed by a variety of mediators, 
including reactive oxygen species (ROS), Ca2+, calpains, cathepsins, 
phospholipases and ceramide (Vanlangenakker et al., 2008).  
 
1.7.3 Chondrocyte Death and Osteoarthritis 
It is well documented that whilst apoptosis occurs in OA, both its relative 
contribution to the pathogenesis of the disease, and its cause(s) within OA 
are unclear (Aigner and Kim, 2002). Possible stimuli of current interest 
include; nitric oxide (NO), TNF-α, IL-1 and Fas receptor activation and 
mechanical stress (Fig. 1.8; (Aigner and Kim, 2002).  
 
NO has long thought to be important in the pathogenesis of OA due to the 
large amount produced by OA cartilage, thus it’s role in inducing 
chondrocyte apoptosis is unsurprising (Pelletier et al., 2001). Recently, it 
has been observed that NO-induced apoptosis is blocked by inhibitors of 
Caspase-3 and -9, implicating the mitochondrial pathway in the mechanism 
of NO-induced apoptosis (Miwa et al., 2000). Additionally, NO induces 
cyclooxygenase 2 (COX-2) expression and thus prostaglandin E2 (PGE2) 
release, as observed in human OA chondrocytes. The role of PGE2 in 
initiating apoptosis however, is currently unclear, as PGE2 stimulation has 




2000), but a separate study noted that PGE2 simply sensitised 
chondrocytes to NO-induced apoptosis in human OA tissue (Notoya et al., 
2000). It is possible the action of PGE2 in apoptosis is species or disease 
state dependent.  
 
TNF-α and IL-1 are known to be important mediators in OA, inducing the 
production of ceramide. Ceramide, has been reported to both increase 
expression of matrix metalloproteinases (MMPs; Sabatini et al., 2000) and 
induce apoptosis (Notoya et al., 2000), although it is unclear if these actions 
are concurrent or alternatives dependent on cell differentiation or activation 
as they are yet to be reported together. Whilst IL-1 stimulation alone has 
not been observed to induce apoptosis (Blanco et al., 1995), TNF-α 
stimulation has resulted in apoptosis in chick embryonic chondrocytes 
(Aizawa et al., 2001), but conversely, no apoptosis was induced in human 
OA chondrocytes (Kuhn and Lotz, 2001). Interestingly, combination 
stimulation of chondrocytes with TNF-α and proteasome inhibitor MG132 
initiated apoptosis in human OA chondrocytes (Aigner and Kim, 2002). As 
TNFR is known to induce NF-κβ activation, a recognised protective 
mechanism (Van Antwerp et al., 1996), and MG132 has been noted to 
inhibit this activation (Aigner and Kim, 2002), it can be hypothesised that 
NF-κβ has a role in chondrocyte survival.  
 
Fas receptors have been reported in chondrocytes, thus suggesting a role 
for Fas-mediated apoptosis, however the observation of this mechanism in 
chondrocytes is controversial (Hashimoto et al., 1998, Lisignoli et al., 2001, 
Masuko-Hongo et al., 2000). Fas receptor agonists have not been seen to 
induce apoptosis (Lai et al., 2001), however it has been noted that they 
induce DNA fragmentation, an indicator of apoptosis (Aigner and Kim, 
2002). Again, co-stimulation with MG132 resulted in apoptotic death being 
observed, further supporting the importance of NF-κβ in chondrocyte 
protection (Aigner and Kim, 2002).  
 
It is acknowledged that cell attachment is required for cell function and 
survival in most cell types, ECM degradation and alterations, such as 




disturbance (Poole et al., 1991, Hambach et al., 1998). Mechanical stress is 
known to induce apoptosis from pressures as low as 4.5 MPa (Loening et 
al., 2000), which has been reported as caspase dependent apoptosis 
(D'Lima et al., 2001b). It is not yet clear whether apoptosis precedes ECM 
destruction post mechanical stress, or if apoptosis and ECM degradation 
act as a destructive cycle. Additionally, mechanical stress has been 
observed to induce biphasic chondrocyte death, thought to be by both 
necrosis and apoptosis in bovine samples (Tew et al., 2000). Apoptosis has 
been reported to increase by 30 % by 96 h post mechanical load, though no 
significant apoptosis was noted in the first 6 h, suggesting initial 
chondrocyte death induced by mechanical load to be necrotic (D'Lima et 







Figure 1.8: Schematic diagram of the factors leading to chondrocyte apoptosis in 
osteoarthritis 
Inflammatory mediators such as nitric oxide (NO), tumor necrosis factor (TNF) α, ceramide 
and IL-1 are noted to induce chondrocyte apoptosis via the mitochondrial pathway, in 
addition to inducing extracellular matrix (ECM) degradation. Resultant disturbance of the 
ECM is additionally observed to induce apoptosis. The presence of Fas receptor in 
chondrocytes indicates a role for Fas-mediated apoptosis and mechanical trauma is known 
to induce load dependent apoptosis. The role of age in osteoarthritic chondrocyte 
apoptosis is not yet elucidated (Aigner and Kim, 2002, Aizawa et al., 2001, Blanco et al., 
1995, D'Lima et al., 2001a, Hashimoto et al., 1998, Kuhn and Lotz, 2001, Lai et al., 2001, 




1.7.4 Chondrocyte Senescence and Osteoarthritis 
Another theory for the loss of chondrocyte viability in OA is that of 
senescence. Cell senescence classically refers to the loss of ability of a cell 
to further divide and is associated with shortened telomeres; an area of 
repetitive DNA at the end of the chromosome (Hayflick, 1984). The 
shortened telomeres result progressively from repeated cell division, thus 
cell senescence is normally seen in older cells. This type of replicative 
induced senescence is commonly termed intrinsic senescence. However, in 
post-mitotic or quiescent cells such as neurones and chondrocytes intrinsic 
senescence is unlikely, thus another form of senescence has been 
suggested. Extrinsic senescence has been found to result from a range of 
stimuli including oxidative damage and inflammation, the former of which 
has been shown to result in telomere shortening as seen in intrinsic 
senescence (Itahana et al., 2004).  
 
Senescent cells have been found to have an altered metabolic activity and 
protein expression, including an increased production of cytokines, growth 
factors and matrix metalloproteinases (MMPs). This is termed the 
senescent secretory phenotype (Campisi and d'Adda di Fagagna, 2007).  
 
Chondrocytes from older donors have been shown in vitro to exhibit 
increased production of cytokines and MMPs, as well as increased reactive 
oxygen species (ROS) and indications of oxidative damage, all of which are 
indicative of the senescent secretory phenotype (Del Carlo and Loeser, 
2002). As chondrocytes very rarely, if at all, divide it is most likely these 
changes are due to extrinsic senescence, which chondrocytes are thought 
to have an increased susceptibility due to their long lifetime. There has 
been evidence of telomere shortening in chondrocytes exhibiting the 
senescent secretory phenotype, but this has been shown to be a result of 
DNA damage from increased ROS (Kurz et al., 2005). Additionally, older in 
vitro bovine chondrocytes have been observed to produce a less functional 
extracellular matrix (ECM) than younger animals, this again is indicative of 





Oxidative stress is thought to play a major role in chondrocyte senescence 
and, thus, in the link between ageing and osteoarthritis development, as it 
has been observed in vitro that the addition of ROS induces the senescent 
secretory phenotype (Dai et al., 2006). Both aging and mechanical stress 
have been shown to result in increased ROS which leads to oxidative 
stress and thus senescence. The changes resulting from the senescent 
secretory phenotype in chondrocytes as a result of increased ROS from 
ageing and mechanical stress, all result in decreased ECM turnover and 





1.8 Exercise, Joint Injury and Osteoarthritis 
Sport/exercise participation is acknowledged to be of benefit to general 
health, however, it is widely acknowledged that such participation increases 
risk of injury (Saxon et al., 1999). There is also concern that excessive or 
prolonged participation in sport can increase risk of the development of OA 
later in life (Saxon et al., 1999). Two possible mechanisms behind the 
perceived increased OA risk are postulated; (1) joint injury and the resultant 
damage are known to increase OA risk, whereby the injury can trigger 
chronic cartilage remodelling or induce abnormal loading patterns 
(Hoffman, 1993), and (2) continuous stress placed on the joints by long-
term and prolonged exercise training may result in microtrauma and 
degeneration (Moskowitz, 1984), thus increasing the risk of OA 
development. Indeed injury, especially lower limb injury, is prevalent 
amongst athletes, with 78.9 % of runners experiencing lower limb injury 
within 7 days post marathon, with the knee being the most injured site 
(Satterthwaite et al., 1996), and 2 % of all visits to accident and emergency 
centres in the UK in 2010 were due to sport injury. Given that the lower limb 
experiences forces equivalent to 2-3 times bodyweight per foot strike 
(Bobbert et al., 1991, Chan and Rudins, 1994, Dufek and Bates, 1990, 
Farley and Gonzalez, 1996, James et al., 1978), and that the average 
endurance runner strikes the ground 600 times per km (Milner et al., 2006, 
Pohl et al., 2009), this is unsurprising.  
 
Increased joint force is noted to increase both injury and OA risk, whereby 
high impact sports, such as running, induce greater prevalence (Kujala et 
al., 1994, Lane, 1995, Lindberg et al., 1993, Saxon et al., 1999, Spector et 
al., 1996). Thus, there is some interest in determining means to reduce joint 
force without damaging performance. An area of interest is foot strike 
patterns, whereby the order in which the foot strikes the ground whilst 
running are known to vary. Two distinct styles are in evidence, ‘pose’ 
running and heelstrike running.  Pose running is characterised by a mid-
forefoot strike pattern, whereby the ball of the foot strikes the ground first. 
This style is claimed to produce better speed and thus sprinters tend to 




Conversely, heelstrike running involves striking the ground with the heel 
before the rest of the foot and is claimed to produce greater stride length, 
endurance runners are reported to favour heelstriking (Hasegawa et al., 
2007, Lieberman et al., 2010). As yet, no definitive reports of which foot 
strike pattern is most effective at injury risk or force reduction, although 
there is evidence to suggest that heelstriking increases the force the lower 
limb joints are subjected to (Sol, 2001).  
 
The increased risk in joint damage and OA development has lead to a 
market for products claiming to maintain ‘healthy’ joints. 46 % of the UK are 
reported to have tried such products, and approximately £450 million is 
spent on purchasing these products per year (Thomas et al., 2001, Thomas 
and Coleman, 2004). A few common products used include chondroitin 
sulphate, glucosamine sulphate, fish oil, ginger, evening primrose oil, 
devil’s claw and flaxseed oil, with chondroitin and glucosamine sulphate 
(either separately or in combination) the most common (ARC, 2009). 
Despite the prevalence of these products, very little is known about how 






The studies reported in the present thesis aim to investigate the relevance 
of changes in chondrocyte volume, actin and inflammation upon 
mechanical impact, to cell viability, and further study the osmotic sensitivity 
of these mechanisms. Additionally, nutriceuticals and pharmaceuticals were 
studied to isolate possible chondroprotective mechanisms. Furthermore, in 









































2.1.1 Tissue Culture 
 
Table 2.1: Tissue culture reagents. 
 
 
2.1.2 Cytoskeleton Studies 
 


























Foetal Calf Serum Invitrogen, Paisley 
UK 
16170-078 10% 
Trypsin-EDTA Invitrogen, Paisley 
UK 
25300 0.05% 














Triton X100 Fisher Scientific, 
Leicestershire, UK 
ZT3751 0.5% 
Ammonium Chloride Sigma-Aldrich, 
Poole, UK 
A0171 50mM 
Glycine Fisher Scientific, 
Leicestershire, UK 
BPE381 100mM 






2.1.3 ELISA Reagents 




Table 2.4: Fluorophores used for confocal laser scanning microscopy. 
Name Company Product Code Working Concentration 





LTB4 Assay Kit R&D Systems, 
Abingdon, UK 
KGE006B N/A 
Phosphate Buffer Saline Oxoid Ltd, 
Hertfordshire, UK 
BR0014G N/A 
Tween 20 Fisher Scientific, 
Leicestershire, UK 
BPE337 0.05% 
Bovine Serum Albumin Sigma-Aldrich, 
Poole, UK 
A2153 0.1%, 1% 






Dimethyl Sulphoxide Fisher Scientific, 
Leicestershire, UK 
D4121 1% 
Sulphuric Acid Fisher Scientific, 
Leicestershire, UK 
J/8410/17 2M 
Phosphate Citrate Buffer Sigma-Aldrich, 
Poole, UK 
P4809 0.05M 
Name Company Product Code Solvent Working Concentration 
Calcein AM Anaspec Inc, 
Freemont, USA 


















2.1.5 Pharmacological Reagents 
 
Name Company Product Code 
Working 
Concentration Comment References 











U73122 Sigma-Aldrich, Poole, UK U6756 100 µM 
PLCβ3 
inhibitor 
(Hou et al., 
2004) 
Rottlerin Sigma-Aldrich, Poole, UK R5648 100 µM PKC inhibitor 
(Gschwendt 





























































for joint care 
(ARC, 
2009) 






Jasplakinolide Invitrogen, Paisley, UK J7473 5 µM 
Stabilises 
actin filaments 
(Bubb et al., 
1994) 











2.1.6 Culture Media and Experimental Salines 
Bovine tissue samples were cultured using Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 1 % penicillin/streptomycin solution 
(pen/strep) under aseptic conditions. DMEM with an osmolarity of 280 
mOsm/kg H2O (mOsm) was termed isotonic as synovial osmolarity has 
been previously observed to be 280-300 mOsm (Hall et al., 1996a). To 
investigate the effects of a hyperosmotic challenge, the osmolarity of 
DMEM was adjusted to 380 mOsm by the addition of 3.14 mg/ml of filter-
sterilised sodium chloride (NaCl) using a 2 µm filter.  Conversely, to 
investigate the effects of a hypo-osmotic challenge, the osmolarity of 
DMEM was adjusted to 140 mOsm by the addition of filter-sterilised distilled 
water (ddH20). The osmolarity was measured using Vapro™ vapour 
pressure osmometer and accurate to 0.1 mOsm.   
For experiments that required the removal of extracellular calcium ([Ca2+]e), 
basic physiological saline (BPS) containing; HEPES (15 mM), glucose (10 
mM), potassium chloride (KCl; 5 mM), magnesium chloride (MgCl2; 1 mM) 
and either ethylene glycol tetraacetic acid (EGTA; 2 mM) or calcium 
chloride (CaCl2; 1 mM) as a paired control. The pH was measured using 
Fisher Scientific pH meter and adjusted to 7.40 ± 0.05 using sodium 
hydroxide (NaOH), and the osmolarity measured using Vapro™ vapour 





2.2 Bovine Dissection 
Bovine metacarpal and metatarsal phalangeal joints from freshly 
slaughtered 18-21 month old females (obtained from a local abattoir with 
permission, used within 2 days), were de-skinned and de-hoofed to expose 
the joint capsule (Hall, 1995). Under aseptic conditions the joint capsule 
was opened (Fig. 2.1) and full depth cartilage explants excised and stored 
in 280 mOsm/kg H2O DMEM containing 1 % penicillin/streptomycin for up 
to 24 h.  
 
2.2.1 Mononuclear Phagocyte Isolation and Culture 
Upon bovine dissection synovial fluid was removed from the 
metacarpal/metatarsal phalangeal joint and diluted in RPMI culture media 
and the cells subsequently washed by centrifugation. The cells were plated 
in flasks, the culture resulting from each individual leg plated separately. 
After allowing 24 h for cell attachment and neutrophil death, the non-
adhering cells were removed and the culture incubated with trypsin 
(Adams, 1979). The resultant supernatant was removed and discarded and 
the trypsin-resistant mononuclear phagocytes lifted from the flask by gentle 
scraping and seeded at a density of 1 x 104 cells/cm2 (Dechanet et al., 
1995). Cells were used within two weeks of isolation (Adams, 1979, 
Dechanet et al., 1995). 
 
The mononuclear phagocytes were cultured with the supernatants taken 
from impacted explants 4 h post impact, or with impacted explants for 4 h 











Figure 2.1: Bovine dissection of full-depth explants 
A) An undissected bovine metacarpal/metatarsal phalangeal joint. B) The apical surface of 




2.3 Impact Tower 
To investigate the effects of impact trauma on articular cartilage and cell 
death, each individual cartilage explant was subjected to a single impact 
using a vertical ‘drop tower’ following a previously published method (Fig. 
2.2; (Bush et al., 2005). Assuming linear acceleration under gravity, known 
mass (134 g) and height (10 cm) of the “drop”, the impact force, pressure 
and energy were calculated.  
To confirm the accuracy of these theoretical, calculated values as well as 
the precision of the technique, video analysis of the drop tower was carried 
out, measuring the exact time the load took to drop from 5 cm, 10 cm and 
20 cm. It was concluded that when dropped from a height of 10 cm an 
impact of 1.14 N, and 6.47 Kpa was measured and that the technique was 
reproducible from all heights (Table 2.6).  
 
Whilst these values are significantly lower than published values for human 
in vivo joint forces (oscillating between 0.2 and 4-5 MPa in the hip during 
the normal walking cycle; (Hodge et al., 1986), they have been optimised 
as an efficient magnitude for investigating cell death as a result of impact to 
dissected articular cartilage (Fig. 2.3), providing sufficient measurable cell 
death to study without destroying the tissue. It should also be noted that as 
the explants in question have neither the support of the bone or the 
protection of synovial fluid, as they would in vivo, they would not be 
expected to withstand the large forces they are subject to in vivo and thus 
the impact tower model is not intended as an exact model for human joint 
forces, but merely as a tool to investigate the effects of mechanical impact 











 Theoretical (10cm) Experimental (10cm) 
Work (J) 0.134±0.00 0.114±0.00 
Pressure (Kpa) 7.58±0.00 6.47±0.07 
Force (N) 1.34±0.00 1.14±0.01 
 
Table 2.6: Theoretical and experimental forces for the impact tower 
Theoretical values were calculated using basic physics equations. Experimental values 
were obtained by video analysis of the impact tower being dropped from 10cm. The time 
taken to drop was used to calculate velocity (v = d/t) and, thus, acceleration (a=v/t). Force 
was then calculated from the known mass (134 g) and the acceleration (F=ma). Pressure 
was calculated from the force and the “drop” area (1.77 cm2) of the impact tower (P=F/A). 








Figure 2.3: Optimisation of drop tower height  
Explants were subjected to a single impact using the vertical drop tower from 5, 10 or 20 
cm and analysed for cell viability using confocal laser scanning microscopy. Samples were 
incubated with 5 µM calcein-AM and 1 µM propidium iodide prior to visualisation to 
indicates viable and non-viable cells respectively. Samples were imaged at 2, 4, 24 and 48 
h post impact. Viability is expressed as a percentage of the total cell number. 10cm was 
observed to be the most effective at inducing measurable cell death without destroying the 




2.4 Tissue Fixing and Cytoskeletal Staining 
In order to investigate the effects of impact trauma on actin cytoskeletal 
organisation, bovine explants were fixed before impact and at 0, 2, 4, 24 & 
48 h post impact in ice-cold 4 % paraformaldehyde (PFA) for 1 h at 4°C. 
The samples were then subsequently washed 3 times in ice-cold PBS to 
remove excess PFA and then quenched for 10 min in ice-cold 50 mM 
NH4Cl. Subsequently the samples were permeabilsed with 0.5 % Triton 
X100 in PBS for 5 min on a rocker and dipped in 100 mM Glycine to stop 
permeablisation before being washed 3 times in ice-cold PBS and blocked 
with 1 % bovine serum albumin (BSA) and 0.05 % Tween-20 in PBS. After 
washing 3 times with ice-cold PBS the samples were labelled with Alexa 
488-phalloidin (5 µl/ml) and placed on a rocker in the dark for 45 min. After 
incubation the samples were washed 3 times in 0.05 % Tween in PBS and 
visualised using CLSM. 
 
2.5 Confocal Laser Scanning Microscopy (CLSM) 
Confocal laser scanning microscopy (CLSM) is a powerful tool that permits 
the in vitro 3D imaging of interior structures within tissue (Jones et al., 
2005, Kerrigan and Hall, 2008a). By controlling the depth of focus, CLSM 
allows the acquisition of individual images from multiple selected depths 
(termed optical sectioning), which are subsequently reconstructed resulting 
in three-dimensional (3D) objects. Briefly, a laser beam passes through the 
light source aperture and is focused onto a focal point on the surface or 
within the sample being imaged by the objective lens. The fluorescent light 
emitted from the fluorophores used to stain the sample, is collected by the 
objective and separated into the detection aperture by the beam splitter 
where it is passed through the pinhole, which blocks any light not returning 
from the focal point thus resulting in a sharper image. The light signal is 
ultimately converted into an electrical signal able to be interpreted by a 
computer by a photodetection device. By assembling images from 






CLSM was utilised to investigate changes in cell viability, cell volume and 
the actin cytoskeleton. For imaging to determine cell viability and volume, 
samples were visualised at 0, 2, 4, 24 and 48 h post impact. Prior to 
visualisation samples were incubated for 30 min at 37°C and 5% CO2 with 
5 µM Calcein-AM and 1 µM Propidium Iodide (PI) to indicate viable and 
non-viable cells respectively. Viability images were acquired using a x10 
objective and a z-step of 5 µm and volume images using a x63 dipping 
objective and a z-step of 1 µm. Calcein-AM was excited using a laser with 
an excitation wavelength of 488 nm and an emission passband of 510-590 
nm was recorded (Fig. 2.4A). PI was excited at a wavelength of 543 nm 
and an emission passband of 570-710 nm was recorded (Fig. 2.4B). For 
imaging to investigate the actin cytoskeleton samples were fixed and 
stained using Alexa 488-phalloidin as previously described (Section 2.4). 
Actin images were acquired using a x63 dipping objective and Alexa 488-
phalloidin was excited using a laser with an excitation wavelength of 488 
nm and a recorded passband of 535-590 nm (Fig. 2.4C). All images were 
acquired at 0.6 Hz and the power output of each laser adjusted to ensure 
maximal excitation with minimal bleaching.  
 
During the optimising of the CLSM settings, it was noted that there was the 
potential for bleedthrough between calcein-AM and PI, as the emission 
passband of each overlaps (Fig. 2.4). This could lead to false images when 
imaging samples stained with both fluorophores. In order to combat this, a 
sequential imaging technique was used. Sequential imaging prevents 
bleedthrough by exciting each fluorophore consecutively instead of 
simultaneously. This technique ensures the image acquired is solely due to 
the emitting fluorophore and not due to bleedthrough from the second 
fluorophore (Leica, 2006, Ramshesh and Lemasters, 2008).  
 
All Images were acquired at a resolution of 1024x1024 pixels using an 
optimal pinhole radius of 1 Airy unit, which is defined as the diameter of the 
Airy disc for each given objective and excitation wavelength (Ramshesh 
and Lemasters, 2008). Briefly, the Airy Disc refers to the inner light circle of 




System, as used in this study, the diameter of the Airy Disc, and thus 1 Airy 
unit can be described as: 
       (Leica, 2004)
 
Where: 
→ Diameter of Airy disc 
 → Excitation wavelength 
 → Numerical aperture of objective 
 → Magnifying factor of objective 
 
By adjusting the pinhole radius to the diameter of the Airy disc, or 1 Airy 
unit, light from outside the focal plane is suppressed and the signal to noise 























Figure 2.4: Excitation and Emission spectra for Calcein-AM, Propidium Iodide and 
Alexa Fluor 488 Phalloidin. 
Observation of the spectra for the fluorophores revealed excitation wavelengths of 488 nm 
for both calcein-AM and alexa fluor 488 phalloidin, and 543 nm for propidium iodide. 
Optimal passband for calcein-AM was observed to be 510-590 nm and propidium iodide to 
be 570-710 nm. The overlapping of the passband for these two fluorophores used 
simultaneously indicated the need for sequential imaging. Optimal passband for alexa fluor 






Following impact, supernatants were collected and analysed for production 
of pro and anti-inflammatory mediators by ELISA. The levels of IL-1β, IL-10 
and MCP-1 were assessed using the commercially available Duoset® 
human Immunoassay kits (R & D systems), additionally the levels of LTB4 
was assessed using LTB4 Immunoassay kit (R & D systems). These 
quantitative colorimetric assays were conducted according to the 
manufacturer’s protocol. Briefly, the capture antibody was pre-coated onto 
a high-binding 96 well microplate overnight at room temperature. The plate 
was subsequently washed and blocked for 1 h with 1 % BSA in PBS. It 
should be noted that the previously described steps were unnecessary for 
the LTB4 assay as the plate is coated prior to purchase. Sample (100 µl) 
was added to the appropriate wells and bound to the immobilised antibody. 
Unbound sample and standard were removed by washing and a biotin-
labelled detection antibody added for 2 h forming an analyte-antibody 
complex. Unbound detection antibody was removed by washing and 
Streptavidin-HRP added for 20 min at room temperature. Following the 
removal of non-bound antibodies using the washing procedure the 
TMB/peroxide (substrate) was added and was converted by the HRP 
(enzyme) to form a blue colour. The intensity of the colour indicating the 
concentration of the cytokine present within the sample. Following a 20 min 
incubation, 50 µl of 2M H2SO4 was added to terminate the reaction and 
thus turn the blue colour to a stable yellow product. The concentration of 
the cytokine detected was measured spectrophotometrically at 450 nm with 
a wavelength correction of 570 nm. The levels of cytokines present within 
the samples was compared to a standard curve for each cytokine ranging 
from (0 – 2000 pg/ml) and constructed using 2-fold serial dilution with the 










Figure 2.5 Example ELISA standard curve for IL-1β   
Average optical density for triplicate standards was plotted against concentration. 
Concentration of experimental samples were calculated using the equation generated by 




2.7 Human Testing  
The effects of diurnal exercise on circulating inflammatory cytokines was 
investigated by the recruitment of a pool of healthy male participants. 
Initially, in order to standardise the joint forces across the participant 
population and thus ensure a homogenous set of participants for cytokine 
analysis, the effect of physiological characteristics on the magnitude of joint 
loading was investigated by recruitment of a varied pool of participants and 
subsequent physiological analysis. By investigating the correlations 
between physiological characteristics and joint forces, the characteristics 
needing to be controlled were elucidated.  
 
A total of 48 male and female participants were recruited by mailing list 
emails and poster advertising from within the University of Westminster and 
from London based running, cycling and triathlon clubs. After completion of 
a retrospective “Training and Injury Questionnaire” and “medical form” 
(Appendix I; modified with permission from (Vleck and Garbutt, 1998), the 
participants were divided into 4 groups; Sedentary Females (SF; N=10), 
Sedentary Males (SM; N=10), physically Active Females (AF; N=14) and 
physically Active Males (AM; N=14). AF and AM were defined in this study 
as individuals that participated in more than 3 h of training per week over 
the last year. Participants were analysed for physiological parameters 
including height, body mass, percentage body fat, leg power (as estimated 
by vertical jump height) and thigh circumference (Section 2.7.1) and 
analysed for joint forces when running barefoot (Section 2.7.2). Statistical 
comparison between the different groups revealed a significant difference, 
both between males and females, and between active and sedentary 
participants, indicating gender and activity level affected joint forces (Table 
2.7). Additionally, correlations between both body mass and percentage 
body fat, as well as thigh circumference with joint forces indicated these 
three physiological factors all affected joint force magnitude (Table 2.8). No 
correlation was seen with leg power or velocity, indicating these factors did 
not need to be controlled. Thus it was concluded that participants for the 
study should be male, active, with a controlled thigh circumference, body 










 Significance value Significant difference? 
Male vs. Female 0.00018 Yes 
Active vs. Non-Active 0.02002 Yes 
 
Table 2.7: Student T-Test analysis of in vivo running knee impact force differences 
between males and females, and actives and non-actives.  
Dominant leg running knee forces were compared between males and females, and 
between actives and non-actives. There was a significant difference observed between the 
genders and activity levels indicating both these factors needed to be controlled to 








Significance value Correlation? 
Leg Power 0.2044 0.1886 No 




Velocity 0.0969 0.5364 No 
Thigh Circumference 0.639 0.000004 Yes 
 
Table 2.8: Pearson correlation coefficient analysis between in vivo running knee 
force and physiological characteristics.  
Correlations between dominant leg running knee force and physiological parameters were 
investigated using the Pearson Coefficient. A significant correlation was observed when 
knee force was compared to body mass, percentage body fat and thigh circumference, 


















2.7.1 Participant Characteristics 
A total of 14 participants were recruited by mailing list emails and poster 
advertising from within the University of Westminster and from London 
based running, cycling and triathlon clubs. Participants accepted were 
active males, aged 20 – 39 years old, with a body mass of 65 – 75 kg, a 
percentage body fat of 10 – 13 % and a dominant leg thigh circumference 
of 48 – 53 cm. Dominant leg was determined as the leg stepped back onto 
when the participant was pushed backwards.  
 
Participants were weighed and measured for height whilst barefoot. In order 
to ensure the participants were healthy, resting heart rate (HR) and blood 
pressure (BP) were taken 3 times using a Polar heart rate monitor and 
sphygmomanometer (A&D,Oxfordshire, UK) respectively. 
 
Anthropometric measures were collected with the participants dressed 
solely in tight-fitting underwear/swimwear. Limb circumferences were 
measured on the thigh to standardise the participant pool as indicated by 
the initial testing. Lengths of the tibia and femur also collected to be used 
later in combination with forceplate data for calculation of the joint forces. 
Tibia length was measured from the tibiale mediale to the sphyrion tibiale 
and femur length from the trochanterion to the tibiale laterale (Fig. 2.6). All 
measurements were taken according to standard protocol using measuring 
calipers (Marfell-Jones, 1991). 
 
A BODPOD (Concord, CA, USA) system was used to collect percentage 
body fat and lean. After weighing the participant entered the BODPOD 
dressed in tight-fitting underwear/swimwear with all jewellery/glasses etc 
removed and with hair covered in a tight cap.  The BODPOD performed 3 
measurements and gave an average reading for percentage body fat and 







Figure 2.6 Anthropometric measurements. 
A) Identification of the landmarks trochanterion, mid trochanterion-tibiale laterale and 
tibiale laterale. B) Measurement of thigh length, the distance between the trochanterion 
and tibiale laterale landmarks. C) Measurement of thigh circumference, taken at the mid 
trochanterion-tibiale laterale landmark. D) Identification of the landmarks tibiale mediale 
and sphyrion. E) Measurement of tibia length, the distance between the tibiale mediale and 
sphyrion landmarks. E) Measurement of calf circumference, taken at the observed widest 





2.7.2 Mechanical Testing 
Barefoot participants stood on the Forceplate (AMCube, France) with both 
feet and the pressure profile generated was analysed. Participants then ran 
across the force plate (Fig. 2.7) 10X times, 5X with the left foot hitting the 
plate and 5X with the right foot, at a pace similar to “long distance running” 
(13.4 km.h-1; (Zamparo et al., 2001). The pressure profiles were analysed 
and used to generate maximum force exerted onto the mat for each foot. 




All participants underwent a submaximal aerobic fitness test to estimate 
VO2max. The participants warmed up on a treadmill (HP Cosmos, Gaiam, 
UK) set a 0 % grade and a walking speed sufficient to bring the heart rate 
(HR) to 50 – 70 % of the individual’s age-predicted maximal HR (220 - age) 
for 4 min. Subsequently, whilst the treadmill speed was kept the same, the 
incline was increased to 5 % and the subject continued to exercise for a 
further 4 min. HR was recorded every 5 sec and averaged for the final 30 
sec of each of the last 2 min. If these two values differed by more than 5 
bpm, the test was extended for an additional minute until the average HR of 
the last 30 sec of the final 2 min were within 5 bpm. The median of these 
two values was then termed the steady-state HR (SS HR) and used to 
estimate VO2max using the following equation: 
 
Estimated VO2max (ml.kg-1.min-1) = 15.1+21.8 (speed in mph) – 0.327 
(SS HR in bpm) – 0.263 (speed in mph x age in years) + 0.00504 (SS HR 
in bpm x age in years) + 5.98 (gender; male=1, female=0) 
 












Figure 2.7: Representative Image of Gait Analysis Using Footwork Pro.  
(A) Plantar elevation of ground reaction force (GRF). The red line shows force transference 
and the white line shows centre of mass. (B) 3D posterior elevation of GRF. (C) Barefoot 
running on the forceplate. Colour Scale: Represents force magnitude within the step from 







2.7.4 Diurnal Exercise 
Participants underwent 30 min of treadmill exercise at an intensity of 60 % 
VO2max. Each participants’ running speed was calculated from their 
VO2max previously measured. HR was monitored continuously through-out 
the session. Venous blood (6 ml) was obtained from the antecubital vein 
using a Vacutainer lancet and EDTA collection tube (BD Diagnostics - 
Preanalytical Systems) prior to, immediately post and at 2 and 4 h post 
exercise. Participants commenced exercise at either 8am or 6pm. For the 
24 h preceding the tests participants were asked not to take part in any 
strenuous activity (i.e. no training sessions) or take any anti-inflammatory 
medications. Between blood samples participants were asked to sit and 
refrain from any unnecessary activity and to not consume medications or 
stimulants. Blood samples collected were stored at 4°C prior to 
centrifugation at 2500 rpm for 10 min. The blood serum was then removed 
and stored at -80°C until analysis. The levels of IL-1β, MCP-1 and IL-10 
were assessed using the commercially available Duoset® human 
Immunoassay kits (R & D systems). This quantitative colorimetric assay 
was conducted according to the manufacturer’s protocol as previously 




2.8 Data Analysis 
2.8.1 CLSM Viability Analysis 
To determine cell viability post impact, CLSM data was imported into and 
analysed using Imaris 7.1 (Bitplane; Netherlands). Based on the average 
diameter of the “live” green cells and the “dead” red cells in the explant, 
spot analysis was used to determine the total number of cells and the 
number of viable cells within the explant (Fig. 2.8). Viable cells were then 
expressed as a percentage of the total cells within the sample.  
 
The optimal threshold for calcein-AM and PI when using spot analysis was 
calculated by selecting an area with a countable, known number of cells. 
Different threshold percentages were then applied and a linear relationship 
observed between threshold percentage and cell number. The correct cell 
number was shown to be ascertained with a threshold percentage of 20 % 
for cells stained with calcein-AM and 60 % for PI.   
 
2.8.2 CLSM Volume Analysis 
Analysis of cell volume changes post impact was ascertained by importing 
CLSM volume images into Imaris 7.1 (Bitplane; Netherlands). An 
“Isosurface” was added to each individual cell and the volume of the 
resultant object calculated (Fig. 2.9).  
A threshold percentage of 60 % was employed, and confirmed as optimal 
using “bead analysis”. Briefly, glass beads of a known volume (520 µm3) 
were imaged and Isosurface volume analysis applied with a spectrum of 
threshold percentages. A linear relationship was found between the 
threshold percentage and the apparent volume (Fig. 2.9) with the correct 






Figure 2.8: Optimisation of spot analysis 
A) Bovine explants were stained with 5 µM Calcein-AM and 1 µM Propidium Iodide to 
visualise viable and non-viable cells respectively. Samples were imaged using CLSM. B) A 
visually countable number of both viable and non-viable cells was cropped from the CLSM 
image. C) Spot analysis was applied to the cropped section for both viable and non-viable 
cells at different threshold percentages. D) Apparent cell number was plotted against 
threshold percentage and linear regression applied. Actual cell number was used to 







Figure 2.9: Optimisation of volume analysis using beads 
A) Latex beads were stained with 5 µM Calcein-AM and imaged using CLSM. B) A single 
bead was cropped from the CLSM image. C) An isosurface was applied to the cropped 
bead at different threshold percentages. D) Apparent bead volume was plotted against 
threshold percentage and linear regression applied. Actual bead volume was used to 




2.8.3 CLSM Actin Analysis 
The organisation of the actin cytoskeleton was studied using ImageJ 1.43U 
(NIH; USA) with the fluorescence intensity of individual cells determined 
using Linear Profiling across the cell diameter (Fig. 2.10). As the acquisition 
protocol was standardised between images, thus maximal fluorescence 
being constant, mean fluorescence intensity (
€ 
I) for the population of cells 
within a sample was obtained in arbitrary fluorescent units. It can be argued 
that the changing cell volume resultant from osmotic changes (for example 
when subject to a hyperosmotic challenge) could result in an apparent 
increase in F-actin, caused by the condensation of the fluorescence 
(Alvarez-Leefmans, 1995). To combat the possibility of this phenomenon, 
mean fluorescence intensity was expressed relative to the mean cell 
volume using the newly termed ‘Parker-Qusous Factor’ as follows: 
F-actin (
€ 
Fa) is assumed to be proportional to fluorescence (
€ 
Fluo), and 
similarly  fluorescence is assumed to be inversely proportional to cell 
volume  (
€ 








I  is the fluorescence divided by the radius (
€ 
r ) of the cell, thus; 
€ 
I = Fluor → Fluo = Ir  
Volume of a sphere can be calculated as;  
€ 
V = 43 πr
3→V ∝ r3  
Thus;  
€ 
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Therefore the Parker-Qusous Factor (
€ 
PQ) for F-actin is: 
€ 




In this study F-actin was calculated independent of cell volume using the 
above described Parker-Qusous Factor and expressed in Mauricean Units 








Figure 2.10: Analysis of the organisation of the Actin cytoskeleton by Linear 
Profiling. 
A) Bovine explants were fixed in 4 % paraformaldehyde and stained with alexa fluor 488 
phalloidin. Samples were imaged using CLSM. B) Images were imported into ImageJ and 
analysed by Linear Profiling, whereby lines were drawn horizontally and vertically across 
the diameter of each individual cell and the fluorescence along the line recorded. C) The 









2.8.4 Mechanical Analysis 
Knee impact forces were calculated from the data collected from the force 








Fi−1,i → force between segments i-1 and I at joint i-1 
€ 
Fi,i+1 → force between segments I and i+1 at joint i 
€ 
mi → mass of segment i 
€ 
g → gravity vector 
€ 
ai  → acceleration vector of C.O.M of segment i 
GRF → Ground reaction force 
 
and; 
Segment masses (Winter, 1990): 
Mass of foot = 1.4 %  total mass 
Mass of shank = 4.6 % total mass 
Mass of thigh = 9.9 % total mass 
 
Therefore; 
1) GRF = AnkleForce – (massfoot x g) + (massfoot x speed) 
2) AnkleForce = KneeForce – (massshank x g) + (massshank x speed) 
3) KneeForce = HipForce – (massthigh x g) + (massthigh x speed) 
 
By collecting the GRF from the pressure plate, the mass of the foot 
(calculated from the published percentage of the total body mass) and the 
speed, equation 1 can be rearranged to calculate the ankle force. This can 
then be entered into equation 2 along with shank mass (again calculated 
from the published percentage of the total body mass) and speed. Equation 














Figure 2.11: Schematic diagram of the forces on a limb segment. 
A single limb segment and it’s forces, where Fi-1,i is the force between segment i and the 
preceding segment, or in the case of the foot, the force between the ground and the foot, 
i.e. GRF. Fi,i+1 is the force between segment i and the succeeding segment. Diagram 







Statistical analysis of Pearson Correlation Coefficient was completed using 
StatPlus (AnalystSoft; Canada) and all other statistical analysis was 
performed using Microsoft® Excel 2008 for Mac. The plotting of all graphs 
and obtaining of graph equations and linear regression statistics (R2 values 
given for every equation) were performed using Graphpad Prism 5 (CA, 
USA).  
 
Linear regression was calculated for viability, volume and actin, to 
determine rates of cell death, volume decrease and actin polymerisation 
respectively. Initial (0-4 h) and subsequent (4-48h) rates were calculated 
(Fig. 2.12). 
 
All values are shown as mean ± standard error of the mean (s.e.m) unless 
otherwise stated. Two-tailed Student’s T-tests were employed to determine 
the significance of results, which were deemed significantly different if the p 
value was p<0.05 (*), p<0.01 (**), or p<0.005 (***). 
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HI→ Mean intensity + s.e.m 
€ 
LI→ Mean intensity – s.e.m 
€ 
HV →  Volume + s.e.m 
€ 
LV →  Volume – s.e.m 
  
Experiment repetitions are described in individual legends, where (N) 
denotes the number of individual joints used and (n) denotes the number of 
















Figure 2.12: Linear regression to determine rate of cell death 
Bovine explants were subjected to a single impact from a vertical drop tower and stained 
with 5 µM Calcein-AM and 1 µM Propidium Iodide to visualise viable and non-viable cells 
respectively. Samples were imaged using CLSM prior to and at 2, 4, 24 and 48 h post 
impact. Spot analysis was applied for both viable and non-viable cells and percentage cell 
viability plotted against time. Linear regression was applied for both initial (0-4 h) and 











Chapter 3: Osmotic Sensitivity of In Situ 





Mechanical loading is known to be essential for the maintenance of healthy 
articular cartilage tissue, whereby production of an extracellular matrix 
(ECM) of sufficient durability to withstand the loading is induced (Helminen, 
1987). However, excessive loading, from mechanical trauma or repetitive 
high impact exercise, is observed to induce cartilage damage and 
chondrocyte apoptosis in addition to increasing the risk of osteoarthritis 
development (OA; (Oliveria et al., 1999, Tew et al., 2000). Excessive 
loading is noted to induce tissue swelling, indicative of damage to the 
collagen network (Jeffrey et al., 1995), which is thought to play a role in the 
loss of viable chondrocytes within OA tissue, whereby over-hydrated cells 
are thought to be more sensitive to mechanical stresses (Bush et al., 2005). 
Additionally, cytoskeletal actin filaments (F-actin), known to provide 
mechanical cellular support and play a role in maintaining chondrocyte 
durability and strength, are reported to be disassembled in response to 
mechanical trauma (Blain, 2009), such that there is a loss of F-actin fibres 
and reorganisation of the filament distribution from a cortical to a more 
scattered arrangement (Knight et al., 2006, Parkkinen et al., 1995). It is 
further reported that mechanical trauma induces release of cytokines, 
including pro-inflammatory cytokines IL-1β and MCP-1, and anti-
inflammatory cytokine IL-10. IL-1β is known to disrupt F-actin and bring 
about ECM degradation by inducing a decrease in proteoglycan (PG) 
synthesis and an increase in catabolic enzyme release (Liu et al., 1994, 
Rowan and Young, 2007, Westacott and Sharif, 1996).  
 
Joint articulation, as a consequence of daily activity compresses cartilage 
tissue, inducing the expulsion of water and thus an increase in tissue 
osmolarity. It is therefore postulated that tissue in vivo is at a higher osmotic 
pressure at the end of the diurnal cycle. Whilst it has been observed that 
decreased extracellular osmolarity and thus cell swelling, such as observed 
in early-stage OA, results in chondrocyte deformation, and loss of viability 
when the tissue is subjected to mechanical trauma (Bush and Hall, 2001b), 




resultant from daily joint articulation, will have on cartilage integrity when 
subjected to similar abnormal loading.  
3.1.1 Chapter Aims 
This study aims to build on the previous work described, investigating the 
effects of prolonged static loading, as simulated by hyperosmotic challenge, 
on in vitro cartilage integrity and inflammation post mechanical impact.  
Specifically by: 
1. Investigation of changes in chondrocyte viability and volume in 
response to single mechanical impact. 
2. Investigation of the actin cytoskeletal response to mechanical 
impact. 
3. Determining the changes in inflammatory cytokine concentrations in 
articular cartilage post mechanical impact. 
4. Investigation of the role of extracellular osmolarity in responses 






3.2.1 The Osmotic Sensitivity of Articular Chondrocytes 
The effects of increased extracellular osmolarity on the integrity of articular 
chondrocytes post mechanical impact was investigated initially by 
determining cellular responses to an osmotic gradient. Thus, articular 
cartilage explants were dissected from bovine metacarpal/metatarsal 
phalangeal joints and incubated at 37°C for 1 h with DMEM of 280, 320, 
360 or 380 mOsm. Subsequently, samples were subjected to a single 
mechanical impact as previously described (See Materials and Methods) 
and analysed by CLSM for viability and volume. 
 
Mechanical impact induced chondrocyte death under control, isotonic 
conditions, whereby a biphasic decrease in cell viability was observed (Fig. 
3.1). This observation was characterised by rapid initial cell death 
(2.75±0.14 %.h-1) followed by slower subsequent cell death (0.66±0.03 %.h-
1). Increasing extracellular osmolarity to 320 and 360 mOsm displayed a 
chondroprotective effect, reducing the rate of both initial (2.00±0.29 %.h-1, 
1.25±0.23 %.h-1) and subsequent cell death (0.23±0.01 %.h-1, 0.13±0.00 
%.h-1), but biphasic cell death was still observed. In contrast, increasing 
extracellular osmolarity to 380 mOsm resulted in no significant (p>0.05) cell 
death over 48 h post mechanical impact (viability of 90±2.12 % at 0 h to 
90±2.20 % at 48 h), abolishing both the initial (0.00±0.03 %.h-1) and the 
subsequent (0.00±0.06 %.h-1) phases of chondrocyte death (Fig. 3.2).  
 
Chondrocyte volume was noted to be 716.14±37.81 µm3 within in situ 
cartilage under isotonic conditions. Following mechanical impact, a biphasic 
decrease in cell volume was observed, with a rapid initial rate of 34.38±1.34 
µm3.h-1 and a slower subsequent rate of 2.87±0.85 µm3.h-1. This 
observation was termed Impact Induced Volume Decrease (IIVD). 
Increasing extracellular osmolarity to 320, 360 and 380 mOsm 
unsurprisingly decreased cell volume prior to mechanical impact (Fig. 3.3), 
to 645.12±46.10 µm3, 587.64±23.22 µm3 and 561.46±25.49 µm3 




prior to mechanical impact significantly (p<0.005) decreased the initial rate 
of IIVD (320 mOsm: 28.00±0.38 µm3.h-1, 360 mOsm: 28.00±0.79 µm3.h-1, 
380 mOsm: 26.95±1.12 µm3.h-1), IIVD was still observed (Fig. 3.3). 
Additionally, increased extracellular osmolarity significantly (p<0.005) 
decreased the subsequent rate of IIVD (320 mOsm: 2.14±0.18 µm3.h-1, 360 
mOsm: 0.97±0.06 µm3.h-1, 380 mOsm: 00.54±0.05 µm3.h-1), where 380 
mOsm was noted to induce a near elimination of the subsequent phase 
(Fig. 3.3). These data thus demonstrated that 380 mOsm DMEM had the 
most effective chondroprotective effects and was used hereafter to model 






Figure 3.1: The role of osmolarity on chondrocyte viability following mechanical 
impact.  
Cartilage explants were pre-treated for 1 h with control isotonic (A,E,I) or hyperosmotic 
DMEM of 320 (B,F,J), 360 (C,G,K) or 380 (D,H,L) mOsm and subjected to a single 
mechanical impact. Samples were loaded with Calcein AM (5 µM) and PI (1 µM) and 
visualised using CLSM at 2 h (A-D), 24 h (E-H) and 48 h (I-L) post mechanical impact. 









Initial rate of chondrocyte 
death (%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
280 2.75±0.14 0.66±0.03 
320 2.00±0.29 * 0.23±0.01 *** 
360 1.25±0.23 *** 0.13±0.00 *** 
380 0.00±0.03 *** 0.00±0.06 *** 
 
Figure 3.2: Hyperosmotic pre-treatment is chondroprotective post-mechanical 
impact.  
Cartilage explants were pre-treated for 1 h with control isotonic or hyperosmotic DMEM of 
320, 360 or 380 mOsm and subjected to a single mechanical impact. Samples were 
loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using CLSM prior to and at 2 
h, 24 h and 48 h post mechanical impact. Imaris Spot analysis was used to quantify the 
number of viable and non-viable cells. Biphasic cell death was observed under all osmotic 
conditions except 380 mOsm. N=12 from 3 distinct experiments. *p<0.05, **p<0.01, 












Initial rate of chondrocyte 
volume decrease (µm3.h-1) 
Subsequent rate of chondrocyte 
volume decrease (µm3.h-1) 
280 34.38±1.34 2.87±0.85 
320 28.00±0.38 *** 2.14±0.18 *** 
360 28.00±0.79 *** 0.97±0.06 *** 
380 26.95±1.12 *** 0.54±0.05 *** 
 
Figure 3.3: Hyperosmotic pre-treatment decreases chondrocyte volume post-
mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic or hyperosmotic DMEM of 
320, 360 or 380 mOsm and subjected to a single mechanical impact. Samples were 
loaded with Calcein AM (5 µM) and visualised using CLSM prior to and at 2 h, 24 h and 48 
h post mechanical impact. Isosurface volume analysis was used to quantify cell volume. 
Hyperosmotic challenge decreased cell volume prior to impact. A biphasic decrease in cell 
volume was observed under all osmotic conditions. N=12 and n=60 from 3 distinct 





3.2.2 Extracellular Osmolarity and Mechanical Impact 
Previously 380 mOsm was determined to be the most effective osmolarity 
for chondroprotection, this osmolarity was thus used for the purposes of this 
study as a hyperosmotic model of ‘evening’ articular cartilage that has been 
subjected to daily joint articulation. Additionally, OA tissue is known to be 
over hydrated (Bush and Hall, 2003), thus a hypo-osmotic challenge of 140 
mOsm was employed to induce cell swelling and thus act as a simulation 
for OA tissue. These simulations were further investigated and compared to 
determine the consequences of changes in the extracellular osmotic 
environment on articular cartilage responses to mechanical loading. 
Consequently, samples were pre-treated with hypo-osmotic (140 mOsm), 
isotonic (280 mOsm) or hyperosmotic (380 mOsm) DMEM prior to 
mechanical impact and samples analysed for cell viability and volume by 
CLSM. 
 
It was observed that hypo-osmotic and hyperosmotic challenge had 
opposing effects on cell viability post mechanical impact, whereby 
hyperosmotic challenge exhibited chondroprotective actions (90.00±2.20 % 
viability at 48 h), and hypo-osmotic challenge resulted in an increase in cell 
death (30.16±0.99 % viability at 48 h; Control: 45.00±1.21 %). Furthermore, 
whilst hyperosmotic challenge abolished the biphasic cell death observed in 
control samples, hypo-osmotic challenge increased both the initial rate 
(6.21±1.56 %.h-1) and the subsequent rate (0.78±0.05 %.h-1) of cell death 
induced by mechanical impact (Fig. 3.4).  
 
As expected, hypo-osmotic challenge was seen to significantly increase cell 
volume (p<0.005) prior to mechanical impact (Fig. 3.5) to 923.27±37.81 
µm3 when compared to control samples (716.14±35.82 µm3; Fig. 3.6A). 
Conversely hyperosmotic treatment significantly decreased cell volume 
(p<0.01) to 578.46±25.49 µm3 prior to mechanical impact (Fig. 3.5 & 3.6). 
The biphasic IIVD observed under control conditions was evident in both 
hypo-osmotic and hyperosmotic conditions, however both the initial rate 
(54.50±0.04 µm3.h-1) and the subsequent rate (4.05±0.49 µm3.h-1) of IIVD 




3.6). Hyperosmotic challenge had the opposing action, decreasing the initial 
rate of IIVD, and severely reducing the subsequent rate, whereby despite 
the lower cell volume prior to impact, the volume of control (516.52±38.86 
µm3) and hyperosmotic samples (482.49±35.93 µm3) were not significantly 









Initial rate of chondrocyte 
death (%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
280 2.75±0.14 0.66±0.03 
380 0.00±0.03 *** 0.00±0.06 *** 
140 6.21±1.56 ** 0.78±0.05 *** 
 
Figure 3.4: Hyperosmotic challenge protects against cell death post mechanical 
impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, hypo-osmotic (140 mOsm) 
or hyperosmotic (380 mOsm) DMEM and subjected to a single mechanical impact. 
Samples were loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using CLSM 
prior to and at 2 h, 24 h and 48 h post mechanical impact. Imaris spot analysis was used to 
quantify cell viability. Hyperosmotic treatment was seen to protect against cell death. N=12 
















Figure 3.5: Isosurface volume analysis of cells.  
Cartilage explants were treated for 1 h with control isotonic (B & E), hypo-osmotic (140 
mOsm; A & D) or hyperosmotic (380 mOsm; C & F). Samples were stained with Calcein 









Initial rate of chondrocyte 
volume decrease (µm3.h-1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
280 34.38±0.03 2.87±0.85 
380 26.95±1.12 *** 0.54±0.05 *** 
140 54.50±0.04 *** 4.05±0.49 *** 
 
Figure 3.6: Chondrocyte volume decreases biphasically post-mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, hypo-osmotic (140 mOsm) 
or hyperosmotic (380 mOsm) challenges and subjected to a single mechanical insult. 
Samples were loaded with Calcein AM (5 µM) and visualised using CLSM prior to and at 2 
h, 24 h and 48 h post mechanical impact. Isosurface volume analysis was used to quantify 
cell volume. A biphasic decrease in cell volume was observed under all osmotic conditions. 
Initial decrease was significantly faster for hypo-osmotic treatment. N=12 and n=60 from 3 





3.2.3 The Responses of Filamentous Actin to Mechanical Impact 
The F-actin cytoskeleton is a dynamic structure known to be involved in 
both mechanotransduction, whereby mechanical stimuli are converted into 
a biochemical response, and in maintaining structural cell integrity (Blain, 
2009, Guilak et al., 1995, Wang et al., 1993). Furthermore, F-actin 
organisation is noted to be less defined in OA tissue, thus possibly 
contributing to the defective function found in OA (Blain, 2009). The 
responses of F-actin to mechanical impact were investigated, post hypo-
osmotic and hyperosmotic challenge to clarify the consequences of altered 
extracellular osmolarity, either due to OA or daily joint articulation, on F-
actin stability post mechanical impact. Articular cartilage samples were 
fixed with 4% paraformaldehyde and stained for F-actin with Alexa Fluor 
488 Phalloidin (5 µl/ml) prior to and 2, 24 and 48 h post mechanical impact. 
F-actin was imaged using CLSM and analysed using linear profiling and the 
PQ Factor, as previously described (See Methods and Materials).  
 
Prior to mechanical impact, hypo-osmotic challenge induced in an initial 
decrease in F-actin to 1.08±0.06 MU, when compared to control values of 
1.91±0.13 MU, whereas hyperosmotic treatment was observed to induce an 
increase in F-actin prior to 2.61±0.21 MU (Fig. 3.7). Mechanical impact was 
noted to induce a rapid decrease in F-actin (0.43±0.03 MU.h-1) under 
control conditions (Fig. 3.7), termed Impact Induced Actin Decrease (IIAD), 
between 0 and 2 h post impact. No significant (p>0.05) alterations in F-actin 
were observed between 2 – 48 h post impact. Additionally, whilst IIAD was 
not observed to be significantly affected by hypo-osmotic challenge (0.40-
±0.03 MU.h-1), hyperosmotic challenge was noted to reduce the rate of IIAD 









Initial rate of actin 
polymerisation (MU.h-1) 
Subsequent rate of 
actin polymerisation 
(MU.h-1) 
280 -0.43 ± 0.03 0.00 ± 0.00 
380 -0.20 ± 0.04 *** 0.01 ± 0.00 
140 -0.40 ± 0.03 * -0.01 ± 0.00 
 
Figure 3.7: F-actin decreases post-mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, hypo-osmotic (140 mOsm) 
or hyperosmotic (380 mOsm) challenges and subjected to a single mechanical impact. 
Samples were fixed with 4 % paraformaldehyde and stained with Alexa Fluor 488 
phalloidin (5 µl/ml). Cells were visualised using CLSM prior to and at 2 h, 24 h and 48 h 
post mechanical impact. Linear profiling analysis was used to quantify f-actin, expressed 
relative to volume changes. An initial decrease in actin polymerisation was observed under 
all osmotic conditions, a significantly less acute decrease was seen under hyperosmotic 
conditions. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all 




3.2.4 The Cytokine Response to Mechanical Impact 
Various cytokines are known to have a role within the OA pathology, 
whereby they induce the breakdown of the extracellular matrix (ECM) via 
increased production of matrix degrading enzymes such as matrix 
metalloproteinases (MMPs) (Rowan and Young, 2007, Westacott and 
Sharif, 1996). Given this sensitivity of articular cartilage to inflammatory 
cytokines, the effect of mechanical impact on cytokine release was 
investigated.  
 
Supernatant samples were collected immediately and at 2, 24 and 48 h 
post mechanical impact and analysed by ELISA for cytokine concentration, 
whereby cytokine concentrations were detected as pg/ml and subsequently 
adjusted for weight. Articular cartilage was observed to release IL-1β 
(33.53±4.20 pg/ml/g), IL-10 (80.98±24.30 pg/ml/g) and MCP-1 (50.02±6.4 
pg/ml/g) prior to impact (Fig. 3.8).  
 
Mechanical impact induced an increase in cytokines, whereby pro-
inflammatory cytokine IL-1β exhibited a near 6 fold increase and MCP-1 a 
0.5 fold increase immediately post impact (Fig. 3.8A), whilst with the anti-
inflammatory cytokine IL-10 a near 6 fold increase at 24 h post impact was 
observed (Fig. 3.8B). When relative to baseline non-impact levels, 
mechanical impact was noted to induce an increase in pro-inflammatory 
cytokines IL-1β and MCP-1 immediately post impact, followed by a decline 
back to baseline levels by 24 h (Fig. 3.9A&C). The anti-inflammatory 
cytokine IL-10 was not significantly (p>0.05) increased immediately, but 
was increased 3 fold by 2 h before peaking at 24 h post impact and starting 
to decline, although still elevated nearly 5 fold at 48 h (Fig. 3.9B).  
 
Whilst neither hyperosmotic or hypo-osmotic challenges were observed to 
effect the profile of cytokine release induced by mechanical impact, 
whereby pro-inflammatory cytokines IL-1β and MCP-1 peaked immediately 
post impact at 0 h before declining to baseline and IL-10 peaked at 24 h, 
hyperosmotic challenge notably decreased the magnitude of cytokine 




MCP-1 at 0 h by 10 % and maximal IL-10 at 24 h by 19 % (Fig. 3.9). 
Conversely, hypo-osmotic challenge increased maximal cytokine 
production, increasing IL-1β at 0 h by 31 %, MCP-1 at 0 h by 98 % and IL-







Figure 3.8: Inflammatory cytokines increase post-mechanical impact.  
Cartilage explants were subjected to a single mechanical impact. Supernatant samples 
immediately following (A) and at 2 h (B), 24 h (C) and 48 h (D) post mechanical impact 
were analysed by ELISA. Mechanical impact was observed to increase inflammatory 
cytokines. IL-1β and MCP-1 were increased for up to 2 h post impact, IL-10 was increased 








Figure 3.9: Hypo-osmotic conditions increase inflammatory cytokines post-
mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, hypo-osmotic (140 mOsm) 
or hyperosmotic (380 mOsm) challenges and subjected to a single mechanical impact. 
Supernatant samples immediately following and at 2 h, 24 h and 48 h post mechanical 
impact were analysed by ELISA and cytokine concentration expressed relative to non-
impacted control samples. Hypo-osmotic treatment significantly increased IL-1β (A), IL-10 
(B) and MCP-1 (C) over the whole time course. Hyperosmotic significantly decreased peak 
IL-1β and peak IL-10. N=12  from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all 




3.2.5 Chondrocyte Death and IIVD as “Active” Processes 
Cell death traditionally is thought to occur by two mechanisms, passive 
uncontrolled necrosis or programmed, active apoptosis. Mechanical impact 
induced biphasic cell death is yet to be definitively described as either 
apoptosis or necrosis, or a combination. To investigate the role of active 
cell death post mechanical impact, articular cartilage explants were 
incubated at a lowered temperature of 20°C or a control of 37°C prior to 
and post mechanical impact and subsequently analysed by CLSM for 
viability prior to and at 2, 4, 24 and 48 h post mechanical impact. 
Additionally, as the mechanism of IIVD is yet unknown, to determine 
whether the process is a passive cell response or an active cellular 
process, samples were also analysed for volume post mechanical impact. 
 
Decreased temperature was observed to have no effect on the rate of initial 
cell death, whereby cell viability was not significantly (p>0.05) different at 4 
h post impact (80.29±4.61 %) to control 37°C (74.01±4.12 %). However, 
decreased temperature was observed to significantly (p<0.005) decrease 
the subsequent rate (0.15±0.06 %.h-1) of cell death compared to control 
temperature (0.66±0.03 %.h-1), resulting in an increased cell viability at 48 h 
of 73.73±4.24 % compared to 45.01±0.99 % (Fig. 3.10). 
 
In addition, 20°C incubation was noted to significantly (p<0.01) decrease 
the initial rate of IIVD, to 22.50±0.23 µm3.h-1, and the subsequent rate to 
0.56±0.01 µm3.h-1, thus implying an active component to both phases of 










Initial rate of 
chondrocyte death 
(%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
37 (control) 2.75 ± 0.14 0.66 ± 0.03 
20 2.65 ± 0.24 0.15 ± 0.06 *** 
 
Figure 3.10: Cell death post impact is temperature dependent.  
Cartilage explants were kept at control 37°C or 20°C and subjected to a single mechanical 
impact. Samples were loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using 
CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. Imaris spot analysis was 
used to quantify cell viability. Decreased temperature was observed to protect against cell 
death, with a significantly slower rate of subsequent cell death. N=12 from 3 distinct 










Initial rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
37 (control) 34.38 ± 0.03 2.87 ± 0.85 
20 22.50 ± 0.23 ** 0.56 ± 0.01 *** 
 
Figure 3.11: Mechanical impact induced decrease in cell volume is temperature 
dependent.  
Cartilage explants were kept at control 37°C or 20°C and subjected to a single mechanical 
impact. Samples were loaded with Calcein AM (5 µM) and visualised using CLSM prior to 
and at 2 h, 24 h and 48 h post mechanical impact. Isosurface volume analysis was used to 
quantify cell volume. Decreased temperature was observed to decrease the mechanical 
impact induced decrease in cell volume was seen. N=12  and n=60 from 3 distinct 





3.2.6 The Role of Extracellular Calcium in Chondrocyte Death and IIVD 
Calcium signalling is known to play a role in many aspects of 
mechanotransduction, including regulatory volume decrease (RVD). 
Calcium changes within the cell can be a result of release from intracellular 
stores, or flux from the extracellular environment via membrane channels. 
To investigate the possible role of calcium signalling in chondrocyte death 
and IIVD, samples were incubated with EGTA (2 mM), a calcium chelator, 
to remove extracellular calcium ([Ca2+]0) and thus reveal any involvement of 
calcium influx via membrane channels in chondrocyte death or IIVD.  
 
Removal of [Ca2+]0 by EGTA was observed to significantly decrease both 
the initial rate (2.34±0.15 .h-1) and the subsequent rate (0.12±0.02 %.h-1) of 
cell death post mechanical impact when compared to control rates of 
2.75±0.14 %.h-1 and 0.66±0.03 %.h-1 respectively. This resulted in a 1.7 
fold increase in cell viability at 48 h compared to control (Fig. 3.12). [Ca2+]0 
was further observed to have a role within the subsequent phase of IIVD, 
whereby the subsequent rate of IIVD was significantly decreased (p<0.005) 
to 0.73±0.13 µm3.h-1 (Fig. 3.13). Conversely, the removal of [Ca2+]0 was not 










Initial rate of 
chondrocyte death (%.h-
1) 
Subsequent rate of 
chondrocyte death (%.h-
1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
EGTA 2.34 ± 0.15 * 0.12 ± 0.02 *** 
 
Figure 3.12: Cell death post impact is dependant on extracellular calcium.  
Cartilage explants were pre-treated for 1 h with control isotonic or EGTA supplemented (2 
mM) conditions and subjected to a single mechanical impact. Samples were loaded with 
Calcein AM (5 µM) and PI (1 µM) and visualised using CLSM prior to and at 2 h, 24 h and 
48 h post mechanical impact. Imaris spot analysis was used to quantify cell viability. 
Removal of extracellular calcium by EGTA was observed to protect against impact induced 
cell death. N=12 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all vs. control. 








Initial rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Control 34.38 ± 0.03 2.87 ± 0.85 
EGTA 35.10 ± 0.04 0.73 ± 0.13 ** 
 
 
Figure 3.13: Mechanical impact induced decrease in cell volume is dependent of 
extracellular calcium.  
Cartilage explants were pre-treated for 1 h with control isotonic or EGTA supplemented (2 
mM) conditions and subjected to a single mechanical insult. Samples were stained with 
Calcein AM (5 µM) and visualised using CLSM prior to and at 2 h, 24 h and 48 h post 
mechanical impact. Isosurface volume analysis was used to quantify cell volume. Removal 
of extracellular calcium was observed to decrease the subsequent rate of mechanical 
impact induced decrease in cell volume. N=12  and n=60 from 3 distinct experiments. 




3.2.7 The Role of IIAD in Chondrocyte Death Post Mechanical Impact 
The F-actin cytoskeleton is essential to maintaining structural cell integrity 
(Blain, 2009, Guilak et al., 1995, Wang et al., 1993), evidenced by the 
defective function and decreased number of viable chondrocytes within OA 
tissue (Blain, 2009), thus the observed IIAD could have a role within impact 
induced cell death. Therefore, latrunculin B (10 µM), an inhibitor of actin 
polymerisation that disrupts actin filaments (Spector et al., 1989), and 
jasplakinolide (5 µM), a stabilizer of F-actin (Bubb et al., 2000), were 
employed to determine the effects of exacerbating and inhibiting IIAD 
respectively, on cell viability post mechanical impact.  
 
Disrupting F-actin, and thus enhancing IIAD, via latrunculin B was observed 
to significantly (p< 0.05) increase chondrocyte death post mechanical 
impact, with a viability of 38.68±3.98 % at 48 h compared to a control 
viability of 45.01±0.99 %. Conversely, stabilising F-actin and thus blocking 
IIAD, via jasplakinolide was noted to be chondroprotective, with no 
significant chondrocyte death at 48 h (85.92±3.50 %; Fig. 3.14).  
 
Latrunculin B and jasplakinolide had opposing effects of the rates of 
chondrocyte death, whereby latrunculin B increased the initial rate of cell 
death by 30 % and the subsequent rate by 8 %. Jasplakinolide, on the other 
hand, decreased the initial rate of chondrocyte death by 52 % and the 
subsequent rate by 88 %, thus establishing a role for IIAD within the 







Initial rate of 
chondrocyte death 
(%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
Latrunculin B 3.52 ± 0.34 ** 0.71 ± 0.01 ** 
Jasplakinolide 1.31 ± 0.59 *** 0.08 ± 0.03 *** 
 
 
Figure 3.14: Cell death post impact is dependant on F-actin depolymerisation.  
Cartilage explants were pre-treated for 1 h with control isotonic, Latrunculin B (10 µM) or 
Jasplakinolide supplemented (5 µM) conditions and subjected to a single mechanical 
impact. Samples were loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using 
CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. Imaris spot analysis was 
used to quantify cell viability. Stabilising of f-actin by Jasplakinolide was observed to 
significantly reduce both the initial and subsequent rate of cell death post mechanical 
impact. Disruption of f-actin by Latrunculin B was observed not to affect cell death. N=12 







Mechanical impact was observed to induce biphasic chondrocyte death 
over 48 h post impact. A rapid initial death was observed, followed by a 
slower subsequent death. Similarly, mechanical impact was seen to result 
in a biphasic IIVD, again a rapid initial decrease was observed followed by 
a slower subsequent decrease. IIAD was additionally observed post 
mechanical impact, although this was a rapid response, limited to the first 2 
h post mechanical impact. Furthermore, mechanical impact resulted in 
increased pro and anti-inflammatory cytokines, pro-inflammatory cytokines 
peaking immediately post impact, and anti-inflammatory cytokines peaking 
at 24 h (Table 3.1). 
 
Cell swelling induced by hypo-osmotic challenge increased both the initial 
and subsequent rates of cell death post mechanical impact, and additionally 
resulted in an increased initial and subsequent rate of IIVD. Furthermore, 
hypo-osmotic treatment decreased initial F-actin and but did not affect the 
rate of IIAD. Additionally, hypo-osmotic treatment was observed to increase 
both pro and anti-inflammatory cytokines, whilst not affecting the 
expression pattern of cytokine release. These data indicated cell swelling, 
such as that occurring within OA tissue, increases chondrocyte sensitivity to 
mechanical impact. 
 
Cell shrinkage by hyperosmotic challenge was seen to have 
chondroprotective effects post mechanical impact. Hyperosmotic challenge 
additionally induced a decrease in both initial and subsequent rates of IIVD, 
and increase in F-actin prior to impact, and protected against IIAD. 
Furthermore, hyperosmotic treatment was seen to decrease pro and anti-
inflammatory cytokines. These data imply a role for cell shrinkage in 
chondroprotection.  
 
Decreasing tissue temperature was observed to protect against cell death 
post mechanical impact, decreasing the subsequent rate of chondrocyte 




subsequent rates of IIVD, indicating that IIVD and the secondary phase of 
impact induced cell death are active processes.  
 
Similarly, removal of [Ca2+]0 with EGTA was chondroprotective, decreasing 
both the initial and subsequent rates of chondrocyte death. However, 
removal of [Ca2+]0 only decreased the secondary phase of IIVD, indicating 
that whilst the initial phase of IIVD is independent of calcium influx via 
membrane channels, the secondary phase is not.  
 
Finally, simulation of IIAD with latrunculin B was observed to exacerbate 
cell death, whereas prevention of IIAD with jasplakinolide was observed to 















 Mechanical impact induced responses 
Viability Biphasic cell death 
Volume Biphasic IIVD 
F-actin Rapid IIAD 
Cytokines 
Increased, pro-inflammatory peak at 0h, anti-inflammatory 
peak at 24 h 
 
Table 3.1: Articular cartilage responses to single mechanical impact 











Chapter 4: Chondroprotective Actions of Nutritional 








Mechanical loading, whilst integral to maintaining healthy cartilage, at 
abnormal or traumatic levels induces a decrease in viable cells, 
extracellular matrix (ECM) degradation and actin destabilisation (Oliveria et 
al., 1999, Tew et al., 2000). As previously observed (Chapter 3), single 
mechanical trauma stimulated significant biphasic chondrocyte death, 
biphasic trauma induced volume decrease (IIVD) and rapid trauma induced 
actin decrease (IIAD) in addition to inducing increased inflammatory 
cytokine production. Previous studies have reported mechanical impact to 
result in  ECM degradation via a decrease in proteoglycan (PG) and collage 
II synthesis, and an increase in catabolic proteases such as matrix 
metalloproteinases (MMPs). Additionally, pro-inflammatory cytokines, 
including IL-1β have been noted to induce chondrocyte death and stimulate 
ECM degradation (Liu et al., 1994, Rowan and Young, 2007, Westacott and 
Sharif, 1996).  
 
Osteoarthritis (OA) is characterised by a loss of viable chondrocytes and 
ECM degeneration, thus the cellular and ECM effects resultant of 
mechanical impact are indicated as severe risk factors for the development 
of OA. It is therefore of interest to investigate protective mechanisms 
against the effects of mechanical impact, namely chondrocyte death, IIVD, 
IIAD and inflammation. In recent years, promising chondroprotective agents 
evaluated in clinical trials include risedronate, a biphosphonate approved 
for the treatment of osteoporosis (Van Offel et al., 2002, Van Offel et al., 
2005), and doxycycline, an antibiotic (Smith et al., 1996, Shlopov et al., 
1999), though neither has been associated with definitive results (Felson 
and Kim, 2007). Thus, alternative agents with possibilities of 
chondroprotective actions were studied here, including RVD inhibitors; REV 
5901 and tamoxifen, and nutriceuticals; chondroitin sulphate and 
glucosamine sulphate. 
4.1.1 Chondroprotective Agents 
REV 5901 is an antagonist of cysteinyl-leukotriene receptors (a family of G-
protein coupled receptors), in porcine epithelial cells (Van Inwegen et al., 




of regulatory volume decrease (RVD) in articular chondrocytes (Hall and 
Bush, 2001). Given the effect of REV 5901 on RVD, and that IIVD is a 
consequence of mechanical impact, REV 5901 was investigated as a 
possible chondroprotective agent. 
 
Tamoxifen, a tissue-dependent oestrogen receptor agonist/antagonist, is 
routinely used as a cancer treatment, primarily in oestrogen sensitive breast 
cancer. However, it is also know to be an inhibitor of volume-sensitive 
organic anion channels (VSOACs) and thus an inhibitor of RVD, as the 
postulated RVD osmolyte channel is known to be VSOAC similar (Hall, 
1995). Additionally, tamoxifen has anticalmodulin actions, suggesting it 
could have a role in actin regulation as calmodulin is an upstream molecule 
necessary for the expression of cofilin, an actin depolymerising protein 
(Ono, 2007). With IIAD and IIVD features of mechanical impact, tamoxifen 
has the potential for chondroprotective actions. 
 
Chondroitin sulphate, a high molecular weight glycosaminoglycan (GAG), 
constitutes the majority of GAGs found within the ECM, branched from 
PGs. Chondroitin sulphate is thus considered essential for the structural 
integrity of the tissue (Kelly, 1998, Lippiello et al., 2000). It has additionally 
been reported that chondroitin sulphate stimulates cartilage repair, inhibits 
catabolic enzymes and has anti-inflammatory actions (Huskisson, 2008, 
Deal and Moskowitz, 1999), thus indicating a possible use as a 
chondroprotective agent. 
 
Glucosamine sulphate, a monosaccharide, is the principle substrate in the 
synthesis of PGs (Simanek et al., 2005). Loss of PGs within the ECM is a 
characteristic of both mechanical impact and OA, thus it is hypothesised 
that glucosamine sulphate could have chondroprotective mechanisms by 
providing increased potential for PG synthesis (Huskisson, 2008, Simanek 







4.1.2 Chapter Aims 
This study aims to investigate the chondroprotective potential of 
nutriceuticals and pharmaceuticals.  
Specifically by: 
1. Study of the effects of named nutriceuticals and pharmaceuticals 
post mechanical impact on chondrocyte viability, volume and the 
actin cytoskeleton. 
2. Determination of the effects of named nutriceuticals and 
pharmaceuticals on inflammatory cytokine concentrations in articular 
cartilage post mechanical impact. 
3. Investigation of the involvement of a known calcium signalling 
pathway in the potential mechanism of chondroprotection of named 





4.2.1 REV 5901: Chondroprotective Effects 
REV 5901 has been previously shown to have effects on 
mechanotransduction pathways, whereby it is an inhibitor of regulatory 
volume decrease (Bush and Hall, 2001a). Given the effect of REV 5901 on 
RVD, and that IIVD has been observed here to be a consequence of 
mechanical impact, REV 5901 was investigated as a possible 
chondroprotective agent. Before further investigating the potential 
chondroprotective mechanisms of REV 5901, it was first necessary to 
confirm the effects of both REV 5901 and DMSO, the vehicle of REV 5901, 
did not alter DMEM osmolarity and thus simply exert osmotic effects.  
 
The initial osmolarity of DMEM was confirmed using a Vapro™ vapour 
pressure osmometer to be 280.10±0.75 mOsm which did not significantly 
change (P>0.05) either by the addition of REV5901 or the DMSO vehicle 
whereby the osmolarities were 282.30±1.23 mOsm and 283.21±2.36 
mOsm respectively (Fig. 4.1).  
 
Having determined the effects of REV 5901 on cell volume to be 
independent of osmotic changes, the influence of REV 5901 on cell volume 
was investigated on isotonic and hyperosmotic samples as a model of 
‘evening’ cartilage. REV 5901 was observed to significantly decrease 
chondrocyte volume, regardless of initial volume. Whereby, isotonic 
samples (Fig. 4.2A), with a mean volume of 716.14±37.81 µm3, exhibited a 
decrease in cell volume post incubation with REV 5901 (Fig. 4.2B) to 
426.29 µm3. Similarly, hyperosmotic samples (Fig. 4.2C), with a mean 
volume of 561.46±25.49 µm3, further decreased in volume post incubation 











Figure 4.1: The addition of REV 5901 has no effect on medium osmolarity. 
Samples of control isotonic, DMSO (0.1 %) and REV 5901 (5 µM) supplemented DMEM 
were measured for osmolarity using Vapro TM vapour pressure osmometer. Neither DMSO 






Figure 4.2: REV 5901 decreases cell volume post osmotic challenge. 
Cartilage explants were pre-treated for 1 h with control isotonic or hyperosmotic (380 
mOsm) DMEM and for a subsequent 1 h with control isotonic (280 mOsm; A&B) or REV 
5901 (50 µM; C&D) supplemented DMEM. Samples were loaded with Calcein AM (5 µM) 
and visualised using CLSM immediately post treatment. Isosurface volume analysis was 
used to quantify cell volume. REV 5901 was observed to significantly decrease cell volume 
regardless of previous osmotic challenge (E). N=12  and n=60 from 3 distinct experiments. 




The effects of REV 5901 on chondrocyte volume further supported the 
potential for REV 5901 as a chondroprotective agent, thus to investigate 
REV 5901 as a chondroprotective agent samples were pre-treated with 
control (280 mOsm), DMSO (0.1 %) or REV 5901 (50 µM) supplemented 
DMEM and analysed post mechanical impact by CLSM for viability and 
volume. 
 
REV 5901 was initially confirmed to have no adverse effects of cell viability, 
with a pre-impact viability of 94.08±2.12 %.h-1. REV 5901 treatment 
resulted in a decrease in both the initial (1.50±0.58 %.h-1) and subsequent 
(0.04±0.03 %.h-1) rate of cell death compared to control (Initial: 2.75±0.14 
%.h-1, Subsequent: 0.66±0.03 %.h-1). This resulted in no significant change 
in cell viability post mechanical impact (Fig. 4.3), conversely, DMSO had no 
significantly different effects to control conditions, thus demonstrating the 
chondroprotective effects of REV 5901 where not an artefact of the DMSO 
vehicle.  
 
Furthermore, REV 5901 treatment was seen to significantly decrease cell 
volume (p<0.005) by 27 % prior to mechanical impact to 552.68±27.26 µm3 
when compared to control samples (716.14±35.82 µm3; Fig. 4.4C&D). 
Biphasic IIVD was observed in REV 5901 conditions post mechanical 
impact, however both the initial (20.53±0.03 µm3.h-1) and the subsequent 
(0.79±0.06 µm3.h-1) rate of IIVD were observed to be significantly slower 
when compared to control conditions (initial: 34.38±0.03 m3.h-1, 
subsequent: 2.87±0.85 m3.h-1; Fig. 4.5). DMSO conditions did not 
significantly (p>0.05) alter initial cell volume (Fig. 4.4B) or rates of IIVD, 
again confirming the actions of REV 5901 to be solely due to REV 5901 as 








Condition Initial rate of chondrocyte death (%.h-1) 
Subsequent rate of 
chondrocyte death  
(%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
DMSO 3.25 ± 1.29 0.59 ± 0.05 
REV 5901 1.50 ± 0.58 *** 0.04 ± 0.03 *** 
 
 
Figure 4.3: REV 5901 pre-treatment protects against cell death post impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, DMSO or REV 5901 (50 
µM) supplemented DMEM and subjected to a single mechanical impact. Samples were 
loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using CLSM prior to and at 2 
h, 4 h, 24 h and 48 h post mechanical impact. Imaris spot analysis was used to quantify 
cell viability. Treatment with REV 5901 was seen to protect against cell death. N=12 from 3 









Figure 4.4: REV 5901 decreases chondrocyte volume.  
Cartilage explants were pre-treated for 1 h with control isotonic (A), DMSO (B) or REV 
5901 (C; 50 µM) supplemented DMEM and subjected to a single mechanical impact. 
Samples were loaded with Calcein AM (5 µM) and visualised using CLSM prior to 
mechanical impact. Isosurface volume analysis was used to quantify cell volume. REV 
5901 significantly decreased cell volume prior to mechanical impact (D). N=12  and n=60 










Initial rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Control 34.38 ± 0.03 2.87 ± 0.85 
DMSO 35.30 ± 0.14 2.82 ± 0.19 
REV 5901 20.53 ± 0.03 *** 0.79 ± 0.06 *** 
 
Figure 4.5: REV 5901 decreases mechanical impact induced volume decrease.  
Cartilage explants were pre-treated for 1 h with control isotonic, DMSO or REV 5901 (50 
µM) supplemented DMEM and subjected to a single mechanical impact. Samples were 
loaded with Calcein AM (5 µM) and visualised using CLSM prior to and at 2 h, 4 h, 24 h 
and 48 h post mechanical impact. Isosurface volume analysis was used to quantify cell 
volume. REV 5901 treated samples were observed to have a significantly slower initial and 
subsequent rate of volume decrease. N=12  and n=60 from 3 distinct experiments. 




Further, the role of the F-actin cytoskeleton in the chondroprotective effects 
of REV 5901 was investigated using linear profiling and the PQ Factor, as 
previously described (See Methods and Materials). 
 
REV 5901 was observed to increase F-actin prior to mechanical impact by 
68 % to 3.20±0.24 MU compared to control values of 1.91±0.32 MU (Fig. 
4.6). Additionally, REV 5901 treatment induced a decrease in the rate of 
IIAD from a control rate of 0.43±0.03 MU.h-1 to 0.16±0.03 MU.h-1, thus 
resulting in no significant change (p>0.05) in F-actin from prior to impact 
(3.20±0.24 MU) to 48 h post mechanical impact (3.30±0.37 MU; Fig. 4.6). 
DMSO was noted to not alter F-actin prior to impact, or alter the rate of IIAD 
observed in control samples, further confirming the chondroprotective 







Condition Initial rate of actin polymerisation (MU.h1) 
Subsequent rate of actin 
polymerisation (MU.h-1) 
Control -0.43 ± 0.03 0.00 ± 0.00 
DMSO -0.38 ± 0.06 0.00 ± 0.00 
REV 5901 -0.16 ± 0.03 *** 0.01 ± 0.02 
 
 
Figure 4.6: REV 5901 protects against mechanical impact induced F-actin decrease.  
Cartilage explants were pre-treated for 1 h with control isotonic, DMSO or REV 5901 (50 
µM) supplemented DMEM and subjected to a single mechanical impact. Samples were 
fixed with 4 % paraformaldehyde and stained with Alexa Fluor 488 phalloidin (5 µl/ml). 
Cells were visualised using CLSM prior to and at 2 h, 24 h and 48 h post mechanical 
impact. Linear profiling analysis was used to quantify f-actin, expressed relative to volume 
changes. REV 5901 was observed to significantly increase f-actin prior to mechanical 
impact and significantly decrease the rate of mechanical impact induced f-actin decrease. 
N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all vs. control. 





REV 5901 is a known inhibitor of 5-lipoxygenase (5-LO) (Musser et al., 
1987), thus to confirm the presence of 5-LO within articular cartilage, and 
the inhibitory effects of REV 5901, LTB4, a downstream leukotriene of 5-LO, 
concentration was analysed by ELISA. LTB4 concentration was observed to 
increase almost 4 fold in response to mechanical impact (3.72±0.19 AU), 
confirming the presence of 5-LO within articular cartilage. REV 5901 was 
noted to significantly decrease LTB4 by 92 % post mechanical impact, and 
by 70 % when compared to non-impacted controls, to 0.30±0.01 AU (Fig. 
4.7). Thus, the inhibitory effects of REV 5901 on 5-LO were confirmed. 
 
Leukotrienes, such as LTB4, have been noted to be involved in the 
production of inflammatory cytokines in synovial cells (Kageyama et al., 
1994), thus the possible anti-inflammatory effects of REV 5901 were 
investigated post mechanical impact, whereby supernatant samples were 
collected immediately and at 2, 24 and 48 h post mechanical impact and 
analysed by ELISA for cytokine concentration as previously described (See 
Methods and Materials).  
 
REV 5901 was observed to decrease pro-inflammatory cytokine production 
immediately post impact, decreasing IL-1β by 87 % to 0.75±0.09 AU (Fig. 
4.8A) and MCP-1 by 54 % to 0.67±0.11 AU  (Fig. 4.8C). In addition, REV 
5901 decreased anti-inflammatory cytokine release, whereby the peak IL-
10 concentration observed at 24 h in control samples was reduced by 84 % 
to 0.90±0.17 AU (Fig. 4.8B).  Furthermore, REV 5901 was observed to 
prevent any impact induced increase in inflammatory cytokines, with no 
significant (p>0.05) changes in cytokine concentration observed over 48 h 






Figure 4.7: REV 5901 decreases LTB4 concentration in articular cartilage.  
Cartilage explants were pre-treated for 1 h with control isotonic, DMSO or REV 5901 (50 
µM) supplemented DMEM and subjected to a single mechanical impact. Supernatant at 4 
h post mechanical impact was analysed by ELISA and LTB4 concentration expressed 
relative to non-impacted control samples. LTB4 concentration was seen to significantly 
increase post mechanical impact. Conversely, pre-treatment with REV 5901 was observed 
to significantly decrease LTB4 concentration compared to both control and non-impacted 






Figure 4.8: REV 5901 decreases inflammatory cytokines post-mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, DMSO or REV 5901 (50 
µM) supplemented DMEM and subjected to a single mechanical impact. Supernatant 
samples immediately following and at 2 h, 24 h and 48 h post mechanical impact were 
analysed by ELISA and cytokine concentration expressed relative to non-impacted control 
samples. REV 5901 was observed to significantly decrease IL-1β (A), IL-10 (B) and MCP-1 
(C) over the whole time course when compared to both control and non-impacted controls. 





4.2.2 The Role of Calcium Signalling in the Mechanism of Action of 
REV 5901 
REV 5901 is a known inhibitor of RVD, whereby REV 5901 prevents a 
return to resting volume in in situ chondrocytes post hypo-osmotic 
challenge (Bush and Hall, 2001a). These actions have been previously 
observed within the laboratory to be dependent on intracellular calcium 
signalling, via the PKC/PLCβ3 pathway (Qusous et al., 2011). Thus, the role 
of this pathway within the chondroprotective actions of REV 5901 
demonstrated here was investigated, whereby samples were pre-incubated 
rottlerin (100 µM), an inhibitor of PKC, U73122 (100 µM), an antagonist of 
PLCβ3 or EGTA (2mM), a calcium chelator, prior to incubation with REV 
5901 (50 µM). Subsequent to mechanical impact, samples were analysed 
by CLSM for viability and volume and F-actin. 
 
Rottlerin and U73122 both reversed the chondroprotective effects of REV 
5901 post mechanical impact, whereby rottlerin and U73122 pre-incubation 
decreased chondrocyte viability at 48 h post impact by a further 27 %, 
compared to REV 5901 alone (Fig. 4.9). To this end, rottlerin and U73122 
pre-incubation increased the initial rate of cell death to 2.31±0.21 %.h-1 and 
3.13±0.85 %.h-1 respectively, values not significantly (p>0.05) different to 
control (2.75±0.14 %.h-1). Conversely, EGTA pre-incubation did not affect 
the chondroprotective actions of REV 5901, suggesting REV 5901 acts via 
intracellular calcium signalling, not extracellular calcium flux (Fig. 4.9).  
 
Furthermore, whilst REV 5901 was observed to decrease cell volume prior 
to mechanical impact to 552.68±27.26 µm3, pre-incubation with rottlerin and 
U73122 prevented this decrease, displaying cell volumes of 680.89±17.34 
µm3 and 670.92±11.25 µm3 respectively, not significantly different from 
control volumes of 716.14±37.81 µm3 (Fig 4.10). Interestingly, rottlerin and 
U73122 were observed to block the initial rate IIVD, compared to both 
control (34.38±0.03 µm3.h-1) and REV 5901 (20.53±0.03 µm3.h-1) to 
3.00±0.03 µm3.h-1 and 2.50±0.41 µm3.h-1 respectively (Fig. 4.10), indicating 




extracellular calcium by EGTA was again observed to have no effect on the 
actions of REV 5901 or on IIVD. 
 
When studying F-actin responses, it was noted that rottlerin and U73122 
both inhibited the REV 5901 induced increase in F-actin prior to mechanical 
impact, by 40 % and 30 % respectively (Fig 4.11). Furthermore, rottlerin 
and U73122 were seen to restore the observation of IIAD, whereby a 
decrease in F-actin was observed from 0 - 2 h post impact, not significantly 
different (p>0.05) from control (0.43±0.03 MU.h-1), of 0.46±0.03 MU.h-1 and 
0.52±0.01 MU.h-1 respectively (Fig. 4.11). Conversely, EGTA exhibited an 
increase in F-actin prior to mechanical impact, not significantly different 
(p>0.05) to that observed with REV 5901, and did not exhibit IIAD (Fig. 
4.11). 
 
The role of the PKC/PLβ3 pathway was additionally investigated in the anti-
inflammatory effects of REV 5901. Neither rottlerin, U73122 nor EGTA were 
observed to inhibit the anti-inflammatory effects of REV 5901, whereby 
upon pre-incubation with rottlerin, U73122 and EGTA, pro-inflammatory 
cytokines IL-1β (Fig. 4.12A) and MCP-1 (Fig. 4.12C) remained decreased 
below non-impact control concentrations for 48 h post impact. Additionally, 
the decreased expression of IL-10 (Fig. 4.12B) induced by REV 5901 was 
maintained upon pre-incubation with rottlerin, U73122 and EGTA. These 
data suggest that the anti-inflammatory effects of REV 5901 are not 







Initial rate of 
chondrocyte death 
(%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
REV 5901 1.50 ± 0.58 *** 0.04 ± 0.03 *** 
REV 5901 & Rottlerin 2.31 ± 0.21 0.28 ± 0.00 ** 
REV 5901 & U73122 3.14± 0.85 0.25 ± 0.03 ** 
REV 5901 & EGTA 1.35 ± 0.26 *** 0.05 ± 0.01 *** 
 
 
Figure 4.9: REV 5901’s chondroprotective actions are PKC/PLCβ3 dependent.  
Cartilage explants were pre-treated for 1 h with control isotonic, REV 5901 (50 µM), REV 
5901 and rottlerin (100 µM), REV 5901 and U73122 (100 µM) or REV 5901 and EGTA 
(2mM) supplemented DMEM and subjected to a single mechanical impact. Samples were 
loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using CLSM prior to and at 2 
h, 4 h, 24 h and 48 h post mechanical impact. Imaris spot analysis was used to quantify 
cell viability. Treatment with rottlerin and U73122 was observed to reverse the 
chondroprotective effects of REV 5901. N=12 from 3 distinct experiments. *p<0.05, 











Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Control 34.38 ± 0.03 2.87 ± 0.85 
REV 5901 20.53 ± 0.03 *** 0.79 ± 0.06 *** 
REV 5901 & Rottlerin 3.00 ± 0.03 *** 2.79 ± 0.12 
REV 5901 & U73122 2.50± 0.41 *** 3.01 ± 0.30 
REV 5901 & EGTA 18.69 ± 0.56 *** 0.95 ± 0.02 *** 
 
Figure 4.10: REV 5901 decreases cell volume by a PKC/PLCβ3 dependant 
mechanism.  
Cartilage explants were pre-treated for 1 h with control isotonic, REV 5901 (50 µM), REV 
5901 and rottlerin (100 µM), REV 5901 and U73122 (100 µM) or REV 5901 and EGTA 
(2mM) supplemented DMEM and subjected to a single mechanical impact. Samples were 
loaded with Calcein AM (5 µM) and visualised using CLSM prior to and at 2 h, 24 h and 48 
h post mechanical impact. Isosurface volume analysis was used to quantify cell volume. 
Treatment with rottlerin and U73122 was observed to reverse the decrease in cell volume 
seen with REV 5901. Additionally, treatment with rottlerin and U73122 was observed to 
significantly decrease the initial rate of impact induced cell volume decrease compared to 
control. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all vs. 











Initial rate of actin 
polymerisation 
(MU.h-1) 
Subsequent rate of 
actin polymerisation 
(MU.h-1) 
Control -0.43 ± 0.03 0.00 ± 0.00 
REV 5901 -0.16 ± 0.03 *** 0.01 ± 0.02 
REV 5901 & Rottlerin -0.46 ± 0.03 0.00 ± 0.00 
REV 5901 & U73122 -0.52± 0.01 0.00 ± 0.00 
REV 5901 & EGTA -0.13 ± 0.01 *** 0.00 ± 0.00 
 
Figure 4.11: REV 5901’s protection against mechanical impact induced decrease in 
F-actin is PKC/PLCβ3 dependant.  
Cartilage explants were pre-treated for 1 h with control isotonic, REV 5901 (50 µM), REV 
5901 and rottlerin (100 µM), REV 5901 and U73122 (100 µM) or REV 5901 and EGTA 
(2mM) supplemented DMEM and subjected to a single mechanical impact. Samples were 
fixed with 4 % paraformaldehyde and stained with Alexa Fluor 488 phalloidin (5 µl/ml). 
Cells were visualised using CLSM prior to and at 2 h, 24 h and 48 h post mechanical 
impact. Linear profiling analysis was used to quantify f-actin, expressed relative to volume 
changes. Treatment with rottlerin and U73122 was observed to significantly increase the 
initial rate of mechanical impact induced f-actin decrease compared to REV 5901. 
Additionally, treatment with rottlerin and U73122 was observed to have no effect on the 
initial REV 5901 induced increase in f-actin observed prior to mechanical impact. N=12  
and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all vs. control. Arrow 





Figure 4.12: REV 5901 decreases inflammatory cytokines post-mechanical impact 
independent of PKC/PLCβ3.  
Cartilage explants were pre-treated for 1 h with control isotonic, REV 5901 (50 µM), REV 
5901 and rottlerin (100 µM), REV 5901 and U73122 (100 µM) or REV 5901 and EGTA 
(2mM) supplemented DMEM and subjected to a single mechanical impact. Supernatant 
samples immediately following and at 2 h, 24 h and 48 h post mechanical impact were 
analysed by ELISA and cytokine concentration expressed relative to non-impacted control 
samples. Treatment with rottlerin, U73122 and EGTA was observed to have no effect on 
the decrease in IL-1β (A), IL-10 (B) or MCP-1 (C) concentration observed with REV 5901. 







4.2.3 Tamoxifen as a Possible Chondroprotective Drug 
Tamoxifen is known to be an inhibitor of RVD (Hall, 1995), in addition to 
having anticalmodulin actions. Thus, as calmodulin is an upstream 
molecule of actin depolymerising protein cofilin (Ono, 2007) and IIAD has 
been previously shown to be a feature of mechanical impact, tamoxifen has 
the potential for chondroprotective actions. Initially, it was necessary to 
confirm any chondroprotective effects induced by tamoxifen were not the 
result of osmotic changes. Thus, the osmolarity of Tamoxifen supplemented 
DMEM was measured as previously described (See Materials and 
Methods), where it was verified that Tamoxifen (286.01±8.33 mOsm) did 
not significantly adjust medium osmolarity compared to control 
(280.10±0.75 mOsm, Fig. 4.13). Therefore, the effects of Tamoxifen on 
chondrocyte viability and volume post mechanical impact were investigated, 
and compared to the previously noted chondroprotective effects of 
hyperosmotic challenge. 
 
Tamoxifen was observed to have chondroprotective effects post 
mechanical impact, such that a viability of 88.30±3.34 % was noted at 48 h, 
not significantly different to viability prior to impact (95.02±4.51 %). 
Furthermore, the significant (p<0.005) reduction in initial cell death 
observed (0.50±0.03 %.h-1) was similar to the chondroprotective decrease 
in initial cell death observed with hyperosmotic challenge (0.50±0.04 %.h-1; 
Fig. 4.14). 
 
Investigation into cell volume revealed Tamoxifen induced a decrease in 
cell volume to 423.99±15.54 µm3 (Fig. 4.15C), compared to both control 
(716.14±37.81 µm3; Fig. 4.15A) and hyperosmotic challenge (578.46±25.49 
µm3; Fig. 4.15B) prior to mechanical impact (Fig. 4.15D). Additionally, whilst 
the chondroprotective hyperosmotic challenge exhibited a biphasic IIVD, 
Tamoxifen significantly (p<0.005) decreased both the initial and subsequent 
rates of IIVD, to 1.19±0.30 µm3.h-1 and 0.30±0.14 µm3.h-1 respectively. The 
reduction of IIVD resulted in a cell volume of 432.29±5.45 µm3 by 48 h post 












Figure 4.13: The addition of tamoxifen has no effect on medium osmolarity. 
Samples of control isotonic and tamoxifen (10 µM) supplemented DMEM were measured 
for osmolarity using Vapro TM vapour pressure osmometer. Tamoxifen was not observed to 









Initial rate of 
chondrocyte death 
(%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
380 mOsm 0.50 ± 0.04 *** 0.00 ± 0.06 *** 
Tamoxifen 0.50 ± 0.03 *** 0.12 ± 0.02 *** 
 
 
Figure 4.14: Tamoxifen pre-treatment protects against cell death post mechanical 
impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, hyperosmotic (380 mOsm) 
or tamoxifen (10 µM) supplemented DMEM and subjected to a single mechanical impact. 
Samples were loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using CLSM 
prior to and at 2 h, 24 h and 48 h post mechanical impact. Imaris spot analysis was used to 
quantify cell viability. Tamoxifen was seen to protect against cell death. N=12 from 3 







Figure 4.15: Tamoxifen decreases chondrocyte volume. 
Cartilage explants were pre-treated for 1 h with control isotonic (A), hyperosmotic (B; 380 
mOsm) or tamoxifen (C; 10 µM) supplemented DMEM. Samples were loaded with Calcein 
AM (5 µM) and visualised using CLSM prior to mechanical impact. Isosurface volume 
analysis was used to quantify cell volume. Tamoxifen was observed to decrease cell 
volume prior to mechanical impact (D). N=12  and n=60 from 3 distinct experiments. 











Initial rate of chondrocyte 
volume decrease 
(µm3.h1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Control 34.38 ± 0.03 2.87 ± 0.85 
380 mOsm 26.95±1.12 *** 0.54±0.05 *** 
Tamoxifen 1.19 ± 0.30 *** 0.30 ± 0.14 *** 
 
Figure 4.16: Tamoxifen protects against mechanical impact induced cell volume 
decrease.  
Cartilage explants were pre-treated for 1 h with control isotonic, hyperosmotic (380 mOsm) 
or tamoxifen (10 µM) supplemented DMEM and subjected to a single mechanical impact. 
Samples were loaded with Calcein AM (5 µM) and visualised using CLSM prior to and at 2 
h, 24 h and 48 h post mechanical impact. Isosurface volume analysis was used to quantify 
cell volume. Tamoxifen was observed to protect against mechanical impact induced cell 
volume decrease. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, 




The effects of tamoxifen on the responses of the F-actin cytoskeleton to 
mechanical impact were investigated, to determine the role of the potential 
modulation of actin depolymerisation by tamoxifen within the 
chondroprotective mechanism. Thus, articular cartilage samples were fixed 
with 4% paraformaldehyde and stained for F-actin with Alexa Fluor 488 
Phalloidin (5 µl/ml) prior to and 2, 24 and 48 h post mechanical impact. F-
actin was imaged using CLSM and analysed using linear profiling and the 
PQ Factor, as previously described (See Methods and Materials). 
 
Tamoxifen was observed to induce an initial increase in F-actin by 33 % to 
2.54±0.07 MU, comparable to the increase induced by hyperosmotic 
challenge to 2.61±0.21 MU (Fig. 4.17). Additionally, tamoxifen protected 
against IIAD, significantly decreasing the rate of IIAD to 0.07±0.00 MU.h-1, 
a greater decrease than that exhibited by hyperosmotic challenge (Fig. 
4.17). 
 
The chondroprotective mechanism of tamoxifen was further investigated to 
determine any immunomodulatory component, whereby supernatant 
samples were collected immediately and at 2, 24 and 48 h post mechanical 
impact and analysed by ELISA for cytokine concentration as previously 
described (See Methods and Materials).  
 
Tamoxifen was noted to have similar immunomodulatory effects as 
hyperosmotic challenge; the initial peak in IL-1β concentration observed 
under control conditions was decreased by 58 % (Fig. 4.18A) prior to 
declining to non-impact baseline levels by 24 h post impact. Similarly, 
Tamoxifen induced a decrease in peak IL-10 concentration (Fig. 4.18B) at 
24 h by 22 %, but did not change the cytokine expression profile induced by 
mechanical impact. MCP-1 concentration was not noted to be significantly 
different at any time point post impact between tamoxifen, hyperosmotic or 







Condition Initial rate of actin polymerisation (MU.h-1) 
Subsequent rate of 
actin polymerisation 
(MU.h-1) 
Control -0.43 ± 0.03 0.00 ± 0.00 
380 mOsm -0.20 ± 0.04 *** 0.01 ± 0.00 
Tamoxifen -0.07 ± 0.00 *** 0.00 ± 0.00 
 
 
Figure 4.17: Tamoxifen protects against mechanical impact induced F-actin 
decrease.  
Cartilage explants were pre-treated for 1 h with control isotonic, hyperosmotic (380 mOsm) 
or tamoxifen (10 µM) supplemented DMEM and subjected to a single mechanical impact. 
Samples were fixed with 4 % paraformaldehyde and stained with Alexa Fluor 488 
phalloidin (5 µl/ml). Cells were visualised using CLSM prior to and at 2 h, 24 h and 48 h 
post mechanical impact. Linear profiling analysis was used to quantify f-actin, expressed 
relative to volume changes. Tamoxifen was observed to increase f-actin prior to 
mechanical impact, and additionally, to protect against mechanical impact induced f-actin 
decrease. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all 








Figure 4.18: Tamoxifen decreases inflammatory cytokines post-mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, hyperosmotic (380 mOsm) 
or tamoxifen (10 µM) supplemented DMEM and subjected to a single mechanical insult. 
Supernatant samples immediately following and at 2 h, 24 h and 48 h post mechanical 
impact were analysed by ELISA and cytokine concentration expressed relative to non-
impacted control samples. Tamoxifen was observed to decrease both pro-inflammatory 
(IL-1β; A and MCP-1; C) and anti-inflammatory (IL-10; B) cytokines post mechanical 
impact when compared to control. N=12  from 3 distinct experiments. *p<0.05, **p<0.01, 




4.2.4 Nutritional supplements: Chondroprotective Effects 
Nutritional supplements, or nutriceuticals, are used by the general public to 
maintain ‘healthy joints’, and two of the most commonly used are 
chondroitin sulphate and glucosamine sulphate (ARC, 2009). Chondroitin 
sulphate has been reported to stimulate cartilage repair and have anti-
inflammatory actions (Huskisson, 2008, Deal and Moskowitz, 1999) and 
glucosamine sulphate is the principal substrate in the synthesis of PGs 
(Simanek et al., 2005). To investigate any potential chondroprotective or 
immunomodulatory effects of these nutriceuticals, the osmolarity of 
chondroitin and glucosamine sulphate supplemented DMEM was first 
analysed to rule out the possibility of the nutriceuticals acting via osmotic 
mechanisms. It was observed that chondroitin sulphate (282.20±2.48 
mOsm) and glucosamine sulphate (280.21±4.02 mOsm) did not 
significantly adjust medium osmolarity compared to control (280.10±0.75 
mOsm, Fig. 4.19). Subsequently, articular cartilage explants were pre-
incubated with chondroitin sulphate supplemented DMEM of 0.1, 0.2 or 0.3 
mg/ml, or glucosamine sulphate supplemented DMEM of 0.025, 0.05 or 0.1 
mg/ml prior to mechanical impact, in order to determine the optimal 
concentration for further investigation.  
 
A decrease in cell viability was observed post-mechanical impact under 
glucosamine sulphate conditions up to 0.025 mg/ml. However, glucosamine 
sulphate of 0.05 and 0.1 mg/ml exhibited chondroprotective actions, with no 
significant cell death by 48 h post mechanical impact (0.05 mg/ml: 
80.12±4.45 %, 0.1 mg/ml: 90.10±3.25 %; Fig. 4.20A). Similarly, chondroitin 
sulphate was observed to be chondroprotective at concentrations of 0.2 
mg/ml and above, with no significant cell death at 48 h post mechanical 
impact (0.2 mg/ml: 84.29±1.20 %, 0.3 mg/ml: 90.06±2.12 %; Fig. 4.20B). 
 
From these data it was concluded 0.1 mg/ml glucosamine sulphate and 0.3 
mg/ml chondroitin sulphate had the most potential chondroprotective 











Figure 4.19: The addition of chondroitin sulphate or glucosamine sulphate had no 
effect on medium osmolarity. 
Samples of control isotonic, chondroitin sulphate (0.3 mg/ml) and glucosamine sulphate 
(0.1 mg/ml) supplemented DMEM were measured for osmolarity using Vapro TM vapour 
pressure osmometer. Neither chondroitin or glucosamine sulphate was observed to 






Figure 4.20: Chondroitin sulphate and glucosamine sulphate pre-treatment 
decreases chondrocyte death post-mechanical impact.  
Cartilage explants were pre-treated for 1hr with control isotonic, glucosamine sulphate 
supplemented DMEM of 0.025, 0.05 or 0.1 mg/ml (A) or chondroitin sulphate 
supplemented DMEM of 0.1, 0.2 or 0.3 mg/ml (B) and subjected to a single mechanical 
impact. Samples were loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using 
CLSM prior to and at 2 h, 4 h, 24 h and 48 h post mechanical impact. Imaris Spot analysis 
was used to quantify the number of viable and non-viable cells. Glucosamine sulphate was 
observed to increase cell viability at concentrations of 0.05 mg/ml and above. Chondroitin 
sulphate was observed to increase cell viability at all concentrations. N=12  from 3 distinct 




It was observed that chondroitin sulphate significantly decreased the initial 
rate of cell death post mechanical impact to 0.42±0.17 %.h-1, compared to 
control rate of 2.75±0.14 %.h-1, and additionally decreased the subsequent 
rate of cell death to 0.01±0.01 %.h-1, thus exhibiting chondroprotective 
effects. Similarly, glucosamine sulphate treatment decreased the initial rate  
of cell death to 0.67±0.59 %.h-1, and the subsequent cell death to 
0.06±0.02 %.h-1 (Fig. 4.21). Chondroitin and glucosamine sulphate were 
therefore confirmed to have chondroprotective effects.  
 
As cell shrinkage was previously confirmed to be a chondroprotective 
mechanism, the effects of chondroitin and glucosamine sulphate on 
chondrocyte volume were investigated. Both chondroitin (Fig. 4.22B) and 
glucosamine sulphate (Fig. 4.22C) were noted to significantly decrease cell 
volume prior to mechanical impact by 37 % and 27 % respectively (Fig. 
4.22D). Additionally, whilst neither chondroitin or glucosamine sulphate 
exhibited an effect on the initial rate of IIVD, both decreased the 
subsequent rate of IIVD from 2.87±0.85 µm3.h-1 to  0.71±0.18 µm3.h-1 and 
1.07±0.05 µm3.h-1 respectively (Fig. 4.23). 
 
Furthermore, the effects of nutriceuticals on the F-actin response to 
mechanical impact were determined to further investigate the mechanism of 
chondroprotection, whereby articular cartilage samples were fixed with 4% 
paraformaldehyde and stained for F-actin with Alexa Fluor 488 Phalloidin (5 
µl/ml) prior to and 2, 24 and 48 h post mechanical impact. F-actin was 
imaged using CLSM and analysed using linear profiling and the PQ Factor, 
as previously described (See Methods and Materials). 
 
F-actin concentration prior to mechanical impact was significantly increased 
(p<0.005) upon treatment with chondroitin sulphate to 1.92±0.16 MU and 
with glucosamine sulphate to 2.14±0.18 MU, increases of 32 % and 27 % 
respectively (Fig. 4.24). Additionally, both chondroitin and glucosamine 
sulphate exhibited significant (p<0.005) protection against IIAD, decreasing 
the rate of IIAD from 0.43±0.03 MU.h-1, under control conditions, to 







Initial rate of 
chondrocyte death  
(%.h-1) 
Subsequent rate of 
chondrocyte death  
(%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
Chondroitin 0.42 ± 0.17 *** 0.01 ± 0.01 *** 
Glucosamine 0.67 ± 0.59 *** 0.06 ± 0.02 *** 
 
 
Figure 4.21: Chondroitin sulphate and glucosamine sulphate protected against cell 
death post mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml) or glucosamine sulphate (0.1 mg/ml) supplemented DMEM and subjected to a 
single mechanical impact. Samples were loaded with Calcein AM (5 µM) and PI (1 µM) 
and visualised using CLSM prior to and at 2 h, 4 h, 24 h and 48 h post mechanical impact. 
Imaris spot analysis was used to quantify cell viability. Chondroitin sulphate and 
glucosamine sulphate were seen to decrease both the initial and subsequent rate of cell 
death.  N=12 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all vs. control. 






Figure 4.22: Chondroitin sulphate and glucosamine sulphate decrease chondrocyte 
volume.  
Cartilage explants were pre-treated for 1 h with control isotonic (A), chondroitin sulphate 
(0.3 mg/ml; B) or glucosamine sulphate (0.1 mg/ml; C) supplemented DMEM. Samples 
were loaded with Calcein AM (5 µM) and visualised using CLSM prior to mechanical 
impact. Isosurface volume analysis was used to quantify cell volume. Both chondroitin and 
glucosamine sulphate were observed to decrease cell prior to mechanical impact (D). 














Initial rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Control 34.38 ± 0.03 2.87 ± 0.85 
Chondroitin 37.00 ± 0.04 0.71 ± 0.18 *** 
Glucosamine 34.50 ± 0.04 1.07 ± 0.05 ** 
 
Figure 4.23: Chondroitin sulphate and glucosamine sulphate protect against 
mechanical impact induced decrease in cell volume.  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml) or glucosamine sulphate (0.1 mg/ml) supplemented DMEM and subjected to a 
single mechanical impact. Samples were loaded with Calcein AM (5 µM) and visualised 
using CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. Isosurface volume 
analysis was used to quantify cell volume. Both chondroitin and glucosamine sulphate 
were observed to significantly reduce the subsequent rate of mechanical impact induced 
cell volume decrease. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, 








Condition Initial rate of actin polymerisation (MU.h-1) 
Subsequent rate of 
actin polymerisation 
(MU.h-1) 
Control -0.43 ± 0.03 0.00 ± 0.00 
Chondroitin -0.08 ± 0.04 *** 0.01 ± 0.01 
Glucosamine -0.11 ± 0.04 *** 0.00 ± 0.00 
 
 
Figure 4.24: Chondroitin sulphate and glucosamine sulphate protect against 
mechanical impact induced decrease in F-actin.  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml) or glucosamine sulphate (0.1 mg/ml) supplemented DMEM and subjected to a 
single mechanical impact. Samples were fixed with 4 % paraformaldehyde and stained 
with Alexa Fluor 488 phalloidin (5 µl/ml). Cells were visualised using CLSM prior to and at 
2 h, 24 h and 48 h post mechanical impact. Linear profiling analysis was used to quantify f-
actin, expressed relative to volume changes. Both chondroitin and glucosamine sulphate 
were observed to increase f-actin prior to mechanical impact and subsequently protect 
against impact induced actin decrease. N=12  and n=60 from 3 distinct experiments. 





The role of possible immunomodulatory effects in the chondroprotective 
mechanism of chondroitin and glucosamine sulphate was investigated, 
whereby supernatant samples were collected immediately and at 2, 24 and 
48 h post mechanical impact and analysed by ELISA for cytokine 
concentration as previously described (See Methods and Materials).  
 
Chondroitin and glucosamine sulphate were observed to inhibit the cytokine 
response to mechanical impact. Peak IL-1β concentration, observed at 0 h 
post mechanical impact under control conditions, was decreased from 
5.86±0.29 AU to 1.03±0.06 AU and 1.05±0.07 AU respectively, 
concentrations not significantly different from non-impact (non-impact 
concentrations = 1 AU). Furthermore, IL-1β was maintained at non-impact 
levels for 0-48 h post mechanical impact by both chondroitin and 
glucosamine sulphate (Fig. 4.25A).  A similar effect was observed on IL-10 
release (Fig. 4.25B), whereby chondroitin and glucosamine sulphate 
prevented the increase in IL-10 observed in response to mechanical impact 
under control conditions, again maintaining cytokine concentration at non-
impact levels for the 48 h post mechanical impact. Furthermore, MCP-1 
release (Fig. 4.25C) was decreased to near non-impact levels by 
glucosamine sulphate (0.98±0.03 AU) and maintained for the 48 h post 
impact. Interestingly, chondroitin sulphate decreased MCP-1 concentration 
to 0.58±0.03 AU immediately post impact, below non-impact levels. MCP-1 
release further decreased between 0-48 h, reaching a low of 0.40±0.04 AU 
at 48 h post impact (Fig. 4.25C). 
 
Chondroitin and glucosamine sulphate were therefore confirmed to have 
chondroprotective effects, associated with a decrease in initial chondrocyte 





Figure 4.25: Chondroitin sulphate and glucosamine sulphate decrease inflammatory 
cytokines post-mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml) or glucosamine sulphate (0.1 mg/ml) supplemented DMEM and subjected to a 
single mechanical impact. Supernatant samples immediately following and at 2 h, 4h, 24 h 
and 48 h post mechanical impact were analysed by ELISA and cytokine concentration 
expressed relative to non-impacted control samples. Both chondroitin and glucosamine 
sulphate were observed to significantly decrease IL-1β (A), IL-10 (B) and MCP-1 (C) over 
the whole time course when compared to both control. N=12  from 3 distinct experiments. 






4.2.5 The Role of Calcium Signalling in the Mechanism of Action of 
Nutritional Supplements 
Having confirmed the role of intracellular calcium ([Ca2+]i) signalling in 
conveying the chondroprotective effects of REV 5901 using inhibitors of the 
PKC/PLCβ3 signalling pathway, the effect of these inhibitors on a proposed 
chondroprotective [Ca2+]i dependent pathway of chondroitin and 
glucosamine sulphate were investigated, whereby samples were pre-
incubated rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) and 
subsequently with chondroitin sulphate (0.3 mg/ml) or glucosamine 
sulphate (0.1 mg/ml).  
 
Rottlerin, U73122 and EGTA were observed to not inhibit the 
chondroprotective effects seen with chondroitin sulphate post mechanical 
impact (48 h: Chondroitin sulphate: 89.71±1.98 %, Rottlerin: 85.78±2.38 %, 
U73122: 90.58±2.78 %, EGTA: 92.31±2.89 %; Fig. 4.26). Similarly, the 
chondroprotective effects of glucosamine were not significantly affected by 
rottlerin, U73122 or EGTA (48 h: Glucosamine sulphate: 86.85±1.19 %, 
Rottlerin: 84.54±3.69 %, U73122: 84.93±3.67 %, EGTA: 91.56±2.89 %; Fig. 
4.27). Thus suggesting chondroitin and glucosamine exhibit 
chondroprotective effects via a mechanism independent of the 
PKC/PLCβ3/IP3 [Ca2+]i signalling pathway.  
 
Interestingly, whilst rottlerin, U73122 and EGTA did not significantly effect 
the decrease in cell volume induced by chondroitin and glucosamine 
sulphate prior to mechanical impact, rottlerin and U73122 were observed to 
inhibit IIVD, seen with both chondroitin and glucosamine sulphate and 
control (Fig. 4.28/29), whereby the initial rate of IIVD was significantly 
(p<0.005) decreased to 4.91±0.04 µm3.h-1 and 13.70±0.30 µm3.h-1 by 
rottlerin, and 11.00±0.34 µm3.h-1 and 6.21±0.03 µm3.h-1 by U73122 for 
chondroitin sulphate and glucosamine sulphate samples respectively (Fig. 









Initial rate of 
chondrocyte death 
(%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
Chondroitin 0.42 ± 0.17 *** 0.01 ± 0.01 *** 
Chondroitin + 
Rottlerin 0.30 ± 0.05 *** 0.03 ± 0.01 *** 
Chondroitin + 
U73122 0.59 ± 0.03 *** 0.03 ± 0.01 *** 
Chondroitin + EGTA 0.21 ± 0.03 *** 0.04 ± 0.01 *** 
 
Figure 4.26: Chondroitin sulphate’s chondroprotective actions are not PKC/PLCβ3 
dependant.  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml) or chondroitin sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Samples were loaded with Calcein AM (5 
µM) and PI (1 µM) and visualised using CLSM prior to and at 2 h, 4 h, 24 h and 48 h post 
mechanical impact. Imaris spot analysis was used to quantify cell viability. Treatment with 
rottlerin, U73122 and EGTA was observed to not significantly affect the chondroprotective 
effects of chondroitin sulphate. N=12 from 3 distinct experiments. *p<0.05, **p<0.01, 





Condition Initial rate of chondrocyte death (%.h-1) 
Initial rate of chondrocyte 
death (%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
Glucosamine 0.67 ± 0.59 *** 0.06 ± 0.02 *** 
Glucosamine + 
Rottlerin 0.68 ± 0.04 *** 0.04 ± 0.09 *** 
Glucosamine + 
U73122 0.08 ± 0.01 *** 0.03 ± 0.01 *** 
Glucosamine + 
EGTA 0.21 ± 0.15 *** 0.06 ± 0.00 *** 
 
Figure 4.27: Glucosamine sulphate’s chondroprotective actions are not PKC/PLCβ3 
dependant.  
Cartilage explants were pre-treated for 1 h with control isotonic, glucosamine sulphate (0.1 
mg/ml) or glucosamine sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Samples were loaded with Calcein AM (5 
µM) and PI (1 µM) and visualised using CLSM prior to and at 2 h, 4 h, 24 h and 48 h post 
mechanical impact. Imaris spot analysis was used to quantify cell viability. Treatment with 
rottlerin, U73122 and EGTA was observed to not significantly affect the chondroprotective 
effects of glucosamine sulphate. N=12 from 3 distinct experiments. *p<0.05, **p<0.01, 













Initial rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Control 34.38 ± 0.03 2.87 ± 0.85 
Chondroitin 37.00 ± 0.04 0.71 ± 0.18 *** 
Chondroitin + 
Rottlerin 4.91 ± 0.04 *** 0.31 ± 0.09 *** 
Chondroitin + 
U73122 11.00 ± 0.34 *** 0.16 ± 0.01 *** 
Chondroitin + EGTA 41.73 ± 0.35 0.69 ± 0.02 *** 
 
 
Figure 4.28: Chondroitin sulphate decreases cell volume by  PKC/PLCβ3 
independent mechanisms.  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml) or chondroitin sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Samples were loaded with Calcein AM (5 
µM) and visualised using CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. 
Isosurface volume analysis was used to quantify cell volume. Treatment with rottlerin, 
U73122 and EGTA was not observed to significantly affect initial cell volume compared to 
chondroitin sulphate controls, but rottlerin and U73122 inhibited the initial rate of impact 
induced volume decrease. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, 











Initial rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Subsequent rate of 
chondrocyte volume 
decrease (µm3.h-1) 
Control 34.38 ± 0.03 2.87 ± 0.85 
Glucosamine 34.50 ± 0.04 1.07 ± 0.05 ** 
Glucosamine 
+Rottlerin 13.70 ± 0.30 *** 0.36 ± 0.12 *** 
Glucosamine + 
U73122 6.21 ± 0.03 *** 0.02 ± 0.00 *** 
Glucosamine + 
EGTA 33.48 ± 0.04 0.73 ± 0.14 *** 
 
Figure 4.29: Glucosamine sulphate decreases cell volume by  PKC/PLCβ3 
independent mechanisms.  
Cartilage explants were pre-treated for 1 h with control isotonic, glucosamine sulphate (0.1 
mg/ml) or glucosamine sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Samples were loaded with Calcein AM (5 
µM) and visualised using CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. 
Isosurface volume analysis was used to quantify cell volume. Treatment with rottlerin, 
U73122 and EGTA was not observed to significantly affect initial cell volume compared to 
glucosamine sulphate controls, but rottlerin and U73122 inhibited the initial rate of impact 
induced volume decrease. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, 





The influence of the PKC/PLCβ3 signalling pathway on the changes 
induced by chondroitin and glucosamine sulphate on the F-actin 
cytoskeleton were investigated, whereby articular cartilage samples were 
fixed with 4% paraformaldehyde and stained for F-actin with Alexa Fluor 
488 Phalloidin (5 µl/ml) prior to and 2, 24 and 48 h post mechanical impact. 
F-actin was imaged using CLSM and analysed using linear profiling and the 
PQ Factor, as previously described (See Methods and Materials). 
 
Rottlerin, U73122 and EGTA were observed to have no effect on the 
increase in initial F-actin prior to mechanical impact induced by chondroitin 
and glucosamine sulphate (Fig. 4.30/31). Similarly,  rottlerin, U73122 and 
EGTA exhibited no significant effect (p>0.05) on the protection against IIAD 
observed by chondroitin and glucosamine sulphate (Fig. 4.30/31).  
 
Finally, supernatant samples were collected immediately and at 2, 24 and 
48 h post mechanical impact and analysed by ELISA for cytokine 
concentration as previously described (See Methods and Materials).  
 
Investigation of inflammatory cytokines revealed no significant changes, 
compared to chondroitin sulphate treatment, in IL-1β (Fig. 4.32A), IL-10 
(Fig. 4.32B) or MCP-1 (Fig. 4.32C) concentration upon additional treatment 
with rottlerin, U73122 or EGTA. Similarly, no significant effects were seen 
upon additional treatment with rottlerin, U73122 or EGTA in IL-1β (Fig. 
4.33A), IL-10 (Fig. 4.33B) or MCP-1 (Fig. 4.33C) concentration compared to 
sole treatment with glucosamine sulphate. 
 
These data demonstrated that the chondroprotective effects of chondroitin 







Initial rate of actin 
polymerisation (MU 
hour-1) 
Subsequent rate of 
actin polymerisation 
(MU hour-1) 
Control -0.43 ± 0.03 0.00 ± 0.00 
Chondroitin -0.08 ± 0.04 *** 0.01 ± 0.01 
Chondroitin + Rottlerin -0.08 ± 0.30 *** 0.01 ± 0.01 
Chondroitin + U73122 -0.06 ± 0.05 *** 0.00 ± 0.00 
Chondroitin + EGTA -0.05 ± 0.00 *** 0.01 ± 0.00 
 
Figure 4.30: Chondroitin sulphate’s protection against mechanical impact induced 
decrease in F-actin is PKC/PLCβ3 independent .  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml) or chondroitin sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Samples were fixed with 4 % 
paraformaldehyde and stained with Alexa Fluor 488 phalloidin (5 µl/ml). Cells were 
visualised using CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. Linear 
profiling analysis was used to quantify f-actin, expressed relative to volume changes. 
Rottlerin, U73122 and EGTA did not significantly affect the increase in f-actin prior to 
mechanical impact or the protection against impact induced actin decrease observed with 
chondroitin sulphate. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, 








Initial rate of actin 
polymerisation (MU 
hour-1) 
Subsequent rate of 
actin polymerisation 
(MU hour-1) 
Control -0.43 ± 0.03 0.00 ± 0.00 
Glucosamine -0.11 ± 0.04 *** 0.00 ± 0.00 
Glucosamine 
+Rottlerin -0.02 ± 0.00 *** 0.01 ± 0.00 
Glucosamine + 
U73122 -0.06 ± 0.01 *** 0.00 ± 0.00 
Glucosamine + EGTA -0.03 ± 0.01 *** 0.00 ± 0.00 
 
Figure 4.31: Glucosamine sulphate’s protection against mechanical impact induced 
decrease in F-actin is PKC/PLCβ3 independent .  
Cartilage explants were pre-treated for 1 h with control isotonic, glucosamine sulphate (0.1 
mg/ml) or glucosamine sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Samples were fixed with 4 % 
paraformaldehyde and stained with Alexa Fluor 488 phalloidin (5 µl/ml). Cells were 
visualised using CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. Linear 
profiling analysis was used to quantify F-actin, expressed relative to volume changes. 
Rottlerin, U73122 and EGTA did not significantly affect the increase in F-actin prior to 
mechanical impact or the protection against impact induced actin decrease observed with 
glucosamine sulphate. N=12  and n=60 from 3 distinct experiments. *p<0.05, **p<0.01, 






Figure 4.32: Chondroitin sulphate decreases inflammatory cytokines post-
mechanical impact independent of PKC/PLCβ3.  
Cartilage explants were pre-treated for 1 h with control isotonic, chondroitin sulphate (0.3 
mg/ml),or chondroitin sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Supernatant samples immediately following 
and at 2 h, 4 h, 24 h and 48 h post mechanical impact were analysed by ELISA and 
cytokine concentration expressed relative to non-impacted control samples. Treatment with 
rottlerin, U73122 and EGTA was observed to have no effect on the decrease in IL-1β (A), 
IL-10 (B) or MCP-1 (C) concentration observed with chondroitin sulphate. N=12  from 3 





Figure 4.33: Glucosamine sulphate decreases inflammatory cytokines post-
mechanical impact independent of PKC/PLCβ3.  
Cartilage explants were pre-treated for 1 h with control isotonic, glucosamine sulphate (0.1 
mg/ml),or glucosamine sulphate with rottlerin (100 µM), U73122 (100 µM) or EGTA (2mM) 
and subjected to a single mechanical impact. Supernatant samples immediately following 
and at 2 h, 4 h, 24 h and 48 h post mechanical impact were analysed by ELISA and 
cytokine concentration expressed relative to non-impacted control samples. Treatment with 
rottlerin, U73122 and EGTA was observed to have no effect on the decrease in IL-1β (A), 
IL-10 (B) or MCP-1 (C) concentration observed with glucosamine sulphate. N=12  from 3 







4.2.6 Comparison of Chondroprotective Agents 
REV 5901, tamoxifen, chondroitin sulphate and glucosamine sulphate all 
demonstrated chondroprotective effects, whereby they prevented cell death 
upon mechanical impact. Comparison of the efficiency of the nutriceuticals 
and pharmaceuticals revealed no significant differences in 
chondroprotection at 48 h (p>0.05). Tamoxifen and chondroitin sulphate 
were observed to be the most effective at chondrocyte shrinkage prior to 
mechanical impact, however, tamoxifen was the only compound to prevent 
IIVD, thus indicating inhibition of IIVD is not essential for chondroprotection. 
REV 5901 induced the greatest increase in F-action prior to mechanical 
impact, but all compounds were similarly effective at preventing IIAD. 
Additionally, REV 5901 was the most efficient at decreasing the 
inflammatory cytokine response to mechanical impact, reducing peak IL-1β 
and IL-10 the most, however, chondroitin sulphate decreased MCP-1 more 










Viability at 48 
h (%) 
45.02±0.99 86.26±3.20 88.30±3.34 89.71±1.98 86.85±4.19 
Initial rate of 
cell death 
(%.h-1) 
2.75±0.14 1.50±0.58 0.50±0.03 0.42±0.17 0.67±0.59 
Subsequent 
rate of cell 
death (%.h-1) 
0.66±0.05 0.04±0.03 0.12±0.02 0.01±0.01 0.06±0.02 
Initial volume 
(µm3) 
716.14±35.32 552.68±27.26 423.99±15.54 451.09±20.76 523.64±23.41 
Initial rate of 
IIVD 
(µm3.h-1) 
34.38±0.03 20.53±0.03 1.19±0.03 37.00±0.07 34.50±0.04 
Subsequent 
rate of IIVD 
(µm3.h-1) 
2.87±0.85 0.79±0.06 0.30±0.14 0.71±0.18 1.07±0.05 
Initial F-actin 
(MU) 
1.91±0.32 3.20±0.24 2.54±0.07 2.52±0.16 2.43±0.18 
IIAD 
(MU.h-1) 
0.43±0.03 0.16±0.03 0.07±0.00 0.08±0.00 0.11±0.04 
Peak IL-1β 
(AU) 
5.86±0.12 0.75±0.09 2.31±0.16 1.03±0.06 1.05±0.07 
Peak MCP-1 
(AU) 
1.45±0.07 0.67±0.01 1.38±0.16 0.58±0.03 0.98±0.03 
Peak IL-10 
(AU) 
5.55±0.28 0.90±0.17 4.33±0.18 1.14±0.02 1.07±0.06 
 
Table 4.1: The chondroprotective actions of nutriceuticals and pharmaceuticals 
A summary of the chondroprotective responses of REV 5901, tamoxifen, chondroitin 
sulphate and glucosamine sulphate. All agents had a similarly efficient chondroprotective 
action. REV 5901 was observed to had the greatest impact on decreasing inflammatory 
cytokine release, and increasing F-actin, however, chondroitin sulphate and tamoxifen had 
the greatest decrease in initial cell volume. Additionally, tamoxifen was the only agent to 
inhibit IIVD. IIVD – Impact Induced Volume Decrease, IIAD – Impact Induced Actin 






Investigation of the possible chondroprotective properties of commonly 
used “healthy joint” promoting nutritional supplements and pharmaceuticals 
affecting chondrocyte volume regulation or inflammation revealed that REV 
5901, Tamoxifen, chondroitin sulphate and glucosamine sulphate all exhibit 
chondroprotective actions. REV 5901’s protective effects were blocked by 
rottlerin and U73122, indicating them to be dependent upon [Ca2+]i 
signalling via the PKC/PLCβ3 pathway. Conversely, chondroitin and 
glucosamine sulphate’s chondroprotective actions were revealed to be 
independent of the PKC/PLCβ3 pathway.  
 
All the investigated agents were observed to decrease cell volume prior to 
mechanical impact by osmotically independent mechanisms, supporting the 
observation that cell shrinkage is chondroprotective (Chapter 3). IIVD was 
still observed upon treatment with REV 5901, chondroitin sulphate and 
glucosamine sulphate but blocked by Tamoxifen, thus suggesting a role for 
VSOAC within the IIVD mechanism. Inhibition of the PKC/PLCβ3 pathway 
by rottlerin and U73122 was observed to inhibit IIVD when used to pre-treat 
REV 5901, chondroitin sulphate and glucosamine sulphate samples, 
suggesting a role for [Ca2+]i signalling via the PKC/PLCβ3 pathway within 
IIVD.  
 
F-actin was seen to be increased by REV5901, tamoxifen, chondroitin 
sulphate and glucosamine sulphate prior to mechanical impact, suggesting 
increased F-actin concentration prior to mechanical impact is 
chondroprotective. Conversely, IIAD was not observed in samples treated 
with REV 5901, tamoxifen, chondroitin sulphate or glucosamine, suggesting 
a role for IIAD in cell death post mechanical impact.    
 
Finally, REV 5901 was observed to decrease LTB4 and also decrease 
inflammatory cytokine production post mechanical impact, suggesting REV 
5901’s anti-inflammatory actions are mediated by inhibition of 5-LO. 
Similarly, tamoxifen, chondroitin sulphate and glucosamine sulphate 




independent of the investigated [Ca2+]i signalling pathway. These data 
suggest that reduced inflammatory cytokines play a role in the 
chondroprotective mechanisms of the investigated agents.  
 
To summarise, chondroprotective agents consistently decreased initial 
chondrocyte volume, increased initial F-actin, protected against IIAD and 
decreased the inflammatory cytokine response (Table 4.2), indicating a role 
for these within chondroprotection. REV 5901 was the most efficient at 
increasing initial F-actin, but chondroitin sulphate and tamoxifen induced 
the greatest decrease in initial volume. Chondroitin sulphate and REV 5901 
had the greatest impact on reducing inflammatory cytokine release. Given 
the unknown safety of REV 5901, chondroitin sulphate is likely to be the 

















Initial cell volume ↓ 
IIVD Possible active cell mechanism for chondroprotection 
Initial F-actin ↑ 
IIAD Likely to play a role in cell death 
Cytokines ↑ 
 
Table 4.2: The cellular responses involved in chondroprotection 
A summary of the cellular responses that are indicative of chondroprotection. IIVD – 













Chapter 5: The Effects of In Vivo Joint Forces and 







Whilst exercise participation is acknowledged to be of benefit to general 
health (Saxon et al., 1999), and similarly, mechanical loading, such as 
exercise activity, is known to be essential for the maintenance of healthy 
cartilage tissue (Helminen, 1987),  the long-term safety of sporting/exercise 
activity from a musculoskeletal stand-point with respect to osteoarthritis 
(OA) is less defined. It is noted that continuous stress placed on the joints 
by long-term and prolonged exercise training may result in microtrauma and 
degeneration (Moskowitz, 1984), as in vitro excessive loading is observed 
to induce cartilage damage and chondrocyte apoptosis, thus increasing the 
risk of OA development (Oliveria et al., 1999, Tew et al., 2000, Pohl et al., 
2009).  
 
Additionally, exercise has been reported to induce a systemic inflammatory 
response, with sequential increase in pro-inflammatory and anti-
inflammatory cytokines observed (Pedersen et al., 1998). Increased release 
of pro-inflammatory cytokines are characteristic of OA, and upregulation in 
these leads to degradation of the ECM and chondrocyte apoptosis (Rowan 
and Young, 2007, Westacott and Sharif, 1996). The magnitude of the 
inflammatory response to exercise is observed to differ depending on the 
intensity of the exercise undertaken (Bruunsgaard et al., 1997, Nieman et 
al., 1998, Moldoveanu et al., 2001), suggesting increased joint forces may 
play a role in elevating inflammation, as higher intensity exercise tends to 
also be higher impact.  
 
Foot strike patterns, when running are known to vary, with no distinctive 
style being confirmed as ‘best’. In terms of sporting performance, there are 
advocates for the ‘pose’ style of running, a mid-forefoot strike pattern, 
claiming better speed, and conversely, advocates for the heelstrike style of 
running, claiming greater stride length (Hasegawa et al., 2007, Lieberman 
et al., 2010). Thus, sprinters tend to favour forefoot striking, and 75-80 % of 
elite endurance runners are reported to favour heelstriking (Hasegawa et 
al., 2007, Lieberman et al., 2010). Lower limb injury is prevalent amongst 




post marathon, with the knee being the most injured site (Satterthwaite et 
al., 1996). Given that the lower limb experiences forces equivalent to 2-3 
times bodyweight per foot strike (Bobbert et al., 1991, Chan and Rudins, 
1994, Dufek and Bates, 1990, Farley and Gonzalez, 1996, James et al., 
1978), and that the average endurance runner strikes the ground 600 times 
per km (Milner et al., 2006, Pohl et al., 2009), this is unsurprising. As yet, 
no definitive reports of which foot strike pattern is most effective at injury 
risk reduction, although there is evidence to suggest that heelstriking 
increases the force the lower limb joints are subjected to (Sol, 2001).  
 
Given the links between strike pattern and joint forces, and joint forces and 
inflammatory cytokine release, and the role that uncontrolled inflammation 
can play in the development OA, it is of interest to investigate the possible 
links between strike pattern and alterations in pro and anti-inflammatory 
cytokine levels. Furthermore, it is conceivable that there is a link between 
the diurnal nature of cartilage (Chapter 3) and the known involvement of 
inflammatory cytokines in cartilage degradation, suggesting a possible 
diurnal inflammatory response to exercise/trauma.  
 
Systemic inflammation is a multicellular and multi-tissue process. As such 
inflammation within a single tissue, such as articular cartilage, has multiple 
contributors. Within the synovial fluid are a variety of cell types, including 
polymorphonuclear granulocytes (PMNs) and mononuclear phagocytes, 
such as macrophages  (Freemont, 1991). Macrophages in culture have 
been observed to produce a number of both pro and anti-inflammatory 
cytokines, including IL-1β and IL-10, in addition to matrix 
metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases 
(TIMPs; (Bondeson et al., 1999, Amos et al., 2006), and have been 
identified in abundance within OA tissue (Benito et al., 2005, Farahat et al., 
1993, Haywood et al., 2003). This suggests a role for mononuclear 
phagocytes within cartilage inflammation, and thus ECM degeneration and 
the potential onset of OA. 
 
Given the widely reported role of inflammatory cytokines within the OA 




apoptosis (Haywood et al., 2003, Goldring et al., 2008), the potential exists 
for unravelling the cascade of events that ensues following impact trauma 
and the role that anti-inflammatory agents could play in chondroprotection. 
Agents such as Curcumin, the naturally occurring active polyphenolic 
component of the powdered turmeric (Curcuma longa) root, have been 
reported to possess potent anti-inflammatory and anti-oxidant properties  
(Sharma et al., 2005). These effects include down-regulation of MCP-1 
expression, most likely through differential regulation of PKC, which in turn 
is reported to be an upstream signaling molecule of MMP-9, a ECM 
degrading enzyme (Wu et al., 2006, Herman et al., 2009). Thus, it is 
suggested curcumin has both anti-inflammatory and anti-catabolic actions, 
both of which have the potential to be chondroprotective. The glucocorticoid 
dexamethasone, is a potent anti-inflammatory drug used to treat a large 
number of inflammatory and autoimmune disorders including rheumatoid 
arthritis. Thus, dexamethasone and curcumin are investigated here as 
possible chondroprotective agents. 
 
5.1.1 Chapter Aims 
This study aims to investigate the role of joint forces and alterations in pro 
and anti-inflammatory cytokines at a systemic level in participants and at 
the joint and tissue level in bovine cartilage in conjunction with chondrocyte 
death post mechanical trauma. Specifically by: 
1. Investigation of the relationship between knee joint force and 
inflammatory cytokine production. 
2. Study of the effects of strike pattern on knee joint force and 
inflammatory cytokine production. 
3. Elucidation of the possible diurnal nature of the inflammatory 
response post exercise. 
4. Determination of the role of synovial mononuclear phagocytes within 
the inflammatory response to mechanical impact in articular 
cartilage. 
5. Investigation of the role of inflammatory cytokines in chondrocyte 







5.2.1 Maximal Knee Force 
Participants were recruited within a defined age group (20-39 yrs), weight 
(65-75 kg), percentage body fat (10-13 %) and thigh circumference (48-53 
cm). GRF data was collected via forceplate, and leg anthropometry used to 
calculate joint forces through inverse dynamics (Hutchinson, 1994). 
Controlling weight, percentage body fat and thigh circumference resulted in 
an average population barefoot running knee force ± less than 7% (Table 
5.1).   
 
GRF data was used to calculate ankle, knee and hip joint forces when 
running both barefoot and in running shoes. It was observed that joint 
forces were not significantly different between joints, but all were 
significantly increased (p<0.05) when running barefoot, whereby ankle, 
knee and hip force all increased by 13 % when running barefoot (Fig. 5.1). 
 
When comparing maximal dominant leg (MDL) knee force whilst running, 
no correlation was observed between barefoot and when wearing running 
shoes, despite population data revealing a 13 % increase in joint forces 
when running barefoot compared to in shoes (Fig. 5.1), thus demonstrating 
footwear had a non-standard effect on knee force (Table 5.2). Additionally, 
maximal knee force when running barefoot was compared between 
dominant and non-dominant legs, and again no correlation was observed, 
indicating a non-standardised effect of leg dominance on knee force (Table 
5.2). Based on these data, MDL knee force when running barefoot was 
used henceforth.  
 
The possible association between joint force and systemic circulating 
inflammatory cytokine concentration was investigated, whereby circulating 
cytokines were analysed by ELISA from venous blood samples obtained 
immediately post 30 min treadmill exercise at 60 % VO2max and 
standardised to pre-exercise levels, as previously described (See Materials 
and Methods). MDL knee force when running barefoot was determined 




Circulating pro-inflammatory cytokines IL-1β and MCP-1 were observed to 
associate positively with MDL knee force when running barefoot, with a 
Pearson correlation coefficient (r2) of 0.85 and 0.70 revealed respectively. 
Additionally, the circulating anti-inflammatory cytokine IL-10 was observed 
to significantly (p<0.05) correlate with MDL knee force, whereby an r2 of  
0.89 was noted (Fig. 5.2). These data suggested a role for increasing joint 











 Average ± SEM 
Age (Years) 34.63 ± 2.16 
Weight (Kg) 69.89 ± 3.34 
Height (cm) 173.14 ± 2.89 
Body Fat (%) 11.60 ± 1.19 
BMI 22.12 ± 2.63 





UK Shoe Size 9 ± 0.61 
Sole Depth (cm) 3.28 ± 0.30 
 
 
Table 5.1:  Subject characteristics summary 
A homogenous subject population was recruited, controlled for age (20-39 yrs), weight (65-
75 kg), body fat percentage (10-13 %) and thigh circumference (48-53 cm) to standardise 














Figure 5.1: Dominant leg joint forces are decreased by footwear. 
GRF forceplate data was used to calculate dominant leg joint forces whilst running, both 
barefoot and in running shoes. Joint forces were observed to be significantly decreased 

















 Correlate (Y/N) P Value 
Pearson 
Coefficient 
Barefoot Vs Shoes N 0.34 0.08 
Dominant Vs Non-
dominant N 0.30 0.12 
 
Table 5.2: Effect of footwear and leg dominance on knee force. 
GRF forceplate data was used to calculate dominant and non-dominant leg knee forces 









(Y/N) P Value 
Pearson 
Coefficient 
Maximal Force Vs 
Relative IL-1β Y 0.001 0.85 
Maximal Force Vs 
Relative IL-10 Y 0.001 0.70 
Maximal Force Vs 
Relative MCP-1 Y 0.001 0.89 
 
Figure 5.2: Effect of elevated Knee force on systemic pro and anti-inflammatory 
cytokines. 
GRF forceplate data was used to calculate dominant leg knee forces whilst running 
barefoot. Circulating blood cytokines were analysed by ELISA from venous blood samples 
obtained immediately post 30 min treadmill exercise at 60 % VO2max. Cytokine 
concentrations are expressed relative to resting values obtained prior to exercise. Data is 







5.2.2 The Influence of Strike Pattern on Knee Force 
The varying strike pattern of participants was analysed to elucidate any 
links between strike pattern and maximal knee force, whereby strike pattern 
was determined by mapping maximal GRF during each footstrike (Fig. 5.3) 
and calculating a ratio of maximal heelstrike:ball GRF and 
pronation:supernation as previously described (See Materials and 
Methods).  
 
MDL knee force when running barefoot was observed to have a significant 
(p<0.05) correlation with heelstrike:ball, identified by an r2 of  0.91 (Fig. 
5.4). In addition, pronate:supernate was seen to induce an r2 of 0.85 with 
MDL knee force when running barefoot (Fig. 5.5A), suggesting that 
pronated and heelstrike gaits induced greater knee forces when running.  
 
Given the previous observation that increased knee forces were associated 
with increased systemic circulating cytokines, strike patterns were 
correlated with maximal circulating cytokines. It was observed that 
pronate:supernate associated positively with increasing circulating 
cytokines, whereby r2 values of 0.82, 0.73 and 0.86 were computed when 
pronate:supernate was compared with maximal IL-1β, IL-10 and MCP-1 
respectively (Fig. 5.5B). Conversely, despite increasing heelstrike being 
associated with increased knee force, heelstrike:ball was not observed to 












Figure 5.3: Representative running forceplate GRF data images. 
Participants ran across the forceplate at an approximate long distance running pace (13.4 
km.h-1) while maximal GRF (⊗, mapped by the white line) and centre of mass (°, mapped 








(Y/N) P Value 
Pearson 
Coefficient 
Maximal Force Vs H:B Y 0.001 0.91 
H:B Vs Relative IL-1β N 0.22 0.49 
H:B Vs Relative IL-10 N 0.42 0.33 
H:B Vs Relative  MCP-1 N 0.59 0.23 
 
Figure 5.4: Effect of Heel-striking gait on maximal knee force. 
GRF forceplate data was used to calculate dominant leg knee forces whilst running 
barefoot and analyse heel-strike gait as a ratio of maximal GRF at the heel and maximal 
GRF at the ball. Circulating blood cytokines were analysed by ELISA from venous blood 
samples obtained immediately post 30 min treadmill exercise at 60 % VO2max. Cytokine 
concentrations are expressed relative to resting values obtained prior to exercise. Data are 















(Y/N) P Value 
Pearson 
Coefficient 
Maximal Force Vs P:S Y 0.001 0.85 
P:S Vs Relative IL-1β Y 0.001 0.82 
P:S Vs Relative IL-10 Y 0.002 0.73 
P:S Vs Relative MCP-1 Y 0.001 0.86 
 
 
Figure 5.5: Effect of Pronated gait on maximal knee force and circulating 
inflammatory cytokines. 
GRF forceplate data was used to calculate dominant leg knee forces whilst running 
barefoot and analyse pronated gait as a ratio of maximal GRF at the medial and lateral 
aspects of the ball of the foot. Circulating blood cytokines were analysed by ELISA from 
venous blood samples obtained immediately post 30 min treadmill exercise at 60 % 
VO2max. Cytokine concentrations are expressed relative to resting values obtained prior to 
exercise. Pronate:Supernate ratio was seen to significantly correlate with both force (A) 
and circulating inflammatory cytokine changes (B). Data are from N=14 participants 




5.2.3 Diurnal Exercise and Inflammation 
Following investigation of the effects of maximal knee force and strike 
pattern on knee force, alterations in early morning and evening circulating 
cytokines were analysed by ELISA from venous blood samples obtained 
prior to, immediately post and at 2 and 4 h post 30min treadmill exercise, 
undertaken at either 8am (AM) or 6pm (PM) and at an intensity of 60 % 
VO2max.   
 
It was observed that both the pro-inflammatory cytokines IL-1β and MCP-1 
relative concentration increased post exercise for both AM (Fig. 5.6) and 
PM exercise groups (Fig. 5.6), peaking immediately post exercise before 
decreasing. Peak IL-1β relative concentration post exercise was observed 
to be increased by 20.67±2.58 % after AM exercise, but only by 9.60±2.35 
% after PM exercise (Fig. 5.6A). Similarly, MCP-1 relative concentration 
was seen to be increased after AM exercise when compared to PM 
exercise, whereby AM exercise increased by 25.69±0.53 %, and PM 
exercise by 9.01±2.94 % (Fig. 5.6C). Following observations that exercise 
increased pro-inflammatory cytokine concentration, measurement of the 
anti-inflammatory cytokine IL-10 was determined. IL-10 relative 
concentration was seen to increase post exercise in both AM and PM 
exercise groups, peaking at 2 h post exercise, with no significant difference 
observed between the AM exercise peak increase of 8.97±2.40 % and the 
PM exercise peak increase of 10.08±2.30 % (Fig. 5.6B). 
 
These data suggested a diurnal role for circulating cytokines post exercise, 
whereby PM exercise was associated with decreased systemic pro-






Figure 5.6: Determination of systemic IL-1β , IL-10 and MCP-1 levels post exercise. 
Circulating blood cytokines were analysed by ELISA from venous blood samples obtained 
immediately, 2 and 4 h post 30 min treadmill exercise at 60 % VO2max. Exercise was 
undertaken at 8am (AM) or 6pm (PM). Cytokine concentrations are expressed relative to 
resting values obtained prior to exercise. Peak circulating concentration was observed for 
both IL-1β (A) and MCP-1 (C) immediately post exercise for both AM and PM exercise, 
whereas peak circulating concentration was observed for IL-10 (B) at 2 h post exercise for 
both AM and PM exercise. Peak pro-inflammatory cytokine concentration, both IL-1β (A) 
and MCP-1 (C), was observed to be increased post AM exercise when compared to PM 
exercise. Conversely, no significant difference was observed in peak anti-inflammatory 
cytokine concentration (IL-10, B) post exercise between AM and PM exercise. Data are 





5.2.4 Articular Cartilage Cytokine Release and Mononuclear 
Phagocytes 
Following the identification that impact led to significant increases in the 
release of pro and anti-inflammatory cytokines, supernatants from these 
impacted tissue were used to activate isolated synovial mononuclear 
phagocytes.  
 
Articular cartilage explants subjected to a single mechanical trauma were 
observed to release increased concentrations of IL-1β, IL-6, IL-8, MCP-1 
and IL-10 (Fig. 5.7A) into the supernatant, whereby IL-1β increased from 
33.53±4.21 to 73.23±2.28 pg/ml/g, IL-6 increased from 2.50±0.22 to 
110.84±2.99 pg/ml/g, IL-8 increased from 35.46±1.88 to 100.79±4.61 
pg/ml/g, MCP-1 increased from 50.02±6.44 to 68.98±4.23 pg/ml/g and IL-
10 increased from 80.98±24.31 to 301.75±29.34 pg/ml/g. 
 
Bovine mononuclear phagocytes were isolated from synovial fluid, whereby 
other synovial cells were removed by trypsin, and the remaining trypsin-
resistant mononuclear phagocytes stimulated with supernatants from 
explants immediately post mechanical trauma, as previously noted to be 
the peak pro-inflammatory cytokine time-point. Mononuclear phagocyte 
supernatants were analysed by ELISA prior to and at 1 h post stimulation. 
Mononuclear phagocytes were observed to produce minimal concentrations 
of IL-1β, IL-6, IL-8, MCP-1 and IL-10 prior to stimulation, ranging from 
23.04±4.22 pg/ml of IL-8 to 113.05±12.48 pg/ml of IL-10 (Fig. 5.7B). 
Stimulation with supernatants from impact explants was observed to induce 
a significant (p<0.01) increase in pro-inflammatory cytokines IL-1β and 
MCP-1 from 65.51±9.13 pg/ml and 90.23±11.38 pg/ml to 219.90±23.40 
pg/ml and 366.74±27.88 pg/ml respectively (Fig. 5.7B). Furthermore a 
significant (p<0.01) decrease in anti-inflammatory cytokine IL-10 
concentration of approximately 80 % was induced by mononuclear 





Bovine mononuclear phagocytes were co-cultured with explants subjected 
to mechanical trauma and supernatants analysed by ELISA at 1 h post co-
culture. Resultant cytokine concentration was adjusted to reflect the 
concentration solely produced by the articular cartilage by subtraction of the 
previously observed cytokine concentrations produced by baseline and 
stimulated mononuclear phagocytes. It was noted that articular cartilage co-
cultured with mononuclear phagocytes produced significantly increased 
concentrations of IL-1β compared to both baseline cartilage and cartilage 
subjected to mechanical trauma, whereby IL-1β concentration was 
increased by 118 % by mechanical impact, and by a further 142 % upon co-
culture with mononuclear phagocytes (Fig. 5.7C). The expression of IL-6, 
IL-8, MCP-1 and IL-10 was not observed to be significantly (p>0.05) altered 
upon co-culture.  
 
These data suggest a role within the impact induced inflammatory cytokine 
response, of a possible paracrine positive-feedback loop between articular 





Figure 5.7: Inflammatory cytokine concentrations released by articular cartilage and 
mononuclear phagocytes upon stimulation by single mechanical impact  
(A)Supernatants from control explants and explants submitted to a single mechanical insult 
were analysed at immediately post-impact by ELISA to determine cytokine concentration. It 
was observed that upon impact there was a significant increase in concentration of pro-
inflammatory cytokines (IL-1β, IL-6, IL-8 and MCP-1) in addition to an increase in anti-
inflammatory cytokine concentration (IL-10). (B)Supernatants from control mononuclear 
phagocytes and mononuclear phagocytes stimulated with supernatant from impacted 
explants were analysed 1 h post-stimulation by ELISA. Stimulation with supernatant from 
impacted cartilage containing increased concentrations of inflammatory cytokines was 
seen to significantly increase the release of IL-1β and MCP-1 from mononuclear 
phagocytes. (C)Supernatants from control, explants submitted to a single impact and 
explants submitted to a single impact and incubated with mononuclear phagocytes were 
analysed by ELISA at 1 h. A significant increase in the concentration of IL-1β was 








5.2.5 The Role of Inflammatory Cytokines in Chondrocyte Death Post 
Mechanical Impact 
Following observation of increased inflammatory cytokine release by 
articular chondrocytes in response to mechanical impact, the role of 
cytokines within impact induced cell death was investigated, whereby 
supernatants taken immediately post mechanical impact from explants pre-
treated with isotonic (280 mOsm), hyperosmotic (380 mOsm) or hypo-
osmotic (140 mOsm) DMEM were applied to non-impacted explants and 
samples were analysed by CLSM for viability at 1 h post incubation.  
 
Supernatants from samples pre-treated with isotonic and hypo-osmotic 
DMEM were observed to induce a decrease in cell viability from non-impact 
control levels of 94.28±2.76 % to 75.13±3.26 % and 73.02±2.12 % 
respectively (Fig. 5.8). Conversely, supernatants from explants pre-treated 
with hyperosmotic DMEM did not induce significant cell death. As 
hyperosmotic challenge was previously observed to decrease the cytokine 
release response to impact, these data suggested a role for the 
inflammatory cytokines released into the supernatant in response to impact 
in cell death.  
 
As previous data suggested a role for IL-1β in mediating the inflammatory 
cytokine response (Section 5.2.4), the role of IL-1β in cytokine induced cell 
death was investigated by direct media supplementation with 200 pg/ml IL-
1β per gram of cartilage, the equivalent concentration of IL-1β released by 
articular cartilage in response to impact. Samples were analysed by CLSM 
for viability and volume post 1 h incubation. Treatment with IL-1β (Fig. 5.9A) 
was observed to induce significant cell death, whereby cell viability was 
decreased from 94.28±2.76 % prior to IL-1β stimulation to 75.98±3.80 % 
(Fig. 5.9C). Furthermore, IL-1β treatment (Fig. 5.10A) was observed to 
significantly decrease cell volume by 30 % to 409.30±13.08 µm3 (Fig. 
5.10C). These data suggest IL-1β is a contributor to cytokine mediated cell 









Figure 5.8: Stimulation with supernatants from impacted explants decreases cell 
viability.  
Cartilage explants were pre-treated for 1 h with control isotonic DMEM or supernatants 
from explants immediately post impact after 1 h pre-treatment with control isotonic, 
hyperosmotic (380 mOsm) or hypo-osmotic (140 mOsm) DMEM. Samples were stained 
with Calcein AM (5 µM) and PI (1 µM) and visualised using CLSM at post stimulation. 
Imaris spot analysis was used to quantify cell viability. Stimulation with supernatants from 
impacted explants pre-treated with control and hypo-osmotic DMEM was observed to 
significantly decrease cell viability compared to control non-impacted samples. Conversely, 
stimulation with supernatants from impacted explants pre-treated with hyperosmotic 
DMEM did not significantly effect viability. N=12 from 3 distinct experiments. *p<0.05, 





Figure 5.9: IL-1β  stimulation induces cell death  
Cartilage explants were pre-treated for 1 h with control isotonic (A) or IL-1β (200 pg/ml/g; 
B) supplemented DMEM. Samples were stained with Calcein AM (5 µM) and PI (1 µM) and 
visualised using CLSM post stimulation. Imaris spot analysis was used to quantify cell 
viability. IL-1β stimulation was observed to significantly decrease cell viability compared to 











Figure 5.10: IL-1β  stimulation induces cell death and decreases cell volume 
Cartilage explants were pre-treated for 1 h with control isotonic (A) or IL-1β (200 pg/ml/g; 
B) supplemented DMEM. Samples were stained with Calcein AM (5 µM) and visualised 
using CLSM post stimulation. Isosurface volume analysis was used to quantify cell volume. 
IL-1β stimulation was observed to significantly decrease cell volume (C). n=60 from 3 




5.2.6 Effect of Curcumin and Dexamethasone on Pro and Anti-
Inflammatory Cytokine Release and Chondroprotection. 
Given that the direct addition of IL-1β as well as impact caused a significant 
increase in cell death, the protective effects of the anti-inflammatory agents 
curcumin (50 µM) and dexamethasone (1 µM) were subsequently 
evaluated. Specifically, the release of  IL-1β, MCP-1, IL-10 were 
determined by ELISA and chondrocyte viability by CLSM as previously 
described.  
 
In response to mechanical impact, an increase in the release of IL-
1β, MCP-1 and IL-10 were observed, whereby IL-1β and MCP-1 increased 
immediately post impact to 5.86±0.29 AU and 1.45±0.07 AU respectively, 
before declining down to baseline levels (1 AU). IL-10 was observed to 
additionally increase post impact, peaking at 24 h at 5.55±0.28 AU (Fig. 
5.11).  
 
Curcumin and dexamethasone were confirmed to have immunomodulatory 
actions, whereby a prevention of IL-1β increase in response to impact was 
observed. IL-1β concentration immediately post impact was decreased to 
1.02±0.01 AU and 0.92±0.04 AU by curcumin and dexamethasone 
respectively. Subsequently, curcumin and dexamethasone induced a 
decrease in IL-1β release to 0.66±0.02 AU and 0.65±0.03 AU by 48 h 
respectively (Fig. 5.11A). Furthermore, peak IL-10 observed at 24 h was 
decreased from 5.55±0.28 AU to 1.27±0.06 AU and 1.24±0.05 AU by 
curcumin and dexamethasone (Fig. 5.11B) and peak MCP-1 observed at 0 
h was decreased to 1.11±0.10 AU by dexamethasone and to below non-
impact levels (1 AU) by curcumin to 0.95±0.03 AU where it subsequently 
decreased to a low of 0.40±0.09 AU by 48 h (Fig. 5.11C). 
 
Having confirmed the antagonistic effects of curcumin and dexamethasone 
on the inflammatory cytokine response to impact, the possible 
chondroprotective effects of curcumin and dexamethasone were evaluated. 
Whilst neither agent was observed to significantly (p>0.05) effect the initial 




dexamethasone significantly (p<0.005) reduced the subsequent rate of 
death, whereby the rate of death was decreased from 0.66±0.03 %.h-1 to 
0.07±0.02 %.h-1 and 0.13±0.09 %.h-1 respectively. This duly resulted in an 
overall chondroprotective effect with cell viability at 48 h post impact 
increased from 45.02±2.52 % to 82.58±3.12 % by curcumin and 79.68±3.06 
% by dexamethasone (Fig. 5.12).  
 
These data suggest that suppression of the inflammatory cytokine response 
to impact by curcumin and dexamethasone results in chondroprotection, 
further supporting the role of cytokines in chondrocyte death post impact 








Figure 5.11: Effect of Curcumin and Dexamethasone on pro and anti-inflammatory 
cytokine release following post-mechanical trauma.  
Cartilage explants were pre-treated for 1 h with control isotonic, curcumin (50 µM) or 
dexamethasone (1 µM) supplemented DMEM and subjected to a single mechanical insult. 
Supernatant were collected at 2, 24  and 48 h post mechanical trauma and analysed by 
ELISA for IL-1β;(Panel  A), IL-10 (Panel B) and MCP-1(Panel C). Data is mean ± s.e.m ( 
cytokine concentration relative to non-impacted control samples) from  N=12 explants  








Initial rate of 
chondrocyte death 
(%.h-1) 
Subsequent rate of 
chondrocyte death 
(%.h-1) 
Control 2.75 ± 0.14 0.66 ± 0.03 
Curcumin 2.95 ± 0.01 0.07 ± 0.02 *** 
Dexamethasone 2.52 ± 0.03 0.13 ± 0.09 *** 
 
 
Figure 5.12: Curcumin and dexamethasone pre-treatment protects against cell death 
post mechanical impact.  
Cartilage explants were pre-treated for 1 h with control isotonic, curcumin (50 µM) or 
dexamethasone (1 µM) supplemented DMEM and subjected to a single mechanical 
impact. Samples were loaded with Calcein AM (5 µM) and PI (1 µM) and visualised using 
CLSM prior to and at 2 h, 24 h and 48 h post mechanical impact. Imaris spot analysis was 
used to quantify cell viability. Both curcumin and dexamethasone were seen to protect 
against cell death by significantly decreasing the subsequent rate of chondrocyte death. 
N=12 from 3 distinct experiments. *p<0.05, **p<0.01, ***p<0.005 all vs control. Arrow 





The relationship between increased force and inflammatory cytokines was 
investigated to determine the potential role of cytokines within the response 
of cartilage to mechanical impact and the potential implications in the in 
vivo system. Firstly, analysis of joint forces revealed that shoes decreased 
all leg joint forces, confirming a protective role for footwear. Additionally, 
dominant and non-dominant maximal knee force when running barefoot 
was observed to be non-proportional, indicating leg dominance has a non-
standardised effect on knee force. MDL knee force when running barefoot 
revealed positive correlations with both pro (IL-1β and MCP-1) and anti-
inflammatory (IL-10) circulating cytokines, suggesting increased knee force 
may be associated with increased inflammation.  
 
Analysis of strike patterns demonstrated an increased heelstrike gait was 
associated with an increased MDL knee force when running barefoot, but 
did not show any increase in either pro or anti-inflammatory circulating 
cytokines. An increased pronated gait was also observed to be associated 
with increased MDL knee force when running, but additionally correlated 
with increased pro and anti inflammatory cytokines. These data suggested 
that a heelstrike, pronated gait was optimal for increasing force, but a solely 
heelstrike gait was optimal for increasing force without increasing 
inflammation. 
 
IL-1β, MCP-1 and IL-10 were all observed to increase post exercise, for 
both AM and PM exercise, with pro-inflammatory cytokines (IL-1β and 
MCP-1) peaking immediately post exercise and anti-inflammatory cytokines 
(IL-10) peaking at 2 h post exercise, again for both AM and PM exercise. 
Peak pro-inflammatory cytokine concentration was observed to be 
increased post AM exercise compared to PM. Conversely, peak anti-
inflammatory cytokine concentration was not seen to be significantly 
different between groups.  
 
Mononuclear phagocytes were observed to be involved in a cytokine 




impact resulting in increased production of IL-1β, IL-6, IL-8, IL-10 and MCP-
1 from articular cartilage which induced an increased production of IL-1β 
and MCP-1 from mononuclear phagocytes. This, in turn, led to an increase 
of IL-1β from articular cartilage. Given the cumulative nature of this 
paracrine loop, it is likely to be regulated by additional factors.  
 
Supernatants containing cytokines released by isotonic and hypo-osmotic 
samples in response to impact resulted in chondrocyte death, conversely, 
supernatants from hyperosmotic samples, shown to produce decreased 
cytokine concentrations, did not induce chondrocyte death. These data 
suggested a role for inflammatory cytokines within chondrocyte death in 
response to impact. This was further supported by the observation that 
stimulation with IL-1β concentrations comparable to those released by 
articular chondrocytes in response to impact additionally induced 
chondrocyte death. 
 
Curcumin and dexamethasone were confirmed to have suppressive actions 
on the inflammatory cytokine response to impact and further observed to 
protect against cell death upon mechanical impact by decreasing the 
subsequent rate of cell death. These data indicated a role for inflammatory 
cytokines in the second phase of chondrocyte death post mechanical 















Musculoskeletal conditions, such as osteoarthritis (OA), are the second 
largest cause of lost working days within the UK (after anxiety and 
depression), with ~10 million days lost in 2006/7 (ARC, 2008). Additionally, 
musculoskeletal conditions are the biggest contributor to the number of 
claimants for disability living allowance, representing more that 18 % (ARC, 
2008). Combined, this brings an economic annual cost of £5.7 billion, solely 
within the UK (ARC, 2008). OA is the most common form of arthritis, 
affecting more than 8 million people within the UK and with an estimated 1 
in 5 adults over the age of 50 suffering OA in one or both of their knees 
(ARC, 2008). Given the prevalence of OA and its economic and social 
impact, it is of no surprise that research into OA is an ever-growing field, 
but despite this plethora of research, the multifactorial nature of the disease 
has, as yet, impeded the discovery of a cure (Arthritis Research UK, 2010). 
However, there are a number of known risk factors for the development of 
OA, indicating possible areas of intervention, with age being the most 
prominent, and others including: (1) genetic predisposition, (2) obesity and 
(3) abnormal loading (Felson et al., 2000). Whilst age appears the largest 
risk factor, with the risk of OA increasing with age, it is noted that OA can 
occur in people of all ages including the young and those in mid-life, and 
additionally, that not all elderly develop OA. With obesity, another major risk 
factor for OA development, due to the excessive loading on the joints, it is 
suggested that the ‘wear and tear’ of joints over the years due to repetitive 
or excessive loading is a cause of OA (Arthritis Research UK, 2010).  
 
When considering repetitive joint loading as a risk factor for OA, an obvious 
area of interest is high impact sports, including activities such as endurance 
running, sprinting, football and tennis (Lequesne et al., 1997). Despite this, 
there has been little to no research on the links between sport participation 
or sport injury and OA, until recently brought to light by the Arthritis 
Research UK campaign entitled “Taking the pain out of sport”, spear-
headed by its “Tackling osteoarthritis in sports” conference in October 2010 
(Arthritis Research UK, 2010). Whilst it is acknowledged that joint injury 
through sport increases OA risk (Buckwalter, 2004, Lotz, 2010, Brown et 
al., 2006), evidence also suggests that the repetitive loading involved in 




(Spector et al., 1996, Marti et al., 1989). Indeed, animal models involving 
the application of loading stresses comparable to joint loading forces in 
sport have demonstrated the induction of OA (Andriacchi et al., 2009, 
Milentijevic et al., 2005). Based on this current evidence there is clearly a 
need for further research into the links between repetitive loading and OA, 
and the mechanisms involved. This would enable the provision of 
preventative advice for athletes and amateurs alike, targeting of high-risk 
groups, and elucidation of targets for chondroprotective, preventative 
strategies (Arthritis Research UK, 2010, Lequesne et al., 1997).  
 
This study investigated the cellular responses of chondrocytes to 
mechanical impact, and the effects of possible chondroprotective agents. 
This would allow for a better understanding of the effects of loading on 
cartilage tissue with a view to identifying viable targets for preventative 
strategies in individuals exposed to high impact, repetitive loading.  
 
Mechanical impact of 6.47 KPa and 1.14N was used to investigate the 
cellular viability responses of articular chondrocytes to impact. Whilst it is 
acknowledged these pressure values are lower than in vivo physiological 
values, approximately 5 MPa upon walking (Hodge et al., 1986, Urban, 
1994), it is to be noted that within this model samples did not have the 
protection of the subchondral bone or synovial fluid that they are afforded in 
vivo (Jeffrey et al., 1995). The model used here is intended not to replicate 
in vivo pressures, nor study injurious, matrix damaging loads, but to provide 
a mechanical impact of sufficient magnitude to study cellular responses, 






6.1 Mechanical Impact and Chondrocyte Viability 
Mechanical impact has been previously shown to result in decreased 
chondrocyte viability and matrix deformation (Milentijevic and Torzilli, 2005, 
Szczodry et al., 2009). Here it was observed that mechanical impact 
induced a biphasic decrease in viable cells, with initial, localised 
chondrocyte death being observed within the first 2 hours post mechanical 
impact. This was subsequently followed by a less acute rate of death of 
0.66±0.03 %.h-1 between 2 and 48 hours post mechanical impact (Fig. 3.4). 
The data reported here is in agreement with published findings showing 
that chondrocyte death occurs following mechanical impact (Chen et al., 
2001, Amin et al., 2009, Bush and Hall, 2001b, Bush et al., 2005, D'Lima et 
al., 2001a, D'Lima et al., 2001b, Milentijevic et al., 2005, Milentijevic and 
Torzilli, 2005, Szczodry et al., 2009, Tew et al., 2000), as is the observation 
of biphasic death (Bush et al., 2005, Chen et al., 2001), although the time 
course of the phases and the mechanism of death are as yet inconclusive. 
This can no doubt be attributed to the variety of techniques used to apply 
load, including drop tower (Szczodry et al., 2009), cyclic indentation (Chen 
et al., 2001), and cyclic compression (Campbell et al., 2007), and to 
quantify viability, as well as to the variety in load magnitudes used. Studies 
have reported initial rapid death with 3 min of impact and more expansive 
death over the subsequent 25 min in in situ bovine cartilage, with the 
Superficial Zone (SZ) displaying the most sensitivity (Bush et al., 2005). 
Whilst the mechanism of chondrocyte death post mechanical impact is still 
poorly understood, there have been reports of chondrocyte apoptosis post 
mechanical loading, with z-Vad.fmk, a broad spectrum caspase inhibitor, 
markedly reducing cell death post a single static 14 MPa load in human 
articular cartilage, thus suggesting caspase-dependent apoptosis as the 
mechanism of cell death (D'Lima et al., 2001a). Conversely, there is also 
evidence for necrosis post mechanical loading, with no nuclear 
fragmentation, a marker of apoptosis, being observed post 6 hour cyclic 
loading or 3 hour static loading of up to 1 MPa (Lucchinetti et al., 2002). 
 
To further investigate the mechanisms of chondrocytic death post 




cultured at 20°C and at 37°C to elucidate the role of active cell processes 
within chondrocyte death. Whilst it is known that apoptosis is an active 
cellular process, necrosis is considered a passive process, thus apoptosis 
should be impeded by decreased temperature, in contrast to necrosis 
(Duprez et al., 2009). Observed here, initial death post mechanical impact 
was not affected by the decreased temperature, providing further evidence 
for necrosis being the initial mechanism of chondrocyte death (Fig. 3.10). 
Conversely, subsequent death was impeded by the lower temperature, 
suggesting the mechanism of subsequent death requires active cellular 
processes and is thus likely to be apoptosis (Duprez et al., 2009).  
 
It has been reported that ethylene glycol tetraacetic acid (EGTA) has 
prevented cellular apoptosis in chick chondrocytes when induced by 
inorganic phosphate (Mansfield et al., 2003), and similarly in murine 
macrophages, when apoptosis was induced by cadmium, a carcinogenic 
metal found in cigarette smoke (Kim and Sharma, 2004). Additionally, 
previous work in bovine in situ chondrocytes has shown that removal of 
[Ca2+]0 by EGTA significantly reduced superficial zone chondrocyte death 
post scalpel induced injury when compared to calcium-rich conditions (Amin 
et al., 2009). To determine the role of extracellular calcium ([Ca2+]0) in 
chondrocyte death post mechanical impact, [Ca2+]0 was removed via EGTA. 
EGTA incubation was observed to decrease the subsequent rate of 
chondrocyte death post mechanical impact, but conversely not the initial 
rate, strongly suggesting the involvement of apoptosis in the subsequent 
phase of chondrocyte death post mechanical impact, but not the initial 
phase (Fig. 3.12). Calcium dependent apoptosis has been similarly 
observed post impact loading in equine articular cartilage, whereby 
increased intracellular calcium ([Ca2+]i) following single impact induced 
mitochondrial depolarisation 3-6 hours post impact leading to chondrocyte 
apoptosis. Sequestering of [Ca2+]0 by EGTA inhibited both the observed 
mitochondrial depolarisation and apoptosis (Huser and Davies, 2007).  
 
The data presented here suggests a role for both necrosis and apoptosis 
within chondrocyte death post mechanical impact, with the initial phase 




and the subsequent phase to be spreading apoptosis. A similar observation 
of biphasic death has been previously observed over comparable time 
periods, whereby Terminal deoxynucleotidyl transferase dUTP nick end 
labelling (TUNEL) assay, a DNA fragmentation detection assay, was 
implemented at 4 and 48 hours post loading, determining the percentage of 
death achieved through apoptosis post cyclic indenting loading in canine 
cartilage (Chen et al., 2001, Duprez et al., 2009). The study reported that 
initial death up to 4 hours was not determined to be apoptotic, thus 
indicating necrosis was observed initially. Conversely, cell death measured 
at 48 hours was confirmed as apoptosis.  
 
This study thus concludes that mechanical impact induces biphasic 
chondrocyte death, as previously described, whereby initial necrotic death 




6.2 The Link Between Chondrocyte Volume and Viability 
Post Mechanical Impact 
Cartilage osmolarity changes dynamically in response to the ever-changing 
extracellular environment (Stockwell, 1979). Chondrocytes are constantly 
exposed to mechanical loading of a variety of pressures, depending on 
activity and posture, which alter the extracellular environment (Urban, 
1994). Loading induces tissue deformation, leading to an increase in 
hydrostatic pressure and thus disturbance of the osmotic balance within the 
tissue (Urban, 1994). Chondrocytes, as most cell types, are known to be 
osmotically sensitive, whereby changes in extracellular osmolarity induce a 
volume response (Bush and Hall, 2001b, Hoffmann and Dunham, 1995, 
McGann et al., 1988). Indeed, despite the mesh network of the extracellular 
matrix (ECM) that surrounds the chondrocytes and thus could possibly 
restrict volume changes, it has previously been observed that chondrocytes 
behave as perfect osmometers, following the classic Boyle-van’t Hoff 
relationship (Bush and Hall, 2001b). This observation is further confirmed 
by data presented here (Fig. 6.1), whereby chondrocyte volume changes 
are proportional to changes in osmolarity, further validating iso-surface 
volume analysis as a viable technique for determining in situ chondrocyte 
volume. Given that normal walking results in a fluid loss of 1-5 % 
(Weightman, 1979), and the diurnal cycle of activity and rest 20 % fluid loss 
in the intervertebral discs (Boos et al., 1993), it is evident that chondrocyte 
volume will fluctuate during the course of a day. Cell volume maintenance 
is imperative for effective cell function (Urban et al., 1993), evidenced by 
the observed cell swelling in degenerate chondrocytes in OA tissue (Bush 
and Hall, 2003). Considering the osmotic, and thus volume, changes that 
articular cartilage is subjected to throughout the day, and the importance of 
volume in maintaining a healthy tissue (Urban et al., 1993), it is of interest 
to investigate the involvement of cell volume in maintaining cell viability post 






Figure 6.1: Osmotically induced changes in chondrocyte volume follow the Boyle 
Van’t Hoff relationship  
Mean experimental chondrocyte volume plotted against the reciprocal of the extracellular 
osmolarity following the Boyle van’t Hoff relationship. The y-intercept was the osmotically 
inactive volume ( 130 µm3), and the line of best fit for the data given had a regression 





Articular cartilage explants were exposed to a hypo-osmotic (140 mOsm) or 
hyperosmotic (380 mOsm) challenge for 1 hour prior to mechanical loading, 
to induce cell swelling and cell shrinkage respectively. Initial chondrocyte 
volume was observed to inversely affect chondrocyte viability post 
mechanical loading, whereby increased volume due to cell swelling resulted 
in a decreased number of viable cells and, conversely, a decreased cell 
volume resulted in increased cell viability (Fig. 3.4). The data reported here 
supports previous studies demonstrating decreased sensitivity, in terms of 
cell viability, to mechanical loading in chondrocytes with decreased cell 
volume and similarly, increased chondrocyte volume resulted in increased 
cell death (Bush et al., 2005). Thus, whilst chondrocyte shrinkage can be 
termed chondroprotective, it is further evidenced here that chondrocyte 
swelling results in increased sensitivity to mechanical load, suggesting 
swollen OA chondrocytes (Bush and Hall, 2003) are more susceptible to 
damage and death following mechanical load. 
 
Chondrocytes are known to respond to external stimuli, including osmotic 
changes, mechanical loading and fluid flow, by inducing 
mechanotransductory responses (Hall, 1998, Roberts et al., 2001, 
Yellowley et al., 1997), which have been shown to include changes in 
chondrocyte volume. Taking this into account with the data presented here, 
and supported by the literature (Bush et al., 2005), that has shown 
decreased cell volume to be chondroprotective, the question of whether 
chondrocytes have an endogenous chondroprotective 
mechanotransduction volume response to mechanical loading is raised. To 
investigate the presence of a possible chondroprotective volume response, 
chondrocyte volume was subsequently studied post mechanical impact in 
the presence and absence of hyperosmotic or hypo-osmotic conditions.  
 
It was observed that chondrocyte volume decreased biphasically post 
mechanical impact, under isotonic, hyperosmotic and hypo-osmotic 
challenge (Fig. 3.6). This supports previous studies where decreased 
chondrocyte volume post mechanical load has been observed, although 
over shorter time periods (Bush et al., 2005). Interestingly, there are 




(Quinn et al., 1998). It is likely that these discrepancies are a result of non-
standardised loading between studies, as an impact load great enough to 
induce physical injury to the tissue has been shown to disrupt the collagen 
network, induce proteoglycan (PG) swelling and thus induce reduced 
osmotic pressure and consequently cause cell swelling (Bush et al., 2005, 
Farquhar et al., 1996, Jeffrey et al., 1995). The data presented here is 
evidence of the cellular response to mechanical impact of pressure lower 
than that necessary to induce tissue injury, suggesting that chondrocytes 
display a biphasic impact-induced volume decrease (IIVD) upon non-
injurious loading. 
 
As apoptotic cells are observed to display a decrease in volume (Apoptotic 
Volume Decrease; AVD) prior to cell death (Bortner and Cidlowski, 2002), it 
should be considered whether IIVD is in fact AVD, and thus an artefact of 
chondrocyte death, or potentially a volume regulatory mechanism. 
Comparisons of cell viability post mechanical impact and IIVD reveal that 
samples subjected to a hyperosmotic challenge displayed no significant cell 
death (Section 6.1), however, these samples were still observed to undergo 
IIVD, suggesting no involvement for AVD. Closer inspection of the biphasic 
IIVD response in these chondroprotected samples revealed that although 
the cells still exhibit IIVD, a decrease in the subsequent rate was observed 
(Fig. 3.6). Taken together with previously discussed data suggesting a role 
for apoptosis in the secondary stage of cell death, it is possible that the 
secondary stage of IIVD is AVD. In addition, when impacted and cultured at 
a decreased temperature (20°C), whilst IIVD was still evident, the 
secondary phase was severely decreased (Fig. 3.11). As apoptosis is an 
active cell process (Duprez et al., 2009), this provides further evidence for 
AVD being responsible for the subsequent phase of IIVD and suggests a 
role for active processes in the mechanism of IIVD.  
 
As the process of chondrocyte shrinkage shown here and previously (Bush 
et al., 2005) to be chondroprotective, elucidating the mechanism of the 
newly described IIVD is of interest. It is possible that mechanical loading is 
switching on a regulatory volume decrease (RVD) mechanism (Bush et al., 




chondroprotective mechanism. Whilst the mechanism of RVD within in situ 
chondrocytes is yet to be fully described, it is known to involve a transient 
rise in intracellular calcium ([Ca2+]i; (Hopewell and Urban, 2003, Urban et 
al., 1993) via gadolinium-sensitive stretch activated cation channels 
(SACC), gadolinium-insensitive calcium channels (Kerrigan and Hall, 2008) 
and intracellular store release (Sánchez et al., 2003) in isolated cells, in 
addition to an efflux of taurine, potassium (K-) and chloride (Cl-) ions via a 
volume sensitive organic anion channel (VSOAC)-like osmolyte channel 
(Hall, 1995). To investigate the potential of RVD mechanisms as part of the 
IIVD process, samples were incubated with REV 5901, a documented 
inhibitor of RVD (Bush and Hall, 2001a), or Tamoxifen, an inhibitor of 
VSOAC and thus RVD (Hall, 1995), prior to mechanical impact.  
 
Tamoxifen incubated samples displayed an initial decrease in cell volume 
prior to mechanical impact, and subsequently conferred chondroprotection 
(Fig. 4.14). Interestingly, tamoxifen incubation abolished the IIVD response, 
indicating a potential role for VSOAC (Hall, 1995) within the mechanism of 
IIVD (Fig. 4.16). The chondroprotected response mediated by tamoxifen, 
despite the removal of IIVD, suggests that initial cell shrinkage is most 
important within chondroprotection, compared to the possible protection 
offered by IIVD. Additionally, REV 5901 induced a similar decrease in cell 
volume prior to mechanical impact, and subsequent chondroprotection (Fig. 
4.3). However, IIVD was still observed, indicating IIVD to not be solely 
reliant on RVD mechanisms (Fig. 4.5).  
 
Whilst REV 5901 is an inhibitor of RVD usually observed in response to 
hypo-osmotic challenge, recent report has suggested REV 5901 may 
induce RVD mechanisms under isotonic conditions (Qusous et al., 2011). 
Given the apparent role of calcium signalling in RVD (Kerrigan and Hall, 
2008), a known calcium signalling pathway was investigated in REV 5901 
samples. Articular cartilage explants were additionally incubated with 
rottlerin, an inhibitor of PKC (Gschwendt et al., 1994), U73122, an inhibitor 
of PLCβ3 (Hou et al., 2004) or EGTA (Kerrigan and Hall, 2008). The 
addition of EGTA and thus the sequestering of [Ca2+]0 had no significant 




mechanism (Fig. 4.11). Conversely, both rottlerin and U73122 eliminated 
the IIVD response observed, thus implicating the PKC/PLCβ3 pathway in 
the mechanism of IIVD (Gschwendt et al., 1994, Hou et al., 2004). The 
PKC/PLCβ3 pathway is known to induce IP3 mediated intracellular Ca2+ 
store release, implying store Ca2+ release to be involved in the IIVD 
response, as opposed to [Ca2+]0 influx via SACC or other channels. 
Interestingly, studies have noted an increased sensitivity in IP3 receptors 
and thus an increase in store-mediated [Ca2+]i post mechanical loading 
(Zhang, 2006), further suggesting the involvement of PKC/PLCβ3 pathway 
mediated store release in the chondrocyte response to impact. 
 
This study observed a newly defined biphasic decrease in cell volume post 
mechanical impact, of which the initial phase was observed to be an active 
mechanotransduction mechanism, termed IIVD and the subsequent phase 
is likely to be AVD. IIVD was concluded to be dependant on PKC/PLCβ3 
pathway mediated intracellular Ca2+ store release and VSOAC channel 







Figure 6.2: Theoretical model of the mechanism of IIVD 
Mechanical impact induces signalling by the PKC/PLCβ3 pathway, inhibited by rottlerin 
(Rott) and U73122 (U7) respectively, which activates intracellular store calcium release. 
Volume sensitive organic anion channel (VSOAC)-like osmolyte channel, possibly the 




6.3 Filamentous Actin and Chondrocyte Viability Post 
Mechanical Impact 
The actin cytoskeleton, comprising of filaments termed F-actin, is a 
dynamic network that cells maintain via a highly regulated balance of 
polymerisation and depolymerisation termed ‘treadmilling’ (Blain, 2009, 
Pollard and Borisy, 2003). Actin is involved in many cellular processes, 
including mechanotransduction, and most relevantly for this study, provides 
cells with mechanical integrity and thus the durability to withstand 
mechanical stresses (Blain, 2009, Grodzinsky et al., 2000, Wang et al., 
1993). Given the importance of F-actin in maintaining a structurally sound 
cell, the effects of mechanical load on F-actin are of interest when studying 
the viability of chondrocytes. Thus, changes in F-actin were studied post 
mechanical impact, quantified independent of volume using CLSM and PQ.  
 
Mechanical impact was observed to induce a rapid decrease in F-actin 
content, reaching a plateau at 2 hours post impact (Fig. 3.7), hereafter 
termed impact-induced actin decrease (IIAD). These data support previous 
reports of actin remodelling post impact, with a loss of actin fibres observed 
after application of hydrostatic pressure noted to be reversible after 2 h 
(Parkkinen et al., 1995). Interestingly, studies have observed a 20 fold 
increase in thymosin β4 expression in in situ articular cartilage after 
dynamic loading (Blain et al., 2003). Thymosin β4 is an actin sequestering 
protein which actively disassembles actin filaments by binding to globular 
actin monomers (G-actin) preventing polymerisation (Weber et al., 1992). 
Additionally, cyclic compression has been shown to upregulate cofilin, an 
actin disassembly protein, in isolated chondrocytes where a disassembly of 
actin was also observed (Campbell et al., 2007). The upregulation of actin 
depolymerising proteins thymosin β4 and cofilin post mechanical load 
suggests a possible mechanism by which IIAD could be mediated.  
 
The role of IIAD, and thus the importance of F-actin stability in chondrocyte 
viability post mechanical impact was further investigated using latrunculin B 
and jasplakinolide. Latrunculin B, purified from the Red Sea sponge 




actin filaments (Spector et al., 1989) and jasplakinolide, a cyclic peptide 
isolated from the marine sponge Jaspis johnstoni, binds to and stabilizes F-
actin (Bubb et al., 2000). Thus, latrunculin B and jasplakinolide was used as 
enhancer and an inhibitor of IIAD, respectively. 
 
Latrunculin B was observed to give rise to a biphasic decrease in 
chondrocyte viability post mechanical impact, similar to that seen under 
isotonic conditions. Conversely, jasplakinolide induced chondroprotection, 
with no significant death observed post mechanical impact (Fig. 3.14). 
These data suggest a role for IIAD in chondrocyte death post mechanical 
impact, with prevention of IIAD being a potential target for 
chondroprotection. This is thought to be the first report of the effects of actin 
destabilisation on chondrocyte viability post mechanical loading, however a 
study using human alveolar epithelial cells observed latrunculin to enhance 
and jasplakinolide to have no effect on viability post single air bubble 
application (Yalcin et al., 2009).  
 
Changes in osmotic environment have been previously shown to alter F-
actin within chondrocytes whereby a decrease in extracellular osmolarity 
has been observed to decrease F-actin (Chao et al., 2006) and, similarly, 
hyperosmotic challenge to increase F-actin (Ong et al., 2010) in isolated 
chondrocytes. Here in situ chondrocytes were confirmed to have a similar 
F-actin response to extracellular osmolarity, with hypo-osmotic challenge 
reducing F-actin prior to mechanical impact, and hyperosmotic challenge 
increasing F-actin. Additionally observed here, for the first time, were the 
effects of osmotic challenge on IIAD, whereby both hypo-osmotic and 
hyperosmotic challenge were seen to display IIAD, but to a decreased rate 
when compared to isotonic controls (Fig. 3.7). It is hypothesised that the 
decrease in IIAD could be a result of the increased initial F-actin post 
hyperosmotic challenge and similarly, a result of the decreased initial F-
actin post hypo-osmotic challenge. Interestingly, as IIAD is still observed 
under hyperosmotic challenge yet hyperosmotic challenge has 
chondroprotective effects, it is implied that increased initial F-actin prior to 






Together these data suggest a role for rapid IIAD, possibly mediated by 
increased thymosin β4 and cofilin post mechanical impact, in chondrocyte 
death, however, increased F-actin prior to mechanical impact appears to 





6.4 The Role of Inflammatory Cytokines in Chondrocyte 
Viability Post Mechanical Impact 
Whilst OA is classically considered not to be an inflammatory disease, there 
is a growing body of research supporting the role of inflammatory cytokines 
within the pathogenesis of OA (Pelletier et al., 2001). Increased 
concentrations of a range of pro and anti inflammatory cytokines have been 
observed in OA tissue, including IL-1β, TNF-α, IL-8 and IL-10 (Martel-
Pelletier et al., 1999), although the exact role of these cytokines within the 
OA pathology is yet to be fully elucidated (Pelletier et al., 2001). It is known 
that articular cartilage is sensitive to inflammatory cytokines, whereby IL-1β 
and TNF-α are known to upregulate production of matrix 
metalloproteinases (MMPs) and inhibit collagen II synthesis, thus 
contributing to ECM degradation (Goldring et al., 1994, Goldring et al., 
1988). In addition, IL-1β and TNF-α have positive feedback loops within the 
synovial joint, stimulating their production further as well as the production 
of other inflammatory cytokines including IL-6, IL-8 and nitric oxide (NO) 
(Pelletier et al., 2001).  
 
A rise in inflammatory cytokines has been noted in response to differing 
exercise, with maximal exercise (Brenner et al., 1999, Suzuki et al., 2003a), 
resistance exercise (Brenner et al., 1999, Hirose et al., 2004, Nieman et al., 
2004a, Smith et al., 2000), eccentric cycling (Toft et al., 2002) and 
endurance running (Brenner et al., 1999, Nieman et al., 2004b, Ostrowski 
et al., 1999b, Peters et al., 2001, Suzuki et al., 2000, Suzuki et al., 2003a, 
Suzuki et al., 2003b) all inducing cytokine changes. However, there has 
been limited work investigating the effects of exercise intensity or exercise 
force on cytokine production. Here, knee joint forces were quantified using 
forceplate collection and inverse dynamics, and compared with maximal 
inflammatory cytokine changes post submaximal exercise (60 % VO2max). 
It was observed that increased knee force was positively correlated with 
increased production in serum inflammatory cytokines IL-1β, MCP-1 and IL-
10, suggesting a role for exercise force magnitude on inflammatory 
cytokines (Table 5.3). This is was also observed in a previous study 




plasma cytokine concentration compared to medium intensity exercise (60 
% VO2max) (Peake et al., 2005). Following this perceived role for exercise 
intensity in modulating cytokine concentration, it is thus of interest to 
consider factors which may influence exercise intensity, and thus joint 
impact, including running styles and protective footwear. 
 
Investigated here were the effects of footwear, leg dominance and strike 
pattern on knee force. Footwear was, unsurprisingly, observed to have a 
suppressive, non-standardised, effect on knee force. Given the variety of 
footwear used, this effect was to be expected, as sports footwear is 
designed using a variety of different elastic materials to cushion the foot 
and absorb force (Nigg and Segesser, 1986).  Leg dominance was 
additionally observed to have a non-standardised effect on knee force, 
whereby knee force was not habitually equal between legs, but the 
dominant leg did not have a uniform effect on force magnitude (Table 5.2). 
These data support previous studies observing ground reaction force (GRF) 
asymmetry between legs, unrelated to leg dominance in both young (23±4 
years) and older (70±4 years) sprinters (Korhonen et al., 2010). 
Conversely, strike pattern exhibited a correlated effect on knee force 
whereby both a pronated gait and heelstrike were observed to increase 
knee force. Strike pattern is of interest in running injury, with two differing 
running styles currently adopted, ‘pose’ style forefoot and heelstrike 
running. Currently, there is no definitive conclusion of which style is 
superior in terms of force generation or injury prevention, although these 
data supports previous study that heelstrike increase lower limb force (Sol, 
2001). Furthermore, whilst a pronated gait was observed to be associated 
with increased serum concentrations of IL-1β, MCP-1 and IL-10, 
heelstriking was not, despite both correlating with increased force (Table 
5.4/5). The increase in inflammatory cytokine release in pronated gaits, 
could be an indicator of joint damage, as excessive pronation is linked to 
increased incidence of lower limb injury, including patellofemoral disorders 
(James B, 1978, Clanton, 1992, Hintermann and Nigg, 1998). 
 
Further investigated here, were the cytokine changes post exercise, 




hours post submaximal (60 % VO2max) exercise. Interestingly, whilst both 
IL-1β and MCP-1 were seen to peak immediately post exercise before 
resolving towards pre-exercise levels, IL-10 was observed to have a 
delayed onset, peaking at 2 hours post exercise before subsequently 
declining (Fig. 5.3). These findings are supported by previous studies which 
observed peak increases of pro-inflammatory cytokines, including IL-1β, 
immediately post marathon running (Ostrowski et al., 1999a). The delayed 
peak of IL-10 compared to the pro-inflammatory cytokine peak, similar to 
that observed in other reports (Cox et al., 2007), is thought to be a result of 
anti-inflammatory cytokine activity in response to pro-inflammatory 
cytokines, for the purpose of restricting further pro-inflammatory cytokine 
production (Peake et al., 2005, Toft et al., 2002).  
 
In addition to contributing to OA pathology by inducing upregulation of 
MMPs and inhibiting collagen II synthesis (Goldring et al., 1994, Goldring et 
al., 1988), cytokines are additionally noted to contribute to OA pain by 
inducing hyperalgesia via a number of direct and indirect actions. IL1β is 
known to activate nociceptors directly via intracellular kinase activation, but 
it may also cause indirect nociceptor sensitisation (Sommer and Kress, 
2004, Dray and Read, 2007). As OA pain is noted by sufferers to be more 
acute upon waking in the morning than in the afternoon and evening 
(Bellamy et al., 2002), it is suggested that inflammatory cytokines may 
exhibit a circadian rhythm. Considering the osmotically sensitive nature of 
the chondrocyte response to impact (Section 6.2), and the known 
involvement of inflammatory cytokines in ECM degradation in addition to 
cytokine involvement in morning OA pain, a possible diurnal inflammatory 
response to exercise is suggested.  
 
The proposed diurnal inflammatory cytokine response to exercise was 
investigated whereby plasma cytokine concentrations were analysed for 4 
hours post submaximal exercise (60 % VO2max) commencing at 8 am or 6 
pm. Both morning and evening exercise induced the same cytokine 
expression profile, where pro-inflammatory cytokines IL-1β and MCP-1 
peaked immediately post exercise, and anti-inflammatory IL-10 peaked at 2 




peak IL-1β and MCP-1 concentration was double that of peak concentration 
post evening exercise. Conversely, IL-10 peak concentration did not show 
any significant differences between morning and evening exercise (Fig. 
5.3). Whilst this is believed to be the first report of cytokine expression post 
diurnal exercise, previous studies have noted that cytokine production is 
differentially effected by serum cortisol, whereby cortisol suppresses pro-
inflammatory cytokine production, thus pro-inflammatory cytokines, 
including IL-6 and IL-1β, exhibit a diurnal rhythm with peak levels during the 
night and early morning, at a time when plasma cortisol at its lowest (Cutolo 
and Masi, 2005).  
 
It is important to note the in vivo inflammatory cytokine observations 
discussed are systemic cytokine responses to exercise and loading, 
whereby the cytokine changes observed are a product of the effects of 
exercise on the entirety of the body, thus it cannot be assumed that the 
localised cytokine response of articular cartilage is equal or indeed similar. 
Subsequently, the cytokine response to mechanical impact was here 
investigated in situ.  
 
Chondrocytes are known to produce cytokines, including IL-1β, IL-8, IL-10 
and MCP-1 in unstimulated conditions, as determined by antibody 
microarray of human isolated chondrocytes (De Ceuninck et al., 2004). 
Supernatants from non-impacted bovine samples were here analysed to 
determine basal rates of cytokines, which supported this report, 
demonstrating levels of IL-1β, IL-10 and MCP-1 measurable by ELISA (Fig. 
3.8). IL-1β levels were comparable to those of MCP-1, however IL-10 
concentrations were observed to be elevated, possibly a consequence of 
the dissection. Post mechanical impact, pro-inflammatory cytokines IL-1β 
and MCP-1 increased immediately following impact, before declining to 
near baseline levels. Anti-inflammatory cytokine IL-10 was additionally 
observed to increase immediately following mechanical impact, but 
continued to rise, peaking later at 24 hours post impact (Fig. 3.9). 
Observation of both pro-inflammatory and anti-inflammatory cytokines 
supports previous reports, whereby low grade mechanical load induces an 




inflammatory response, thought to be mediated via integrin signalling and 
the NF-κβ pathway (Deschner et al., 2003). These data suggests a pro-
inflammatory cytokine response to high dynamic load, as modelled here, 
followed by an anti-inflammatory cytokine response restricting further pro-
inflammatory cytokine production (Peake et al., 2005, Toft et al., 2002).  
 
As normal walking is known to result in a fluid loss of 1-5 % (Weightman, 
1979), and the diurnal cycle of activity and rest induces a 20 % fluid loss in 
the intervertebral discs (Boos et al., 1993), articular chondrocytes are likely 
to be of a decreased cell volume later in the day as a consequence of 
prolonged static loading. Conversely, OA chondrocytes are observed to be 
of increased cell volume, as a result of cell swelling (Bush and Hall, 2003). 
As previously noted (Section 6.2), changes in cell volume prior to 
mechanical load were observed to have significant effects on chondrocyte 
viability, and considering the potential role for inflammatory cytokines within 
the OA pathogenesis, the effects of osmotically induced chondrocyte 
volume changes on the inflammatory cytokine response are of interest.  
 
Cytokine responses to mechanical impact were investigated prior to hyper 
and hypo-osmotic challenge. Both osmotic challenges were observed to 
produce the same cytokine response profile post mechanical impact as 
isotonic controls, whereby IL-1β and MCP-1 displayed an immediate 
increase following impact, and IL-10 peaked at 24 hours post impact. 
However, hypo-osmotic challenge induced an increased expression of all 
cytokines across the measured time course and, conversely, hyperosmotic 
induced a decreased expression (Fig. 3.9). Hypo-osmotic challenge has 
been often reported to induce an inflammatory cytokine response in many 
cell types, including rat hepatocytes (Kim et al., 2000) and human intestinal 
epithelial cells (Hubert et al., 2004), supporting the data collected here. 
However, hyperosmotic challenge is additionally reported to induce an 
increased inflammatory response in various cell types, including human 
limbal epithelial cells (Li et al., 2006), human mononuclear cells (Shapiro 
and Dinarello, 1997) and murine gastric epithelial cells (Zhang et al., 2006), 
contrary to data presented here. Despite these discrepancies, it should be 




upon the cells, and thus the combination of hyperosmotic cell shrinkage 
followed by mechanical impact could have resulted in these differing 
reports. Additionally, the varying tissue and species could have had an 
impact. Interestingly, the in vitro cartilage cytokine response to mechanical 
load displayed a similar expression pattern to that of in vivo, whereby pro-
inflammatory cytokines peaked immediately followed by a later onset anti-
inflammatory cytokine peak. In addition, in vivo evening exercise resulted in 
decrease inflammatory cytokine production parallel to the lowered 
production seen in in vitro hyperosmotic conditions, a model of prolonged 
static loading. 
 
Despite the correlation between the in vitro cartilage cytokine response and 
the in vivo systemic cytokine response, there are still multiple contributors 
to consider in the inflammatory cytokine response, solely within articular 
cartilage, including  polymorphonuclear granulocytes (PMNs), mast cells 
and mononuclear phagocytes (Freemont, 1991), all of which are present 
within the synovial fluid. Mononuclear phagocytes have been observed to 
produce pro and anti-inflammatory cytokines, including IL-1β and IL-10, in 
addition to MMPs, have been identified in abundance within OA tissue 
(Benito et al., 2005, Farahat et al., 1993, Haywood et al., 2003) and 
additionally noted to have an increased number and function post exercise 
(Woods et al., 2000). Thus it is suggested that there is the potential for 
mononuclear phagocyte involvement in both OA pathogenesis and exercise 
induced inflammatory cytokine response. Synovial mononuclear 
phagocytes were isolated from bovine synovial fluid to investigate the 
potential role in cartilage inflammatory cytokine release post mechanical 
impact. 
 
Synovial fluid derived mononuclear phagocyte supernatant was analysed 
by ELISA for baseline cytokine levels, which revealed transient release of 
IL-6 and IL-8, but primarily IL-1β, IL-10 and MCP-1, as previously reported 
(Bondeson et al., 2010). Supernatant containing cytokines produced by 
articular cartilage explants 4 hours post mechanical impact was used to 
stimulate mononuclear phagocytes to investigate the effect of impact-




1β and MCP-1 production were observed to significantly increase (Fig. 5.4). 
Subsequently, mononuclear phagocytes were co-cultured with impacted 
articular cartilage to investigate the summative effect of impact and 
stimulated mononuclear phagocytes, which revealed an additional increase 
in IL-1β release. Whilst it must be noted that these data are not a complete 
model for the inflammatory cytokine signalling within the synovial joint, as 
many other cells present within the synovial capsule are likely to be 
involved, these data newly describe a paracrine loop of cytokine release 
(Fig. 6.3). The paracrine loop is likely driven by IL-1β, inducing an amplified 
cytokine signal, similar to the previously reported paracrine loop between 
adipocytes and mononuclear phagocytes, driven mainly by TNF-α that 







Figure 6.3: Model of the observed paracrine loop of cytokine release between 
articular cartilage and mononuclear phagocytes post mechanical insult. 
Baseline levels of cytokines produced by articular cartilage and mononuclear phagocytes 
(black arrows) were observed to primarily be composed of IL-10 and MCP-1, IL-1β and IL-
10 respectively. Single mechanical impact to articular cartilage increased levels of all 
measured cytokines which in turn increased concentration of MCP-1 and IL-1β from 
mononuclear phagocytes. Stimulation of articular cartilage with cytokines from these 




Given the reported milieu of inflammatory cytokines produced by articular 
chondrocytes in response to mechanical impact, and the known catabolic 
effects of cytokines on articular cartilage, the effects of these cytokines on 
apoptosis are of interest. Accordingly, supernatants from articular cartilage 
samples pre-incubated with isotonic, hyperosmotic or hypo-osmotic 
challenge, were removed post mechanical load, and subsequently used to 
stimulate non impacted cartilage samples. Chondrocyte viability, as 
determined by CLSM and spot analysis (See Materials and Methods) was 
observed to be significantly decreased in explants stimulated with 
supernatants from both isotonic and hypo-osmotic samples, but conversely, 
no significant viability change was observed in explants stimulated with 
supernatants from hyperosmotic samples (Fig. 5.8). As previously 
described here, hyperosmotic challenge induced a decrease in IL-β, MCP-1 
and IL-10 expression compared to both isotonic and hypo-osmotic 
conditions, thus, supernatants containing increased levels of cytokines 
(isotonic and hypo-osmotic) were noted to induce chondrocyte death. 
Whilst cytokines have been reported to have a varied effect on cell death, 
depending on cell type and the cytokine (Haanen and Vermes, 1995, 
Yasuhara et al., 2005), IL-1β has been previously noted to induce cell death 
in chondrocyte-like ATDC5 cells by mitochondrial dysfunction (Yasuhara et 
al., 2005).  
 
As IL-1β was found to be increased upon mechanical impact and a driver in 
the mononuclear phagocyte/cartilage paracrine loop, thus, the involvement 
of IL-1β in cytokine mediated chondrocyte death was investigated. The 
addition of IL-1β was noted to induce a significant decrease in chondrocyte 
viability, as measured by CLSM spot analysis, and an additional decrease 
in cell volume (Fig. 5.6/7). Similar studies have noted a decrease in 
chondrocyte viability when stimulated by recombinant IL-1β, whereby an 
Annexin-V-fluos staining kit was used to detect apoptotic cells, thus 
concluding that IL-1β induced chondrocyte death via apoptosis (Heraud et 
al., 2000). Furthermore, as apoptosis is known to involve a decrease in cell 
volume (AVD) (Bortner and Cidlowski, 2002), these data suggest IL-1β 
mediates chondrocyte death by apoptosis, and thus is likely to contribute to 





The described role for inflammatory cytokines within chondrocyte death 
post mechanical impact, and OA, suggests a possible area of interest in 
regards to chondroprotection, whereby anti-inflammatory agents may 
exhibit a chondroprotection response.  
 
The chondroprotective potential of inhibiting inflammatory cytokines was 
investigated using curcumin, the active component of turmeric, which is 
known to have potent anti-inflammatory properties (Sharma et al., 2005), 
including down-regulation of MCP-1 expression (Wu et al., 2006, Herman et 
al., 2009) and dexamethasone, a potent anti-inflammatory drug used to 
treat inflammatory and autoimmune disorders including rheumatoid arthritis 
(Getting et al., 2009). Curcumin and dexamethasone were confirmed to 
have anti-inflammatory effects, whereby a decrease in IL-1β to below 
baseline non-impact levels and a decrease in IL-10 to baseline non-impact 
levels was observed by both agents. Furthermore, dexamethasone 
decreased MCP-1 concentration to baseline non-impact levels, and 
curcumin to below baseline levels (Fig. 5.8). These data supported previous 
reports of inhibition of MCP-1 gene expression by dexamethasone (Ajuebor 
et al., 1998). Curcumin and dexamethasone were noted to have no initial 
effect on chondrocyte viability, however, both agents exhibited a similar 
significant inhibitory effect on the secondary stage of chondrocyte death 
following mechanical impact, resulting in overall chondroprotection (Fig. 
5.9). These data further support the conclusion that the secondary phase of 
impact induced chondrocyte death is mediated by cytokine induced 
apoptosis, as previously observed here (Section 6.1/2). Previous studies 
have made similar reports of the chondroprotective actions of curcumin, 
whereby curcumin treatment inhibited IL-1β induced apoptosis, via 
inhibition of activated NF-κβ translocation (Csaki et al., 2009). Conversely, 
previous work has reported dexamethasone to induce apoptosis within 
chondrocytic cell line HCS-2/8 with, however a concentration 25 x that used 
here (Chrysis et al., 2005), thereby allowing for these contradictory data, in 





Together these data suggest that both in vivo exercise and in vitro 
mechanical load induce a release of inflammatory cytokines, with a 
decreased response in the evening or after prolonged static loading. 
Chondrocytes are noted to be sensitive to cytokines whereby they induce 
further cytokine production and mediate chondrocyte death by apoptosis, 
inhibited by anti-inflammatory agents. This suggests a role for both evening 




6.5 A Role for Chondroprotective Agents 
Loading is known to induce decreased chondrocyte viability and matrix 
deformation (Milentijevic and Torzilli, 2005, Szczodry et al., 2009) in 
addition to a rise in inflammatory cytokines (Brenner et al., 1999, Suzuki et 
al., 2003a), all of which are noted features of OA. Given the growing body 
of evidence that continued excessive mechanical loading can induce OA 
later in life (Arthritis Research UK, 2010), it is of interest to elucidate 
possible targets for intervention, whereby chondroprotective agents are 
employed in high risk groups prior to the onset of OA. It has been noted 
here that decreased cell volume and increased F-actin prior to impact in 
addition to inhibition of IIAD and inflammatory cytokines release all have 
chondroprotective effects.  
 
6.5.1 Nutriceuticals 
Many nutritional supplements (nutriceuticals) and complimentary therapies 
are utilised by OA suffers and by individuals hoping to maintain ‘healthy 
joints’. Two of the most commonly used are chondroitin sulphate and 
glucosamine sulphate (ARC, 2009). Chondroitin sulphate constitutes the 
majority of glycosaminoglycan (GAGs) found within the ECM, branched 
from PGs. It has reported to stimulate cartilage repair, inhibit catabolic 
enzymes and have anti-inflammatory actions (Huskisson, 2008, Deal and 
Moskowitz, 1999). Orally administered chondroitin sulphate has been 
shown to be rapidly absorbed in the gastrointestinal tract, and a high 
content of chondroitin sulphate, labeled with the metastable radioactive 
tracer Technetium-99m, has been found in the synovial fluid and cartilage 
of both rats and humans (Ronca et al., 1998). Glucosamine sulphate is the 
principle substrate in the synthesis of PGs (Simanek et al., 2005), thus the 
theory behind its use is that it will provide increased potential for PG 
synthesis (Huskisson, 2008, Simanek et al., 2005, Pavelka et al., 2002). 
Glucosamine is confirmed to be increased in the synovial fluid of both OA 
patients and in an equine model following oral administration of 





Both chondroitin and glucosamine sulphate were here observed to have 
chondroprotective actions, preventing any significant chondrocyte death 
post mechanical impact (Fig. 4.21). Additionally, both agents were 
observed to decrease chondrocyte volume prior to impact, a 
chondroprotective mechanism (Section 6.2) but still exhibited initial IIVD 
post mechanical impact (Fig. 4.23). This is the first report of chondroitin and 
glucosamine sulphate induced volume changes and thus the mechanism is 
not yet determined, however it is previously observed that glucosamine 
induces depletion of cellular ATP (Shikhman et al., 2009). Chondrocytes 
are known to express ATP dependent potassium (KATP) channels (Barrett-
Jolley et al., 2010), whereby decreased intracellular ATP opens the 
channel, hyperpolarising the membrane and inducing Ca2+ influx via 
voltage-gated calcium channels (VGCCs) (Barrett-Jolley et al., 2010). 
VGCCs have been previously confirmed as active within freshly isolated 
bovine articular chondrocytes (Raizman et al., 2010). It is possible that 
glucosamine alters cell volume via this mechanism as changes in 
intracellular Ca2+are known to be linked with volume. Similarly, chondroitin 
has been seen to alter cellular ATP in rat liver membranes (Vieira et al., 
2001), thus could be acting via a similar mechanism. Additionally, whilst 
both chondroitin and glucosamine sulphate have been previously seen to 
activate PKC (Miki et al., 2002, Aoyama et al., 2005), blockage of 
PKC/PLβ3 mediated intracellular calcium signalling using rottlerin (PKC 
inhibitor) or U73122 (PLβ3 inhibitor) did not affect the pre-impact volume 
response, suggesting neither chondroitin or glucosamine sulphate initiated 
volume changes via this mechanism. Interestingly, removal of calcium by 
EGTA inhibited the decreased volume observed by both chondroitin and 
glucosamine sulphate, further supporting the proposed mechanism of 
volume decrease by ATP modulation and VGCC mediated influx. Rottlerin 
and U73122 did, however, abolish the observation of IIVD with chondroitin 
and glucosamine sulphate, further strengthening the role of PKC/PLβ3 
mediated store release in the mechanism of IIVD (Section 6.2). 
 
Chondroitin and glucosamine sulphate were further observed to increase F-
actin prior to mechanical impact, another chondroprotective response 




observations were affected by rottlerin, U73122 or EGTA, indicating the 
actions of chondroitin and glucosamine sulphate on F-actin are not 
mediated by extracellular Ca2+ influx or PKC/PLβ3 mediated intracellular 
Ca2+ store release. No previous reports have been made regarding effects 
of glucosamine on actin, however it is noted that chondroitin stabilises actin 
in rats with induced acute necrotising pancreatitis (He and Guo, 2007). It 
can be suggested, that the reported alterations in cellular ATP by 
glucosamine (Shikhman et al., 2009) and chondroitin (Vieira et al., 2001) 
could induce the increase in initial F-actin and subsequent protection from 
IIAD by preventing actin depolymerisation. Whereby, ATP hydrolysis is 
required for actin filament ‘treadmilling’, the process of depolymerising and 
polymerising F-actin (Bugyi and Carlier, 2010).  
 
Finally, both chondroitin and glucosamine sulphate decreased pro-
inflammatory cytokines IL-1β and MCP-1 and induced the anti-inflammatory 
cytokine IL-10 following post mechanical impact to basal levels across the 
measured time course (Fig. 4.25). The observed anti-inflammatory effects 
of chondroitin sulphate are well documented (Bugyi and Carlier, 2010, 
Campo et al., 2009, Iovu et al., 2008, Martel-Pelletier et al., 2010), and 
noted to be driven by the inhibition of NF-κβ activation (Iovu et al., 2008). 
Similarly, glucosamine sulphate is reported to inhibit NF-κβ activation in OA 
chondrocytes (Largo et al., 2003) and in rat middle cerebral artery (Hwang 
et al., 2010). Although the data for these supplements looks promising as a 
protective agent for OA, the results generated here are in an in vitro model 
and further work is required to determine whether these observations 
translate to in vivo pre-clinical models of OA or patients. 
6.5.2 RVD Inhibitors 
Previously discussed inhibitors of RVD, REV 5901 and tamoxifen, were 
also noted to have chondroprotective effects, observed here for the first 
time (Section 6.2). In addition to the previously described chondroprotection 
and decrease in initial chondrocyte volume, both REV 5901 and tamoxifen 
induced an increase in F-actin prior to mechanical impact and subsequently 
protected against IIAD (Fig. 4.6/17). The effects of REV 5901 on actin, in 




presence of rottlerin or U73122 but not affected by EGTA. These data 
suggest a role for PKC/PLCβ3 mediated Ca2+ store release, but not 
extracellular Ca2+ influx, in the mechanism of REV 5901, further supported 
by additional work from within the same research group using isolated 
chondrocytes (Qusous et al., 2011). Tamoxifen induced increases in F-actin 
have been previously noted in endometrial stromal cells (Albright et al., 
1997), but conversely decreases in F-actin have been observed in lens 
epithelial cells (Verdugo-Gazdik et al., 2006). Tamoxifen is known to be 
anticalmodulin (Pawar et al., 2009) and could thus exhibit inhibitory effects 
on actin depolymerisation, whereby calmodulin is an upstream signalling 
molecule for the activation of cofilin, an actin-disassembly protein (Ono, 
2007). 
 
Furthermore, both REV 5901 and tamoxifen were observed to have anti-
inflammatory actions, decreasing IL-1β, IL-10 and MCP-1 post mechanical 
impact to below baseline levels and maintaining them for the measured 
timecourse (Fig. 4.8/18). The anti-inflammatory actions of tamoxifen are 
supported by previous study whereby tamoxifen has been previously 
observed to be an inhibitor of NF-κβ translocation, thus inhibiting further 
cytokine production (Richette et al., 2007). The actions of REV 5901 on 
modulating inflammatory cytokine concentration were not effected by 
rottlerin, U73122 or EGTA, indicating the anti-inflammatory actions of REV 
5901 are the product of a separate mechanism of action.  
 
REV 5901 is additionally an inhibitor of 5-lipoxygenase (5-LO) (Musser et 
al., 1987) which is an enzyme involved in the leukotriene pathway. The 
presence of 5-LO within cartilage tissue was confirmed here by LTB4 assay, 
whereby LTB4 is a product of the 5-LO pathway. LTB4 was detected in non-
impact samples and was additionally observed to be significantly increased 
post mechanical load. Whilst elevated LTB4 has been previously observed 
within OA synovial fluid (Wittenberg et al., 1993), this is thought to be the 
first report of LTB4 production within cartilage tissue.  REV 5901 decreased 
LTB4 to below non-impact levels (Fig. 4.7). Leukotrienes have been 
observed to induce production of cytokine synthesis, namely IL-1, in 




rather than PKC/PLCβ3 as the mechanism of the anti-inflammatory actions 
of REV 5901.  
6.5.3 What is the Most Efficient Chondroprotective Agent? 
Together these data suggest chondroprotective actions for chondroitin and 
glucosamine sulphate; possibly via NF-κβ translocation and ATP 
modulation, REV 5901; via 5-LO inhibition and PKC/PLCβ3 mediated store 
release, and Tamoxifen; possibly via NF-κβ translocation and inhibition of 
VSOAC and calmodulin. Additionally, the previously described anti-
inflammatory agents, curcumin and dexamethasone, were confirmed to 
exhibit chondroprotective actions via modulation of inflammatory cytokine 
release (Section 6.4). Whilst chondroitin sulphate, glucosamine sulphate, 
tamoxifen and REV 5901 were observed to have similarly efficient 
chondroprotective actions, REV 5901 was the most efficient at increasing 
initial F-actin, but chondroitin sulphate and tamoxifen induced the greatest 
decrease in initial volume. Chondroitin sulphate and REV 5901 had the 
greatest impact on reducing inflammatory cytokine release (Table 4.1). 
Curcumin and dexamethasone were observed to have less 
chondroprotective effects than the other investigated agents, indicating that 
merely modulating inflammatory cytokine release is not enough for total 
chondroprotection. Thus, whilst REV 5901 was demonstrated to be the 
most proficient at the greatest number of chondroprotective actions, given 
the unknown safety of REV 5901, chondroitin sulphate is likely to be the 





6.6 Conclusions  
The cellular responses of chondrocytes to mechanical impact were here 
investigated to help elucidate possible targets for chondroprotection in high 
OA-risk individuals.  
 
Mechanical impact was determined to induce biphasic chondrocyte death, 
characterised by an initial necrotic phase and a subsequent apoptotic 
phase. Additionally, biphasic decrease in cell volume post mechanical 
impact was observed, of which the initial phase was observed to be an 
active mechanism, termed Impact-Induced Volume Decrease (IIVD), and 
the subsequent phase to be Apoptotic Volume Decrease (AVD). The newly 
defined IIVD was concluded to be dependent on PKC/PLCβ3 pathway 
mediated intracellular Ca2+ store release and VSOAC channel activity. 
Furthermore, mechanical impact was observed to induce a rapid decrease 
in F-actin, termed Impact-Induced Actin Decrease (IIAD; Fig. 6.4). 
 
Both in vivo exercise and in vitro mechanical load induce a release of 
inflammatory cytokines, with in vivo concentrations being affected by joint 
magnitude and strike patterns. Load induced inflammatory cytokine 
increase was determined to be decreased in the evening or after prolonged 
static loading.  
 
Chondroprotective actions were determined to be induced by decreasing 
pre-impact cell volume, increasing pre-impact actin and inhibiting IIAD. 
Additionally, inflammatory cytokines were noted to mediate chondrocyte 
death by apoptosis, thus anti-inflammatory actions were also deemed 
chondroprotective.  
 
Nutriceuticals, chondroitin and glucosamine sulphate were determined to 
have chondroprotective actions, possibly via NF-κβ translocation and ATP 
modulation. Similarly RVD inhibitors REV 5901 and Tamoxifen exhibited 
chondroprotective mechanism, via 5-LO inhibition and PKC/PLCβ3 
mediated store release, and NF-κβ translocation and inhibition of VSOAC 




dexamethasone had less effective chondroprotective actions, via inhibition 
of inflammatory cytokines and thus apoptosis.  
 
To conclude, mechanical impact induces changes to chondrocyte volume, 
F-actin and cytokine release, resulting in a decrease in chondrocyte viability 
(Fig. 6.4). Cartilage was revealed to have a ‘diurnal’ response to impact, 
whereby ‘PM’ cartilage, as modelled by hyperosmotic challenge, was 
determined to be chondroprotective. Similarly, investigation of diurnal 
exercise revealed PM exercise to induce a less severe inflammatory 
cytokine response, thus high impact exercise is recommended to be carried 
out in the evening rather than the morning. Exploration of possible 
chondroprotective agents revealed that there is a place for 
chondroprotection in high-risk groups, providing intervention occurs before 
OA onset, with current nutriceuticals and natural anti-inflammatory agents 













Figure 6.4: Summary of the responses of articular chondrocytes to mechanical 
impact. 
Impact induces a biphasic decrease in chondrocyte volume, a rapid initial phase and a 
subsequent slower phased linked to apoptosis. Additionally, impact induces a rapid F-actin 
decrease and increased pro- and anti-inflammatory cytokine release, whereby pro-
inflammatory cytokines peak immediately post impact and anti-inflammatory cytokines 
peak at 24 h. These responses resulted in biphasic chondrocyte death, with the initial rapid 
phase likely to be necrosis and the slower subsequent phase to be apoptosis. IIVD: Impact 





6.7 Future Work 
Future work to support these data includes further research into the 
mechanisms involved in IIVD. As the PKC/PLCβ3 [Ca2+]i store release 
signalling pathway was reported here to be involved, [Ca2+]i levels post 
impact could be determined using CLSM, followed by investigation of the 
magnitude of the IIVD response following emptying of intracellular stores by 
thapsigargin. Additionally, the contribution of known membrane channels 
would be investigated by selective inhibition, including inhibition of SACC 
by gadolinium and VGCC by nimodipine. The biphasic cell death post 
impact would be further investigated to confirm necrosis and apoptosis via 
TUNEL technique and the zonal viability response to impact investigated by 
transverse sectioning of articular cartilage explants.  
 
Further investigation into the cytoskeletal responses to impact would 
involve the utilisation of CLSM techniques and antibody labelling to 
investigate the responses of tubulin and vimentin to impact. Additionally, 
PCR and western blots would be used to determine changes in expression 
of cytoskeletal regulatory proteins, such as cofilin, profilin, gelsolin and 
thymosin β4, post impact on both an mRNA and protein level respectively. 
Thus furthering investigation of the mechanism behind IIAD.    
 
An in vivo animal model would be developed for further investigation into 
the chondroprotective potential of chondroitin sulphate, whereby the effects 
on articular cartilage integrity following repetitive high impact exercise of 
chondroitin sulphate administration would be analysed. Subsequently, a 
long-term in vivo human randomised controlled trial of chondroitin sulphate 
administration in high risk individuals would be developed, whereby 
chondroitin efficacy would be analysed by joint MRI, serum cytokine levels 
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Appendix I: Training and Injury Questionnaire 
MEDICAL QUESTIONNAIRE 
 
This form is used as a pre-participation health and risk factor screening device and 
should be completed prior to the commencement of an exercise test. 
 
The information obtained in this medical assessment will be kept as 
CONFIDENTIAL. Only the staff member related to the exercise test may access 
to the information. 
 
Surname (Mr., Mrs., Ms.): _______________________________________ 
 
 
Given Names: _______________________________________________________ 
 
 
















FAMILY MEDICAL HISTORY. 
Has any near relative brother (B), sister (S), father (F), mother (M), grandparents 
(GP) suffered: 
 
Please tick the appropriate column 
 No Yes Relation Age Remarks 
/Details 
Apoplexy (stroke)      
Congenital heart trouble      
Rheumatic heart disease      
Heart operation      
Angina      




Sudden death      
High blood pressure      
High cholesterol      
'Hardening of arteries'      
Asthma      
Lung disorder      
Bronchitis, emphysema      
Hay fever      
Diabetes      
Gout      
Arthritis      
Epilepsy      
      
 
 
PAST MEDICAL HISTORY 
Have you suffered any of the following conditions at any time? 
(Please tick the appropriate column) 
 No Yes       Details 
Rheumatic or scarlet fever    
Heart trouble or murmur    
Heart palpitation    
High blood pressure    
Heart attack    
Chest pain/Angina    
Stroke    
Disease of arteries or veins    
Undue limiting shortness of breath with 
exercise 
   
Fainting or blackout    
Loss of consciousness or fainting with exercise    
Epilepsy    
Lung or bronchial disease    
Asthma    
Hay fever    




Diabetes    
Thyroid disease    
Arthritis, rheumatism or gout spondylitis,  
disc trouble or back injury 
   
Serious accident or injury    
Surgical operation    
Congenital abnormality    
Other serious illness (or conditions that may 
affect exercise) 
   
For female only: 
Having normal/regular periods 




State the name and dosage of any drugs or medicines that you are taking regularly: 
Drug       Dose Time of last dose 
   
   
   











TRAINING & INJURY QUESTIONNAIRE 
Name:....................................................................................................................................... 
Club Name/ Region: .............................................................................................................. 
Date of Birth............................................................................................................................ 












PERSONAL BEST TIMES 
Sport..................................................................................................... 
Level reached (club/county etc)....................................................................................................... 
Personal best time/distance etc............................................................................................... 
 
CURRENT TRAINING  
Please complete the below form for an average 2 weeks. Please include as much detail as possible. 
    AM PM 
Monday  
    
Tuesday 
    
Wednesday 
    
Thursday 
    
Week 1 
Friday 





    
 
Sunday 
    
Monday 
    
Tuesday 
    
Wednesday 
    
Thursday 
    
Friday 
    
Saturday 
    
Week 2 
Sunday 













(an injury is defined as any musculoskeletal problem that caused you to stop training for at least one 
day, reduce mileage, take medicine or seek medical aid). 
 Have you had any traumatic/overuse injuries within the past five years?  Ring answer    Yes        No 
Please give details of traumatic injury/ injuries, including date:  
i Neck ............................................................................................................ 
ii Upper Back   ............................................................................................................. 
iii Hamstrings   ............................................................................................................. 
iv Calf              ........................................................................................................... 
v Achilles Tendon........................................................................................................ 
vi Combination............................................................................................................. 
vii Shoulder .................................................................................................................. 
viii Lower Back................................................................................................................ 
ix Anterior Thigh........................................................................................................... 
x Knees........................................................................................................................ 
xi Ankles....................................................................................................................... 
xii  Other (state what)....................................................................................................... 
 
Are you injury- free at the moment?  Yes       No 
 
Is there any reason why you should not undergo physiological testing?   Yes        No 
 
 







Appendix II: Conference abstracts 
THE EFFECTS OF REV5901 ON CHONDROCYTE VIABILITY 
FOLLOWING MECHANICAL TRAUMA 
 
E. Parker, S.J. Getting, F. Hucklebridge, V.E. Vleck & M.J.P. Kerrigan 
 
Cell Communication Group, School of Biosciences, University of Westminster, 
London W1W 6UW 
 
Mechanical trauma through repetitive, high-impact sport contributes to the 
onset of osteoarthritis. Hypertonicity protects chondrocytes from 
mechanical trauma1 suggesting a role for cell volume in this process. Since 
the 5-lipoxygenase inhibitor REV5901 inhibits chondrocyte volume 
regulation, this study was designed to investigate whether this compound 
exerts a chondro-protective effect following mechanical trauma. 
 
Cartilage explants were dissected from the joints of 18-21 month old steers 
into DMEM. Explants were incubated for 1h in either: isotonic (280mOsm), 
hypertonic (380 mOsm), DMSO supplemented (5µl/ml) or 50µM REV5901 
DMEM and subsequently subjected to a single impact as previously 
described2. Chondrocyte viability was determined by confocal microscopy2 
and data expressed as mean ± s.e.m; *p<0.05. n = 5 distinct experiments. 
 
Explants in isotonic or DMSO supplemented DMEM exhibited a decrease in 
cell viability from 79±0.05% & 83±1.63% to 45±2.52% & 50±3.45% at 48h 
post impact; *p<0.05 and *p<0.05 respectively. Conversely, when incubated 
with hypertonic DMEM or 50µM REV5901 there was no decrease (p>0.05) 
in chondrocyte viability from 89±3.65% to 90±4.51% to 93±2.63% to 
86±3.34% at 48h. 
 
These data suggest that REV5901 exhibits a chondro-protective effect in an 
in vitro model of mechanical trauma. 
 
1. Bush, P., et al., Osteoarthritis and Cartilage, 2005. 13(1): p. 54-65. 
2. From the University of Brighton, Winter 2008 Meeting: Proceedings 




THE EFFECTS OF REV5901 ON CHONDROCYTE VIABILITY 
FOLLOWING MECHANICAL TRAUMA 
 
E. Parker, S.J. Getting, F. Hucklebridge, V.E. Vleck & M.J.P. Kerrigan 
 
Cell Communication and Inflammation and Infection Groups, School of Life 
Sciences, University of Westminster, London W1W 6UW 
 
Mechanical trauma through repetitive, high-impact sport contributes to the 
onset of osteoarthritis. Hypertonicity protects chondrocytes from 
mechanical trauma1 suggesting a role for cell volume in this process. Since 
the 5-lipoxygenase inhibitor REV5901 inhibits chondrocyte volume 
regulation, this study was designed to investigate whether this compound 
exerts a chondro-protective effect following mechanical trauma. 
 
Cartilage explants were dissected from the joints of 18-21 month old steers 
into DMEM. Explants were incubated for 1h in either: isotonic (280mOsm), 
hypertonic (380 mOsm), DMSO supplemented (5µl/ml) or 50µM REV 5901 
DMEM and subsequently subjected to a single impact as previously 
described2. Chondrocyte viability was determined by confocal microscopy2 
and data expressed as mean ± s.e.m; *p<0.05. n = 5 distinct experiments. 
 
Explants in isotonic or DMSO supplemented DMEM exhibited a decrease in 
cell viability from 79.0 ± 0.1%  and 83.0 ± 1.6% for isotonic and to 45.0 ± 
2.5%  and 50.0±3.5% for DMSO supplemented following 48h post impact; 
*p<0.05 and *p<0.05 respectively. Conversely, when incubated with 
hypertonic DMEM there was no decrease (p>0.05) in chondrocyte viability 
(89.0 ± 3.7% to 90.0 ±4.5%) whilst incubation with 50µM REV 5901 did not 
alter cell vialbility (93±2.63% to 86±3.34%) at 48h. Pre-incubation with 50 
µM REV 5901 resulted in a sustained decrease in cell volume (p<0.01) 
from 1547 ± 61 µm3 to 1011 ±19 µm3, which was not significantly different 
(p>0.05) when compared to cells in hypertonic DMEM. 
 
These data suggest that REV5901 exhibits a chondro-protective effect in an 
in vitro model of mechanical trauma by causing a decrease in cell volume 
potentially via activating a volume-regulatory pathway. 
 
1. Bush, P., et al., Osteoarthritis and Cartilage, 2005. 13(1): p. 54-65. 
2. From the University of Brighton, Winter 2008 Meeting: Proceedings 






REV5901: Chondro-protective Effects Post Mechanical Trauma. 
 
E. Parker, S. Noureen, S.J. Getting, V.E. Vleck, F. Hucklebridge & M.J.P. 
Kerrigan 
 
Cell Communication and Inflammation and Infection Groups, School of Life 
Sciences, University of Westminster, London W1W 6UW 
 
Mechanical trauma through repetitive, high-impact sport contributes to the 
onset of osteoarthritis. Hypertonicity protects chondrocytes from 
mechanical trauma1 suggesting a role for cell volume in this process. Since 
the 5-lipoxygenase inhibitor REV5901 inhibits chondrocyte volume 
regulation, this study was designed to investigate whether this compound 
exerts a chondro-protective effect following mechanical trauma. 
 
Cartilage explants were dissected from the joints of 18-21 month old steers 
(obtained with ethical permission) into DMEM. Explants were incubated for 
1h in either: isotonic (280mOsm), hypertonic (380 mOsm), DMSO 
supplemented (5µl/ml) or 50µM REV5901 DMEM and subsequently 
subjected to a single impact as previously described (Bush et al., 2005). 
Chondrocyte viability, volume and relative F-actin concentration were 
determined by confocal microscopy and data expressed as mean ± s.e.m; 
(Student T-test: p<0.05), n=45 cells each from 5 distinct experiments. 
Supernatant from the explants was analysed for inflammatory cytokines by 
ELISA at 0h, 2h, 4h, 24h and 48h post mechanical impact. 
 
Explants in isotonic or DMSO supplemented DMEM exhibited a decrease in 
cell viability from 79±0.05% & 83±1.63% to 45±2.52% & 50±3.45% at 48h 
post impact; p<0.05 and p<0.05 respectively. Conversely, when incubated 
with hypertonic DMEM or 50µM REV5901 there was no decrease in 
chondrocyte viability from 89±3.65% to 90±4.51% to 93±2.63% to 
86±3.34% at 48h. REV5901 incubated samples displayed a decrease in 
cell volume (p<0.01) from 1547±61µm3 to 1011±19µm3 2h post mechanical 
trauma when compared to control conditions. Additionally pre-incubation 
with REV5901 resulted in an increase (p<0.05) in relative F-actin 
(208.70±4.85AU) when compared to non-treated samples (185.00±6.36AU) 
prior to mechanical trauma and a significantly less acute decrease post 
trauma (REV5901 171.00±5.76AU; Isotonic 64.69±3.16AU both at 48h post 
trauma). Cytokine changes relative to control were significantly (p<0.05) 
decreased post trauma in samples pre-incubated with REV5901 (IL-1β: 
Isotonic 1.30±0.18pg/ml/g REV5901 0.55±0.21pg/ml/g; IL-10: Isotonic 
1.18±0.09pg/ml/g REV5901 0.90±0.11pg/ml/g; MCP-1: Isotonic 
1.46±0.20pg/ml/g REV5901 0.60±0.07pg/ml/g; all at 2h post trauma).  
 
These data suggest that REV5901 exhibits a chondro-protective effect in an 
in vitro model of mechanical trauma by reducing cell volume and 
decreasing the release of inflammatory cytokines. 
 




Knee Forces And Inflammation: The Effects of Foot Strike Patterns 
And Footwear. 
E. Parker, S.Domah, S.J. Getting, V.E. Vleck, F. Hucklebridge & M.J.P. 
Kerrigan 
Cell Communication and Inflammation and Infection Groups, School of Life 
Sciences, University of Westminster, London W1W 6UW 
 
With elite level athletes participating more frequently in their chosen sports, 
they are at an ever-increasing risk of injury. The long-term risk is the likely 
development of Osteoarthritis (OA). Joint loading frequency and magnitude, 
as well as build up of inflammatory cytokines, are both contributing factors 
to this condition. With many different training shoes on the market and 
differing running styles favored it is of benefit to investigate the affects of 
foot strike patterns and footwear on joint force magnitude and inflammation. 
 
14 healthy male subjects aged 20-39 underwent anthropometric tests and 
were subsequently analysed for force magnitude and gait whilst running at 
11 kmh-1using a force mat, both barefooted and wearing documented 
footwear. Venous blood samples were taken at 0h, 2h and 4h post 30min 
treadmill run at 60% VO2max. A control sample pre-exercise was also 
taken and inflammatory cytokine concentration determined by ELISA. 
 
Results showed that whilst there was no correlation between knee force 
magnitude when barefoot and when in shoes (Pearson Coefficient = -0.41, 
p>0.05), there was a non-significant correlation between sole depth and 
maximal knee force (Pearson Coefficient = -0.56, p>0.05), suggesting other 
parameters of the footwear have an effect on force. Similarly no significant 
correlation was seen between dominant and non-dominant maximal knee 
force (Pearson Coefficient = 0.73, p>0.05), foot length and maximal knee 
force (Pearson Coefficient = 0.60, p>0.05), and percentage body fat and 
maximal knee force (Pearson Coefficient = 0.66, p>0.05). Conversely a 
significant correlation was displayed between maximal dominant barefoot 
knee force and relative maximal inflammation post exercise (IL-1β: Pearson 
Coefficient = 0.99, p<0.005, IL-10: Pearson Coefficient = 0.91, p<0.05, 
MCP-1: Pearson Coefficient = 0.89, p<0.05), suggesting increased joint 
forces result in elevations in pro-inflammatory cytokines. Additionally a high 
correlation was exhibited between both heel:ball (H:B) ratio and 
pronate:supernate (P:S) ratio with maximal dominant barefoot knee force 
(H:B; Pearson Coefficient = -0.89, p<0.01, P:S; Pearson Coefficient = -0.83, 
p<0.05) and with relative maximal inflammation post exercise (IL-1β: 
Pearson Coefficient = 0.96, p<0.001, IL-10: Pearson Coefficient = 0.90, 
p<0.005, MCP-1: Pearson Coefficient = 0.86, p<0.05), suggesting a 
increased heel strike gait, and increased pronation, both result in an 
increased joint force, and increased inflammation. 
 
These data suggests that whilst it is clear footwear has an effect on joint 
forces, further investigation is needed into footwear. Additionally, it was 
concluded that a heel-strike, pronated gait is optimal for maximal joint force 





Chondroitin And Glucosamine Supplementation Results In Increased 
Chondrocyte Viability Post Mechanical Trauma In Vitro. 
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Dietary supplements are increasingly being used for the symptomatic relief of 
osteoarthritis (OA). As supplements are not regulated as drugs, there is a lack of 
scientific support for their perceived benefits, and recent studies into their effects 
on articular cartilage have been conflicting. The use of supplements is becoming 
more widespread, thus it is in public interest to elucidate their mechanisms and 
effects. Subsequently this study investigates the effectiveness of two commonly 
used joint supplements (chondroitin sulphate; Ch and glucosamine sulphate; Gl) in 
chondro-protection post-mechanical trauma. 
 
Cartilage explants were dissected from the joints of 18-21 month old steers 
(obtained with ethical permission) into DMEM. Explants were incubated for 1h in 
either: isotonic (280mOsm), Ch (0.3mg/ml) or Gl supplemented (0.1mg/ml) DMEM 
and subsequently subjected to a single impact. Chondrocyte viability, volume and 
relative F-actin concentration were determined by confocal microscopy and data 
expressed as mean±s.e.m; (Student T-test: p<0.05), n=45 cells each from 5 
distinct experiments. Supernatants were analysed for IL-1β and MCP1 by ELISA 
at 0, 2, 4, 24 and 48h post mechanical impact. 
 
Explants in isotonic DMEM exhibited a decrease in cell viability from 79±0.05% to 
56.88±3.45% at 48h post impact (p<0.01). Conversely, when treated with Ch there 
was no decrease in chondrocyte viability from 99.08±3.65% to 98.71±4.51% at 
48h. Additionally, samples treated with Gl exhibited a minor decrease in viability 
from 96.66±3.69% to 82.84±4.51% at 48h, which was a significantly smaller 
decrease than the control samples (p<0.01). Ch and Gl treated samples both 
displayed a decrease in cell volume (p<0.01), from 760±61µm3 to 451±19µm3 and 
523±27µm3 respectively, 2h post mechanical trauma when compared to control 
conditions. Additionally pre-incubation with Ch and Gl resulted in a decrease 
(p<0.05) in relative F-actin (61.93±3.24AU and 35.06±1.30AU respectively) when 
compared to non-treated samples (77.32±4.72AU) pre-mechanical trauma. Post 
trauma, samples treated with Ch exhibited a further decrease in relative F-actin 
followed by a recovery to pre trauma levels (2h post trauma: 39.44±2.84AU; 48h: 
65.39±4.82AU). Conversely Gl treated samples exhibited no significant change 
post trauma (p>0.05) and control samples displayed a decrease with no recovery 
within the 48h post trauma (48h: 48.46±3.76AU). Pro-inflammatory cytokine 
production was significantly (p<0.05) decreased post trauma in samples treated 
with Ch (IL-1b: Isotonic 121.59±5.90pg/ml/g Ch 106.81±6.82pg/ml/g; MCP-1: 
Isotonic 1281.57±6.45pg/ml/g Ch 695.75±18.07pg/ml/g; all at 48h post trauma).  
 
These data suggest that despite inducing actin depolymerisation, Ch and Gl 
exhibit chondro-protective effects by reducing cell volume and decreasing the 




Cartilage And Macrophages: Evidence For A Paracrine Loop. 
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Osteoarthritis is the most common form of arthritis (Silman, 2008), affecting 
10-20% of the UK population over the age of 65 with ~8 million sufferers in 
the UK (Arthritis Research Campaign; 2008). It is associated with a loss of 
cartilage integrity due to changes in the regulation of matrix synthesis. 
Cartilage metabolism is sensitive to cytokines whereby IL-1β and other pro-
inflammatory cytokines up-regulate enzymes that breakdown cartilage thus 
influencing cartilage homeostasis. Cartilage explants have previously been 
shown to release inflammatory cytokines as a result of single impact 
trauma, additionally macrophages both release and are induced by 
changes in inflammatory cytokines. Thus it is of interest to investigate the 
cytokine feedback loop of macrophages and cartilage as a result of single 
impact trauma.  
Full depth cartilage explants were dissected from the joints of 18-21 month 
old steers (obtained from a local abattoir with permission). Explants were 
subjected to a single impact as previously described (Bush et al., 2005) and 
incubated in 280mOsm/kg H2O DMEM containing 1% 
penicillin/streptomycin at 37°C for 4hours. Primary macrophages were 
isolated from the synovial fluid and incubated for 4 hours with either the 
supernatant from the impacted explants or with impacted explants and 280 
DMEM. Additionally control non-impacted explants and non-treated 
macrophages were incubated for 4 hours in 280 DMEM. All supernatants 
were subsequently analysed for inflammatory cytokines by ELISA and 
expressed as mean±SEM with statistical analysis; (Student T-Test p<0.05). 
 It was found that upon impact of cartilage, there was an up-regulation 
(p<0.05) of both pro-inflammatory (IL-1β: 32.7±3.1 to 53.1±2.2 pg/ml/g, IL-
6: 2.5±0.2 to 110.8±2.9 pg/ml/g, IL-8: 35.4±1.8 to 100.7±4.6 pg/ml/g and 
MCP-1: 40.6±1.9 to 150.3±7.1 pg/ml/g) and anti-inflammatory cytokines (IL-
10: 340.4±17.0 to 450.1±29.2 pg/ml/g). Upon stimulation with supernatant 
from impacted cartilage explants, macrophages were induced to upregulate 
production of the pro-inflammatory cytokines IL-1β and MCP-1, from 
65.5±9.1 to 219.9±23.4 and from 90.2±11.3 to 366.7±27.8 pg/ml/g (p<0.05) 
respectively. In turn this appears to induce a further increase in IL-1β 
release by cartilage from 53.6±8.9 to 127.3±18.2 pg/ml/g (p<0.05). 
From these data it is suggested that cytokines released by articular 
cartilage upon single impact trauma induce an increase in MCP-1 and IL-1β 
production by macrophages, which in turn induces an additional increase in 
IL-1β release by articular cartilage, providing evidence for a paracrine 
cytokine loop between articular cartilage and macrophages.  
 
Bush, P., et al., Osteoarthritis and Cartilage, 2005. 13(1): p. 54-65. 




Diurnal Inflammatory Cytokine Changes Post-Exercise 
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Whilst mechanical impact is essential for cartilage regulation, excessive 
loading can lead to cartilage damage increasing the risk of Osteoarthritis 
(OA). Cartilage metabolism is sensitive to cytokines whereby IL-1β and 
other pro-inflammatory cytokines up-regulate enzyme, including matrix 
metalloproteases, that breakdown cartilage thus influencing cartilage 
homeostasis. Given that cartilage matrix composition is known to alter 
diurnally, specifically in terms of osmolarity this study investigated the 
effects of exercise on the diurnal expression of pro and anti-inflammatory 
cytokines. 
 
Venous blood samples were taken at 0h, 2h and 4h post 30min treadmill 
run at 60% VO2max from 14 healthy male subjects aged 20-39 years. 
Subjects underwent anthropometric testing to standardise factors 
previously shown to effect joint force magnitude, including thigh 
circumference, body mass and percentage body fat (Browning and Kram, 
2007). Exercise was undertaken at 8am (AM) and 6pm (PM) in a cross-over 
study. A control sample pre-exercise was also taken and inflammatory 
cytokine concentration (IL-1β, IL-8 & IL-10) determined by Duoset ELISA 
(R&D Systems) and expressed as mean±SEM. Data was compared using a 
Student T-Test and deemed significant at p<0.05. 
 
Results showed subjects had a body mass of 69.88±3.34kg, a body fat of 
11.6±1.2% and a thigh circumference of 50.69±2.24cm. A peak pro-
inflammatory response was observed immediately post exercise, and a 
peak anti-inflammatory response at 2h post exercise for both AM and PM 
trials. Pro-inflammatory cytokine (IL-1β and IL-8) concentration were seen 
to increase significantly (p<0.01) more after AM exercise than PM (IL-1β: 
20.67±2.58% and 9.60±2.35% respectively; IL-8: 25.69±0.53% and 
9.01±2.94% respectively), when compared to pre-exercise controls. 
Conversely, no significant differences were seen in the magnitude of the 
maximal anti-inflammatory (IL-10) response between AM and PM 
challenges: 8.97±2.40% and 10.08±2.30% respectively.  
 
These data suggest PM exercise to be more beneficial in terms of reducing 
exposure to potential risk factors for OA when compared to AM exercise of 
the same intensity; whereby the reduction in the maximal pro-inflammatory 
response seen post PM exercise decreases the potential of damaging 
effects on cartilage metabolism.  
 
Browning RC and Kram R, Medicine and Science in Sports and 




Tamoxifen: Chondroprotective Effects Post-Mechanical Trauma. 
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Mechanical trauma through repetitive, high-impact sport contributes to the 
onset of osteoarthritis. Mechanical trauma disrupts cell cytoskeletal 
organization (Blain, 2009), which is important in maintaining cell integrity. 
Since tamoxifen has been shown to have anti-calmodulin effects (Hall et al., 
1999), acting upstream of actin regulatory proteins, this study was designed 
to investigate whether this compound exerts a chondro-protective effect 
following mechanical trauma. 
 
Cartilage explants were dissected from the joints of 18-21 month old steers 
(obtained with permission from a local abattoir) into DMEM. Explants were 
incubated for 1h in either: isotonic (280mOsm), hypertonic (380 mOsm) or 
tamoxifen (10µM) supplemented DMEM and subsequently subjected to a 
single impact as previously described (Bush et al., 2005). Chondrocyte 
viability, volume and relative F-actin concentration were determined by 
confocal microscopy and data expressed as mean ± s.e.m; (Student T-test: 
p<0.05), n=45 cells each from 3 distinct experiments.  
 
Explants in isotonic DMEM exhibited a decrease in cell viability from 
85±0.05% to 45±2.52% at 48h post impact; p<0.05. Conversely, when 
incubated with hypertonic DMEM or 10µM tamoxifen there was no 
significant decrease in chondrocyte viability from 90±3.65% and 95±4.51% 
to 90±2.63% and 88±3.34% respectively at 48h. Tamoxifen incubated 
samples displayed a decrease in cell volume (p<0.01) from 716±23µm3 to 
424±16µm3 at time 0, when compared to control conditions. However 
explants incubated in isotonic and hypertonic DMEM all exhibited an 
impact-induced decrease in cell volume 48hrs post impact, from 
716±23µm3 and 578±31µm3 to 516±15µm3 and 302±12µm3 (p<0.05) 
respectively, whereas tamoxifen incubated explants displayed no significant 
decrease in cell volume post–impact, from 424±16µm3 to 432±5µm3. 
Additionally pre-incubation with tamoxifen resulted in an decrease (p<0.05) 
in F-actin:volume  (0.75±0.04AU) when relative to non-treated samples 
prior to mechanical trauma, conversely hypertonic pre-incubation displayed 
an increase (p<0.05) in F-actin:volume (1.21±0.06AU). Interestingly, 
explants pre-treated with isotonic and hypertonic DMEM all exhibited an 
impact-induced decrease (p<0.01) in F-actin:volume to 0.58±0.03AU and 
0.73±0.04AU respectively at 48hrs post impact, relative to non-treated 
samples prior to mechanical trauma. Conversely tamoxifen treated explants 
showed no significant change in F-actin:volume at 48hrs (0.73±0.04AU).  
 
These data suggest that tamoxifen exhibits a chondro-protective effect in 
an in vitro model of mechanical trauma by inhibiting impact-induced cell 





REV5901 Induces Calcium Dependant Chondroprotective Effects Post In Vitro Mechanical Loading 
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     Mechanical load is essential for cartilage metabolism, providing the 
necessary signalling for the production of a matrix of sufficient 
durability to withstand the stress level. However, it has been noted that 
abnormal loading can lead to cartilage degradation, increasing the risk 
for the development of osteoarthritis (OA). Abnormal joint loading can 
lead to an imbalance in cartilage metabolism and activation of IL-1! 
pathways, promoting synthesis of catabolic proteases and inhibiting 
ECM synthesis. Mechanical loading has also been observed to result in 
tissue swelling, indicative of damage to the collagen network, and 
chondrocyte death by apoptosis and necrosis. However, it was recently 
observed that cell shrinkage, induced by hyperosmotic challenge, 
protects against mechanical loading induced chondrocyte death, 
indicating a role for chondrocyte volume in chondroprotection.  
     Whilst cartilage is an aneuronal and avascular tissue, chondrocytes 
are still able to both sense and respond to external stimuli via 
mechanotransduction. Mechanical loading has been shown to activate 
mechanotransduction responses by inducing fluid flow, osmotic 
changes, changes in pressure and alterations to the cell membrane. 
Volume regulatory mechanisms and Ca2+ signalling pathways have 
been noted as key components of chondrocyte mechanotransduction 
whereby Ca2+ assumes the role of an intracellular secondary messenger. 
It has been observed that mechanical stimuli induces a transient rise in 
[Ca2+]i, a similar response to that seen during cell volume 
changes/regulation as a consequence of osmotic challenges.  
     REV5901 is a 5-lipoxygenase inhibitor, previously demonstrated to 
be an inhibitor of regulatory volume decrease (RVD) in articular 
chondrocytes. REV5901 has been observed to have chondroprotective 
effects post mechanical loading, inducing increased cell viability, 
decreased cell volume and decreased inflammatory cytokine release. 
REV5901 has also been shown to induce a sustained rise in [Ca2+]i, 
suggesting a possible role for Ca2+ signalling in chondroprotective 
mechanisms post mechanical loading.  
     This study aims to investigate the role of [Ca2+]i signalling in 
REV5901 chondroprotective mechanisms post mechanical loading using 
the [Ca2+]i signalling pathway inhibitors Rottlerin and U73122, and by 
removal of extracellular Ca2+. 
 
Figure 1: Representative diagram of currently known intracellular 
calcium signalling pathways (Adapted from Qusous et al, In Press). 
 
Methods 
     Cartilage explants were dissected from the metacarpal and metatarsal 
pharyngeal joints of 18-21 month old bovine steers (obtained from a 
local abattoir) into 280mOsm/kg H2O DMEM. Explants were incubated 
for 1h in the presence of 50"M REV5901, supplemented with either 
100"M Rottlerin, 100"M U73122 or EGTA. Isotonic (280mOsm), 
DMSO (1"l/ml) and 50"M REV5901 conditions were used as 
controls. Post incubation explants were subjected to a single impact as 
previously described (Bush et al., 2005).  
     Chondrocytes were visualised by incubation with 5"M Calcein AM 
and 1"M Propidium Iodide and imaged by confocal laser scanning 
microscopy. Images were imported into Imaris 7.1 (Bitplane, 
Netherlands) and subsequently analysed for viability and volume. 
Supernatant from the explants was analysed for inflammatory cytokines 
by ELISA at 0h, 2h, 24h and 48h post mechanical impact. 
     All data expressed as mean ± s.e.m; (Student T-test: *p<0.05), n=45 
cells or 6 explants each from 5 distinct experiments. 
 
Results 
     Pre-treatment with REV5901 induced a chondroprotective effect post 
mechanical loading, resulting in no significant decrease in cell viability 
during the 48h following loading, from 93#2.63% at 0h to 86#3.34% 
at 48h (p<0.05). Conversely, both control samples (Isotonic and DMSO 
conditions) exhibited a decrease in cell viability from 79#0.05% & 
83#1.63% at 0h to 45#2.52% & 50#3.45% at 48h; p<0.05 and 
p<0.05 respectively. Inhibition of [Ca2+]i signalling with Rottlerin, 
U73122 and EGTA was observed to block the chondroprotective effects 
of REV5901, exhibiting a significant decrease in cell viability post 
mechanical loading from 81#2.12%, 72#2.09%  & 88#1.68% at 0h 
to 59#1.54%, 49#1.98% & 57#2.49% at 48h; p<0.05, p<0.05 and 
p<0.05 respectively. 
     Cytokine changes relative to non-loaded controls were significantly 
increased post mechanical loading in control samples (IL-1!: 
1.70#0.18 AU; IL-10: 1.18±0.09 AU), but conversely decreased in 
samples pre-treated with REV5901 (IL-1!: 0.74#0.21 AU; IL-10: 
0.90±0.11 AU). Additional treatment with Rottlerin, U73122 and EGTA 
also exhibited a decrease in relative cytokine concentration that was not 
significantly different to REV5901 (IL-1!: 0.75#0.05 AU, 0.72#0.10 
AU & 0.70#0.11 AU; IL-10: 0.64±0.12 AU, 0.89#0.08 AU & 
0.65#0.09 AU respectively; all at 2h post trauma). 
     Post mechanical loading, control samples exhibited a decrease in cell 
volume from 716#38"m3 to 516#39"m3. Samples pre-treated with 
REV5901 exhibited an initial significant decrease in cell volume when 
compared to control (716#38"m3 to 552#27"m3; p<0.01), but a 
similar mechanical loading induced decrease (552#27"m3 to 
300#35"m3). Samples additionally treated Rottlerin, U73122 and 
EGTA do not show a significant initial decrease in cell volume when 
compared to control (716#38"m3 to 670#27"m3, 680#21"m3 & 
678#34"m3 respectively), but conversely to control samples do not 
display a significant load induced decrease in cell volume 
(670#27"m3 to 656#35"m3, 680#21"m3 to 633#31"m3 & 
678#34"m3 to 635#29"m3 respectively). 
 
Discussion 
     Intracellular calcium is a key regulator of intracellular functions and 
changes in [Ca2+]i  levels have been observed in response to various 
other mechanical stimuli. REV5901 was shown to induce an elevation in 
[Ca2+]i,  thereby suggesting a potential mechanism by which REV5901 
exhibits chondroprotective activity.  
     Inhibition of [Ca2+]i signalling by Rottlerin, U73122 and EGTA was 
observed to reduce the chondrotection of REV5901, displaying no 
maintained cell viability post mechanical loading. However, Rottlerin, 
U73122 and EGTA did not inhibit the anti-inflammatory effects of 
REV5901, suggesting this action of REV5901 is not Ca2+ dependant. 
Conversely Rottlerlin, U73122 and EGTA all prevented cell shrinkage 
induced by REV5901 and additionally inhibited mechanical load 
induced cell volume decrease, indicating that REV5901 induced and 
mechanically induced cell volume changes are Ca2+ dependant. 
     From these data it can be concluded that REV5901 induces Ca2+ 
dependant shrinkage of chondrocytes, and Ca2+ independant reduction 
of inflammatory cytokines, thus resulting in chondroprotection post 
mechanical loading.  
